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Abstract
Introduction: At the core of UK policy for improving outcomes in cancer are goals for a
healthcare where patients are empowered through information enabling engagement in shared
decision making are lacking within colorectal cancer and high grade glioma care despite
intensive treatment regimens with uncertain outcomes. Navigation, a communication and
decision support intervention, has been successfully piloted with prostate and breast cancer
patients who demonstrated significantly more confidence and less uncertainty in their
treatment decisions. With healthcare policy advocating patients be educated and engaged in
their care, the applicability of this intervention to other cancer settings is required. The
Navigation intervention includes: consultation planning with a Navigator, formulation of a
consultation plan and recording (summary and CD) of the medical consultation.
Objectives: To determine the effectiveness of the Navigation intervention in enhancing
decision-making quality over time when compared with usual care, in patients with colorectal
cancer. To explore repeated experiences of the Navigation intervention from the perspective
of colorectal cancer (CRC) patients, patients with high grade glioma (HGG), and consulting
clinicians.
Design and Studies: A mixed methods study using a pragmatic randomised controlled trial
and qualitative evaluation was undertaken during November 2010 December 2013. The
intervention was trialled separately with two cohorts of cancer patients (CRC and HGG). A
longitudinal parallel-group pragmatic randomised controlled trial was conducted. Study 1
consisted of a longitudinal parallel-group pragmatic randomised control trial. Participants
with colorectal cancer were openly randomised after completion of baseline measures to
receive the intervention or usual care (no intervention). The intervention was administered to




         
            
             
            
           
            
   
            
            
              
             
            
              
           
            
            
           
             
            
           
           
             
              
             
completed tools collecting primary outcome (decision self-efficacy) and secondary outcomes 
(decision conflict, decision regret, anxiety and depression) measured prior to baseline, post
consultation and at follow-up. Mean change in scores overtime and between groups were
compared using Mixed ANOVAS. Study two was a prospective qualitative study undertaking
serial in-depth semi-structured evaluation interviews with patients with High Grade Glioma.
Study three undertook interviews with the consulting HGG and CRC clinicians. Framework
analysis was undertaken.
Setting: Two oncology settings within a tertiary cancer centre in Scotland.
Participants: 132 patients with colorectal cancer (65 intervention, 67 control) participated in
the randomised controlled trial. For the qualitative study, 17 colorectal trial participants (8
intervention, 9 control), 11 high grade glioma patients and 7 clinicians were interviewed.
Evaluation Results: No significant difference was found between the control and Navigation
intervention participants over time in the primary outcome of decision self-efficacy, or in the
following secondary outcomes; decision conflict or anxiety and depression scores. At follow-
up, the intervention group reported significantly less decision regret than the controls
(p=0.039). In the qualitative data, Navigated participants reported being well prepared for
medical consultations, able to actively engage in information exchange during consultation
and enabled to recall and understand information provided. This was in contrast to
participants receiving usual care who described being less prepared for medical consultations
and experienced barriers to gathering information, such as time pressures, forgetting
questions, and gaps in understanding. Clinicians identified that patients benefitted from
preparing for, and having a written summary of, the consultation. Whereas neuro-oncology
clinicians were supportive of Navigation as a tool to tailor information to patients; colorectal




             
       
            
            
             
              
            




















expressed regarding the extra resource required by Navigated patients and therefore about the
feasibility and sustainability of the intervention.
Conclusions: Whilst models of shared decision making remain highly profiled in cancer
strategies, information exchange and use of interventions in context is problematic. This
evaluation of Navigation has demonstrated more impact on the process of decision making,
rather than outcome per se, and has raised questions about its sustainability in clinical
practice. A more nuanced understanding of different cancer pathways and the specific
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Chapter 1: Introduction 
1.1. Overview
Chapter 1 sets out the context and rationale for this research study. By situating the need for
decision support in specific cancer populations, justification for the study and for the study
aims and objectives is presented. The chapter closes with a description of structure of this
thesis.
1.2. Study Context and Rationale
Cancer places a considerable burden on societies and individuals worldwide. In 2012, there
were 14.1 million new cancer cases reported worldwide, 8.2 million cancer deaths and 32.6
million people known to be living with cancer within 5 years of diagnosis (Torre et al., 2015).
In reviewing United Kingdom (UK) statistics for the same time period 157,849 cancer
patients died and 327,812 people were diagnosed with cancer (Torre et al., 2015) indicating
that 0.76% of the UK population (based on World Bank data, 2014) had, or died from cancer
during this time. Whilst it could be argued that cancer therefore holds a small disease profile
in the UK, it is predicted that the rates of cancer are set to rise over the coming decade
(Ferley et al., 2015).
Cancer is a proliferative disease. Currently more than 200 different forms of cancer exist,
although in the UK, four types of cancer, namely breast, lung, prostate and colorectal,
account for over half (53%) of all new cases (Siegel, Naishadham, & Jemal, 2013). While
malignant tumours can occur at any age, cancer is predominately a disease of older people
with more than half of all new cancer cases in the UK diagnosed in people aged 65 and over




                 
      
 
               
           
               
              
               
                 
                
             
                  
            
             
                 
 
             
             
             
              
                
                
                
          
                 
(Jemal, Siegel, Xu & Ward, 2010), this is a further and important factor that contributes to the
on-going global burden of this disease.
Though cancer retains its reputation as a feared disease, cancer survivorship is an area of
increasing clinical and empirical interest. Improvements in treatment, early diagnosis and
public awareness have meant that cancer mortality rates in the UK have decreased by more
than a fifth (23%) since the mid-1980s (Cancer Research UK, 2014). With increasing
numbers of people living with, and surviving cancer (Maddams et al., 2009), the fiscal and
resource impact of this disease is well recognised. The annual cost of cancer services to the
National Health Service is estimated at £5 billion with the cost to society as a whole,
including loss of productivity, estimated at £18.3 billion (Department of Health (DH), 2011).
Indeed, these costs can only be set to rise as the incidence of cancer increases, as people live
longer with cancer, and as new treatments become available (Featherstone & Whitham,
2010). Perhaps most concerning given such investment, is the knowledge that patient cancer
outcomes in England are poor when compared with outcomes in parts of Europe (DH, 2011).
Whilst much cancer research is focussed on medical treatment and management, there has
been increasing empirical, health policy and consumer interest in how having a cancer
diagnosis, undergoing cancer treatment, and indeed living with (and for some, dying from
cancer) impacts on the individual. This has been informed by the concept of patient-centred
care and shared decision making (SDM) that is now well embedded in health care policy and
commentary (DH, 2010a; Coulter & Collins, 2011). The last decade has seen a shift in health
policy now seeking to place patients at the heart of health care through the mechanisms of
shared decision making, information provision, patient feedback and public accountability




              
             
                
               
             
             
         
 
              
             
              
           
               
            
            
                
 
             
                
               
             
            
            
                
               
core of UK policy for improving cancer outcomes; here the same principles are visible
whereby it is envisioned that patients are empowered through having information that enables
full engagement in their care decisions together with the clinicians (DH, 2011). This in turn,
has led to improved engagement and more active working with patients and service users as
evidenced by the BIG Cancer Conversation work in Scotland (Healthcare Policy & Strategy
Directorate Living with Cancer Group, 2009) that outlines how cancer patients can become
genuine partners in decision making about their care.
Despite worldwide recognition of the importance of patients being partners in care and for
patients to have access to high quality information to guide treatment decisions (British
Medical Journal, 2011), patient decision making in cancer is complex. There is potential for
many emotional, psychological, physical and practical challenges during the cancer treatment
and disease trajectory, in addition to a range of decisions to be made including those
concerning cancer treatment, symptom control and even supportive care. There may be
situations leading to uncertain outcomes, and the consequences of successful treatment may
need weighing against the risk of severe side effects (Shaha, Cox, Talman & Kelly, 2008).
It is therefore unsurprising that against this complex decision making backdrop the patient
voice is heterogeneous, with a range of opinions on the role of patients in decision making
about their own health care. Whilst some studies indicate most cancer patients want
engagement and access to all information (Jenkins, Fallowfield, & Saul, 2001) with full
involvement in decision making (Coulter & Jenkinson, 2005), other research offers a
different view reporting that preference for participating in decision making varies greatly
amongst individuals and over time (De Heas, 2006; Leydon et al., 2000). This may be




               
            
               
              
        
 
              
             
               
             
               
           
             
             
              
              
          
           
            
             
 
              
  
potentially preserving hope for survival (Leydon et al., 2000) or as a mechanism to reduce
potential regret about decisions made (Schwartz, 2004). However, what emerges from the
literature is that whatever position is held, many people with cancer do not achieve their
desired level of involvement in decision making and look back on their treatment decision
process with regret (Brehaut et al., 2003).
Shared decision making (SDM) is one approach that seeks to mitigate such patient concerns.
SDM encompasses an active exchange of information and dialogue between the clinician and
the patient to work towards a goal of a mutually agreed treatment decision. Engagement in
the SDM process can help to improve patient understanding, satisfaction and confidence in
the decisions made (Edwards & Elwyn, 2006). However, despite its emphasis in national and
clinical practice (Karnieli-Miller & Eisikovits, 2009; Lipstein Dodds & Britto, 2014).
Consequently, a number of interventions to facilitate SDM have been developed and broadly
include such approaches as: decision aids, question prompt sheets; coaching; and provision of
a recording and/or summary of the consultation (Stacey et al., 2014). A recent Cochrane
review explored the effectiveness of these techniques with particular focus on the outcomes
of increasing question-asking in consultations, increasing patient recall of information
discussed, and increasing patient satisfaction and patient confidence in treatment decisions
(Stacey et al., 2011). Whilst this review demonstrates that SDM interventions improved
knowledge, involvement and perception of outcomes, there is concern that SDM is only
significant





                 
             
           
         
           
          
            
             
               
         
          
            
         
              
               
               
              
               
                 
           
  
 
               
                 
            
To take on this active role in health care, patients require a sense of control over events
relating to their health and healthcare (Bandura, 1994). Three of the SDM intervention
approaches described above, namely, question listing, audio recording and summarising are
evidence based practices which underpin a particular patient-centred communication
intervention, referred to as Navigation. With an aim of facilitating patient-doctor
communication and patient decision making, Navigation has been well-utilised and
successfully evaluated in breast cancer consultations in the United States of America
(Belkora 2008; Belkora 2008b; Belkora et al. 2009) and prostate cancer consultations in
Scotland (Hacking et al., 2013). Use of the Navigation tool in these studies has significantly
reduced patient-reported communication barriers in the medical consultation (Sepucha,
Belkora, Mutchnick, & Esserman, 2002) and significantly increased patient reported
confidence in decision making (Hacking et al., 2013). Prior experiences with CPRS
(Consultation Planning, Recording and Summarising) established its feasibility and
effectiveness across a broad range of clinical conditions. The present work seeks to extend
this body of evidence within oncology. To date, Navigation has only been evaluated at one
time point in the cancer journey, and with only a limited number of cancer populations.
Longitudinal studies are lacking and this is a significant omission given that treating cancer
can be a lengthy process with multiple treatment decisions to be made throughout the disease
course. This thesis seeks to address this gap by evaluating the use of the navigation tool in
two cancer populations with different disease trajectories and different patient information
needs.
The first population is patients with colorectal cancer, the fourth most common cancer in the
UK accounting for 13% of all new cancer cases (Cancer research UK, 2010). It is a cancer




              
              
             
              
              
              
             
              
        
 
     
                
           
           
          
         
           
           
           
            
 
           
         
           
      
diagnosis. The second population is patients with a High Grade Glioma (HGG). This, in
contrast is a rare cancer with no current treatments for improving life expectancy (Cancer
Research UK, 2009). Receiving a diagnosis of HGG is therefore devastating and distressing
for patients and their families (Janda, Eakin, Bailey, Walker & Troy, 2006; Keime-Guibert, et
al., 2007). As treatment is limited, non-clinical aspects of care such as communication and
support practices are an important component of health care for these patients and their
families (Catt, Chalmers & Fallowfield, 2008) and yet, information for HGG patients and
families is more limited (Adelbratt & Strang, 2000). Furthermore, there is little SDM research
undertaken with the population (Davies & Higginson, 2003).
1.3. Aim and Objectives
The aim of this study is to evaluate the effectiveness of the Navigation intervention in two
different cancer populations: patients diagnosed with colorectal cancer and patient diagnosed
with high grade glioma. The aims of the thesis are to:
determine the effectiveness of the Navigation intervention in enhancing decision-
making quality (increasing self-efficacy, reducing decision conflict and decision
regret) in patients with colorectal cancer over time from baseline (pre-initial
consultation) through to and including follow-up when compared with usual care.
explore experiences of the Navigation intervention from the perspective of
patients with high grade glioma and with colorectal patients, contrasting this with
explore experiences of the Navigation intervention from the perspective of
colorectal cancer consultants and high grade glioma clinicians.
make recommendations about the applicability of Navigation within cancer care




       
               
       
 
               
             
              
             
         
 
            
            
            
           
              
 
 
           
               
             
              
             
          
 
1.4. The structure of the thesis
This chapter has set out the rationale, justification and aims of this thesis. The chapter
structure of this thesis is outlined below.
Chapter 2 provides a background to the two oncology populations (CRC and HGG) studied in
this thesis. It contextualises the challenges inherent in receiving the specific cancer diagnosis,
the possible treatments and care pathways. It further reports what is empirically known about
the information needs and decision making preferences of these patient groups, and provides
a justification for the need for decision support.
Chapter 3 provides in-depth discussion of the theoretical, conceptual and empirical evidence
base of shared decision making in health, specifically in medical consultations. Shared
decision making models, related health policy context, barriers to decision making and
decision support technologies are examined. Drawing on the importance of patient
involvement in care, the chapter provides a narrative review of the literature about cancer
Chapter 4 introduces the over-arching study design and provides methodological discussion
and critique of the mixed methods used to evaluate the Navigation intervention in the two
cancer populations: the colorectal and high grade glioma cohorts. The two cancer populations
are described in-depth and the Navigation intervention is detailed. The two studies used to
evaluate impact of the intervention, the randomised controlled trial and qualitative study will




               
            
            
            
      
 
             
            
             
           
                
             
             
          
             
 
 
               
               
              
   
 
               
            
      
Chapters 5 and 6 describe the design and results of the randomised controlled trial conducted
to evaluate Navigation within the colorectal population. Chapter 5 details the research
methods: the setting, recruitment, data collection and analysis. Chapter 6 presents results
from the randomised controlled trial, including results from the intervention and control
groups across multiple time points.
The following three chapters present the methods and findings of the qualitative components
of the evaluation: qualitative interviews with colorectal trial participants, high grade glioma
participants, their carers, and their health care professionals. Chapter 7 explores the
methodological and ethical challenges of conducting interviews to evaluate the intervention
with a sample of colorectal trial participants and a cohort of patients with high grade glioma.
Chapter 8 reports the analysis of the qualitative interviews conducted with participants and
their carers and Chapter 9 presents analysis of the healthcare professional interviews. These
chapters therefore present and contrast results across those participants experiencing
Navigation and those receiving standard care, and across patient and health care professional
groups.
Chapter 10 draws together all results from the studies and critically discusses how these add
to and challenge the current evidence base on shared decision making in medical and health
care consultations. The strengths and weaknesses of the study designs and methods used are
also discussed.
Chapter 11 draws the thesis to a close with final commentary on the results making
suggestions for further research, and presents recommendations to improve patient care and




         
     
 
    
              
              
             
          
              
             
               
         
 
           
              
          
              
                 
                
             
  
           
Chapter 2: Colorectal and high grade glioma cancer populations: care
pathways, information and decision-making needs.
2.1. Overview
This chapter begins by setting out the context and rationale for this research, through
description of the cancer population, and in particular the cancer populations that are the
focus of this thesis: people with colorectal cancer and high grade glioma. Following
information about disease incidence, staging and prognosis, and treatment, research
concerning support and coping with these conditions is given. Finally, the specific issues of
decision making and information needs for each of these populations is explored. This
chapter concludes by drawing on the generic cancer literature to situate the CRC and HGG
population specific literature in the wider cancer context.
The literature review undertaken to inform the population-specific literature was exploratory
in nature. Although a structured approach was undertaken, it did not adhere to conventional
systematic review methodology. Relevant literature was identified by searching Pubmed,
PsycINFO, Cochrane library and Web of Knowledge for publications from 2000 to 2013, and
revisited in 2015. In addition the work of key authors in the area and reference chaining were
used. In order to ensure all relevant studies were identified, broad search terms were used and
-
Specific search terms for colorectal and high grade glioma cancer were used including:




                
               
 
          
              
               
               
              
                 
                  
                 
                 
           
  
 
                 
              
                
              
                
             
               
                
      
 
The literature is presented here using a structure that follows the pathway of a person being
diagnosed with, and navigating the treatment decisions to be made when living with cancer.
2.2. Colorectal Cancer (CRC): disease incidence, staging and prognosis
In Europe, colorectal cancer (CRC) was the second most common cancer (447,000, 13%) and
the second highest cause of death from cancer during 2012 (215,000, 12.2%) (Ferlay et al.,
2015). The incidence rates of CRC are slightly higher in men (13.2%) than women (12.7%)
when calculated as a distribution of expected deaths for the five most common cancers
(Ferlay et al., 2015). A diagnosis of CRC is strongly associated with age; 80% of CRC occurs
in those aged 60 and over, and the median age of diagnosis is 70 (Babb, Brock, Kirby &
Jones, 2001). Scotland, the setting for this study, has one of the highest incidences of CRC in
the world (43.6 per 100,000 in men, 28.4 per 100,000 in women), with CRC identified as the
second most common cause of cancer death (Scottish Intercollegiate Guidelines, SIGN,
2015).
The grading of severity of CRC is based on the TNM staging system (Weitz et al., 2005).
This staging system describes the size of the primary tumour (T), any lymph nodes
involvement (N), and whether the cancer has spread to other parts of the body, known as
metastasis (M). Colorectal cancers are then grouped into stages 1-4; the higher the diagnostic
stage, the greater the chance the cancer will be more aggressive. In daily practice and clinical
guidelines, the TNM category guides treatment strategies and so the staging system has
considerable and direct impact on the treatment a patient receives (Galon et al., 2014). The
higher the diagnostic stage of CRC the higher the chance of morbidity within five years of




              
                  
              
                
               
        
 
            
               
            
             
            
           
 
   
                
               
                   
            
             
               
               
           
 
 
Treatment is highly effective for early stage CRCs, demonstrating five year survival rates of
over 90% for stage I and 72% for stage II disease, reducing to below 60% from stage III
onward, with the presence of lymph node involvement and metastasis (Siegel et al., 2013).
Metastases are present in 20% of individuals at the time of initial diagnosis and in patients
with initially localised CRC, and will develop in approximately 30% of this group within five
years (Markowitz, Dawson, Willis & Willson, 2002).
It has been argued that the current TNM classification provides limited prognostic
information and does not predict response to therapy (Galon et al., 2014). This argument is
based on the premise that clinical outcomes vary significantly among patients classified
within the same stage, for example, some patients with advanced-stage cancer can remain
stable for years (Mlecnik et al., 2014). Consequently, treatment decisions and predicting
prognosis can be difficult for doctors and provide uncertainty for patients.
2.2.1. CRC Treatment
Surgery to remove the tumour and any involved tissue is first line treatment for 80% of
patients with CRC: this is accompanied by the possibility of a temporary or permanent stoma
(SIGN, 2015). For all Stage I and the majority of Stage II patients, surgery is the only form of
treatment. No further oncology intervention is required (SIGN, 2015). Whilst this surgery
may be common place, recovering from surgery involves adapting to many different physical
symptoms and this can be challenging for patients. In a qualitative exploration of follow up
care after surgery in the United Kingdom (UK), Beaver et al., (2010) interviewed 27 patients




                
             
               
                
                 
              
           
               
            
           
                  
             
  
 
             
               
                
                 
               
             
             
                
               
              
Treatment for patients with Stage I and II CRC is complete following surgery. All Stage III
and IV CRC patients are considered for adjuvant chemotherapy as evidence suggests for
patients under 75 years of age, this form of treatment improves survival (SIGN, 2015). With
surgery and chemotherapy there is a five year survival rate of 77.6% for Stage III CRC
patients (Haller et al., 2011) and, for metastatic patients, a 55% survival rate with a median
survival rate of 19.5 months (Cassidy et al., 2008). The evidence for providing adjuvant
chemotherapy for Stage II patients is inconclusive (SIGN, 2015). Consequently, decisions
about the use of chemotherapy for this stage of CRC are based upon consideration of
competing risks i.e. risk of treatment-related morbidity versus risk of recurrence and
mortality associated with increasing age and comorbidities (SIGN, 2015). Patient preference
is often, therefore, a key part of such a treatment decision. The impact of this disease and the
potential severity of side effects, indicates that decision support may be beneficial for
patients.
Chemotherapy regimes for CRC usually involve a combination of the drugs Oxaliplatin and
Capecitabine, administered over a three week cycle for eight cycles over six months. A cycle
consists of a two hour infusion of Oxaliplatin on day one, plus one oral Capecitabine tablet
twice daily for 14 days, followed by a seven day rest period (Haller et al., 2011). Recent
research show a high risk of hospital admission for CRC patients with this form of
chemotherapy (Brindle et al., 2012), mainly from gastrointestinal disturbances as a result of
which 40% of patients do not receive further chemotherapy. The decision to discontinue
chemotherapy before completion is a decision based on the severity of side effects due to the
toxicity, in the context of the tumour stage (Brindle et al., 2012). If peripheral neuropathy




            
            
 
        
              
              
          
 
              
            
            
             
            
              
              
              
            
         
             
             
                
            
             
        
completion of adjuvant chemotherapy, patient and tumour response is assessed for patients
with residual disease, second line chemotherapy is considered (Haller et al., 2011).
2.2.2. Support needs of people with CRC
As with any cancer diagnosis those diagnosed with CRC face many physical, emotional and
existential challenges and concerns. These result from the treatment, concern for whether the
therefore important to understand the concerns of patients with CRC.
People with CRC tend to demonstrate a similar pattern to their emotional response during
their cancer journey. Studies have demonstrated that men and women generally react
similarly in response to receiving the diagnosis of CRC (McGaughan, Prue, Paradoo,
McIlfatrick & Mckenna, 2010). In this qualitative study, all patients reported shock upon
diagnosis, although men suggested they were not emotionally impacted by their diagnosis.
Following surgery, all participants reported altered bowel habits and felt socially limited if a
stoma bag was required (McGaughan et al., 2010). The theme of embarrassment is prevalent
in many studies with people with CRC, as CRC symptoms and treatment necessitates detailed
discussion about bowel habits and bodily functions. Participants (n=8) in Taylor's (2001)
hermeneutical phenomenology study described feelings of isolation and social
embarrassment when living with a diagnosis of CRC. Many described feeling unable to
communicate concerns for fear of upsetting others, and were aware that the diagnosis
impacted on the whole family. Taylor (2001) suggests these findings may be a feature of the
existing taboo around discussing bowels, claiming bowels are not discussed in polite
company, being associated with dirt and smell. This social isolation further compounds how




           
              
              
             
            
            
           
              
        
 
              
              
             
 
            
               
               
              
               
            
              
             
               
Chemotherapy treatment for CRC can be anxiety provoking for patients, specifically
regarding its efficacy, the side effects and the possibility of needing to discontinue treatment
(Beusterien, Tsay, Gholizadeh, & Su, 2013). Beusterien, et al. (2013) used content analysis to
examine1522 posts from 264 individuals on the most active colorectal cancer web forums
that focussed on the experience of chemotherapy. The four most frequently reported
chemotherapy side effects cited by patients on web forums included gastrointestinal issues
(diarrhoea, nausea, vomiting), skin problems (rash, itch, dryness), neuropathy, and mouth
problems (Beusterien, et al., 2013). However, these comments were made by a sample with
advanced stage CRC (Beusterien, et al., 2013).
In addition to the most frequently reported side effects, the authors explored the emotional
impact of chemotherapy for CRC. Hope was reported as the most frequently stated emotion,
followed by anxiety related to treatment efficacy. Hope was represented through gratitude for
f
chemotherapy and, considering the often severe side effects chemotherapy can induce, is
indicative of existential fear of death. This finding is supported by a systematic review of
CRC patient preferences (Currie et al., 2015). Currie et al. (2015) found CRC patients judged
a moderate survival benefit to be sufficient to make chemotherapy worthwhile, in spite of
significant treatment side effects. The gain of a small potential increase in life expectancy and
survival overcame concerns about side effect experience. In contrast patients were prepared
to trade reduction in life expectancy over complications from surgery (Currie et al., 2015).
These reports suggest people are more hopeful about chemotherapy treatment than they are




               
           
 
               
             
             
            
               
             
             
           
            
              
    
 
                
                 
              
          
               
            
          
             
                 
               
explored in either study, the findings emphasise the need to provide patients with clear and
accurate information in order that decisions about treatment are contextualised.
Perceptions about quality of life during and following treatment is a further area of concern
for people with CRC. Analysis of 20 interviews with CRC patients, showed that health-
related quality of life (HrQoL) is dependent upon 3 key themes: physical experiences,
emotional experiences and patient expectations (Wilson, Birks & Alexander, 2010). Key to
shaping these three areas was the information given to patients and how this was assimilated
by patients. Information was seen as reassuring by allaying uncertainties; however too much
information was perceived to provoke anxiety (Wilson et al., 2010). When participants did
not receive enough information they reported feeling unprepared for treatment or
retrospectively regretful of treatment decisions (Wilson et al., 2010). Unfortunately, it is
unclear at what time point following surgery the interviews took place which limits the
impact of these findings.
Emotional distress is seen as an inherent part of a cancer diagnosis. In a cross sectional
survey of 128 CRC patients, 19% of the sample were found to be highly anxious [using the
Hospital Anxiety and Depression scale] and 14% were highly depressed [using the Centre for
Epidemiological Studies Depression scale] (Simon, Thompson, Flashman & Wardle 2009).
This survey found those with advanced disease stage (3c and 4) reported poorer quality of
life, more anxiety and depression, and were less satisfied with medical interactions.
Furthermore, participants with lower socioeconomic status reported high anxiety, depression
and the least satisfaction with medical staff interactions. Although the results should be
interpreted with caution due to a small sample size and lack of sample profile, there is clinical




             
       
 
      
              
            
              
            
               
            
         
            
           
            
              
           
            
             
  
 
               
             
                
           
                
can impact on their satisfaction with health care, with patients requiring decision and
treatment support as their cancer journey progresses.
2.2.3. Improving CRC support through information
As briefly outlined in Chapter 1, there have been strong national guidance recommending that
information sharing with patients is a key component of patient-centered care, especially
within cancer care (NICE, 2011). The NICE guideline for people with CRC recommends that
patients are offered information about all treatment options available (including no treatment)
alongside the risks, benefits and side effects before treatment is initiated. It is suggested this
information should be clear and free from jargon, and used alongside clinician-endorsed
support group organisations information (NICE, 2011). Additionally, guidance indicates
treatment decisions should be made following informed discussions between the patient and
doctor. The Scottish Intercollegiate Guidelines (SIGN, 2015) on managing CRC recommends
some additional best practice guidance including the suggestion that provision of information
should be appropriate to the preference of the patient and that communication should be
sensitive, understandable and accurate. Furthermore, use of summaries or recordings of
consultations is encouraged. The SIGN guidance, compared to NICE guidance, provides a
more directive strategy for clinicians, leaving less room for the subjective interpretation of
recommendations.
In cancer services, information is often used to address areas of uncertainty and concern, and
specifically help to regulate emotional distress (Wilson et al., 2010). Uncertainty about
treatment options is prevalent in the experience of CRC and it has been conjectured that the
role of uncertainty in CRC alongside other cancers may influence the patient 




     
               
              
 
              
               
               
               
               
              
           
               
              
               
               
 
              
            
             
        
              
                
              
                
found uncertainty was present at critical 
knowing if chemotherapy was needed, and at the end of treatment. In order to manage
uncertainty, many patients engage in information seeking behaviours (Shaha et al., 2008).
In 1999 Beaver, Bogg & Luker, used the Information Needs Questionnaire (n=42) to identify
the top three priority information needs of people with CRC and compared these with people
who had breast cancer. The top three information needs were; likelihood of cure, spread of
disease and treatment options. The same three items were also rated top three by breast
cancer patients; suggesting these areas of information may not be cancer specific. In a more
recent large scoping review of the literature (239), the top three information needs were:
treatment related information with a focus on treatment side effects, rehabilitation
information with a focus on stoma care, and information about coping with a focus on
emotional support (Van Mossel et al., 2012). As the two studies were conducted thirteen
years apart, this finding may suggest an evidence-based social rejection of cancer as a death
sentence, and the acceptance of cancer as a disease from which one may survive.
With regards to information sources, Nagler et al. (2010) undertook a large (n=2010) postal
survey in Pennsylnia to explore differences in information seeking amongst breast (n=678),
prostate (n=651) and colorectal cancer patients (n=681). The most frequently cited source of
information was doctors (Nagler et al., 2010), a fi 
review of the literatures (2012). Interestingly, early stage CRC patients were reported to be
less likely to search for information than people with breast or prostate cancer (Nagler et al.,
2010). The authors hypothesise this may be attributable to a lack of treatment options




               
            
             
            
            
            
           
                
              
              
                
              
     
 
                
             
                
            
             
               
               
           
            
             
Although both studies report doctors as the main source of information, patients also seek to
make sense and understand their situation through comparison and conversation with other
cancer patients (McGaughan et al., 2011). In an interview study (n=38), cancer patients
reported how they sought information from other cancer patients about prognosis, treatment,
(especially chemotherapy to provide information of the many different types and subsequent
side effects), and coping strategies (McGaughan et al., 2011). Some patients became
confused with the many different perspectives and conflicting information shared, whilst
others were able to select relevant information and apply this to their own situation. In raising
the issue of gathering information from multiple sources, this study highlights the amount of
information patients are exposed to, and that whilst knowledge from other patients can be
role in helping patients make sense of information (Beaver et al., 2010). This helps the patient
to regain control in their life, further reducing patient anxiety and fear (Lithner, Klefsgard,
Johansson & Andersson, 2015).
The need for information in people with CRC is present across the CRC population, and, as
shown by a Scottish survey (n=80), across all demographic variables including age, sex,
education status or marital status (Knowles et al., 1999). In the same study information at the
pre-treatment stage provided reassurance, unless it held unexpected messages such as no
guarantees that chemotherapy would improve survival. This is supported by studies reported
earlier in this chapter (e.g. Beusterien, et al., 2013, Wilson et al., 2010). Information was
valued and assisted people with coping at the time of diagnosis (Knowles et al., 1999).
However, some patients reported difficulties in making sense of information about
chemotherapy. They reported that clinicians took time to explain yet participants remained




          
              
             
                
 
 
     
                
               
                 
              
             
             
              
               
              
               
               
           
 
            
                
             
             
clinical descriptions did not meet expectations on the information needed (Knowles
et al., 1999). Just under half of participants experienced difficultly with decision making with
clinicians due to a lack of understanding, responsibility, and no definitive clinical suggestion.
Although this is an old study, it highlights key points about the delivery and assimilation of
2.2.4. Decision making in CRC
Information for CRC patients is also used to make treatment decisions. The body of work by
Beaver et al., in 1999, 2005, 2007 and 2009 has substantially added to the empirical
in the North West of England so has useful and relevant implications for this thesis. One of
the first studies to explore the decision-making needs of CRC patients was undertaken by
Beaver, Bogg & Luker (1999) by drawing comparisons with the decision-making needs of
breast cancer patients. Results demonstrated that 78.3% (n=36) of CRC patients stated they
preferred the doctor to make treatment decisions, compared to 52% (n=78) of breast cancer
patients. In this early study, CRC patients reported they took a passive role in decision
making (80%, n=36/45) and for the majority, (60% n=27/45) this had been their preference
(Beaver et al., 1999). When compared with breast cancer patients, it was unclear why CRC
patients wanted to remain passive in decisions. However, the sample size of this study was
small,conducted across the treatment pathway and with only one consultant.
The authors explored this passive decision-making role preference in a larger (n=41)
qualitative study cohort (Beaver et al., 2005). The CRC patients in this study were involved
in decision making in the medical consultation process and were frequently provided with




              
          
               
              
   
 
             
          
            
              
           
                
                
             
             
             
               
               
     
 
                  
               
           
              
making had been defined as deciding the treatment outcome, and not involvement in the
decision-making process which highlights the importance of using clear operational
definitions of terms in empirical work. The study reported that patients wanted to be
involved in the decision-making process, but did not want to take responsibility for the
decision.
In continuing their research programme, Beaver et al. (2007) undertook research to explore
perspective (n=35 interviews, including doctors, nurses and allied health professionals)
(Beaver et al., 2007). Findings suggest that health care professionals acknowledged and
favoured SDM, but in reality their behaviour towards this was tempered by different CRC
patient preferences towards information sharing and decision making in the medical
consultation and the complex nature of the information to be shared (Beaver et al., 2007).
In order to quantify patient preference, Beaver et al., (2009) used the 2005 and 2007 findings
to design an attitudes rating scale to explore CRC participants attitudes towards involvement
in decision making. They concluded the majority of participants (94.7%) wanted to know
what was happening and be involved in decision making, although only 51.7% actually
wanted to decide. This provided further support for the authors conclusion based on the 2005
findings that CRC participants wanted to be involved in the process but not necessarily the
outcome of decision making.
In contrast to the studies by Beaver et al. (1999, 2005, 2009), a recent large scale survey in
the U.S.A. reported that in a sample (n=5315) of CRC patients (56%) and lung cancer
patients (45%), only 6% of patients preferred clinician-controlled decisions, whilst 58%




                 
               
  
 
               
             
            
             
               
              
               
            
  
             
             
    
               
              
            
              
                
    
 
was measured using an instrument similar to the one used by Beaver et al., (1999), this may
reflect a change in social attitudes with an acceptance and uptake of involvement in decision
making.
It is clear that despite evidence indicating a shift towards greater uptake of SDM, certain
treatment decisions remain autonomously made by medical staff. For example, in a recent
audit of decision making in CRC multi-disciplinary team meetings (n=316 CRC patients,
median age 68.3), age was found to significantly impact the likelihood of withholding
chemotherapy for CRC patients (Hamaker et al., 2015) with those over 70 years of age
significantly less likely to be offered chemotherapy (Hamaker et al., 2015). The large U.S.A.
survey described above reported that both CRC and lung cancer patients rated the quality of
controlled decision making (Kehl et al., 2015). This association between clinician controlled
decision making an 
decision-making role preference (Kehl et al., 2015). This suggests that where clinicians do
not control the decision-making process, the patient perceives the care received as higher
qu -making role. Interestingly, this
finding is supported by an earlier small scale survey (n=220) of CRC patients in Australia
which reported trust in the clinician as the most significant factor within the treatment
decision process (Salkeld, Solomon, Short, & Butow, 2003). Trust, defined as competency,
openness, clarity of language and listening skills, appeared crucial for the patient to accept





              
                 
           
               
              
  
 
   
                 
            
              
               
             
             
             
               
                
             
 
It is clear that understanding of information needs and shared decision making has evolved
over time, and remains a complex area. Perhaps one of the biggest challenges in this area is
that although published protocols exist detailing conceptual models of shared decision
making per se, no model of shared decision making specific to CRC exists (Leon-Carlyle et
al., 2009). This lack of consensus makes academic enquiry and critique and clinical
application difficult.
2.2.5. CRC: Summary
CRC is one of the more common types of cancer and impacts a relatively large proportion of
those with cancer in the Scottish population. Although guidelines for treatment exist,
consensus is still developing about the predictive capabilities of the staging systems and the
value of adjuvant treatment for Stage II patients. CRC patients are concerned about the side
effects of treatment and embarrassment resultant from the nature and disease management of
bowel cancer. Information can alleviate patient concern and help people to cope. Although
health care policy recommends the involvement of cancer patients in decision making, the
extent to which this occurs in practice is unclear. Furthermore, it is unclear whether people
with CRC wish to take an active or passive role in decision making about their disease.




          
                
               
             
             
              
               
              
                
         
 
                  
                
                
               
            
              
      
 
                
             
               
            
             
              
2.3. High Grade Glioma (HGG): Disease Incidence, Staging and Prognosis
Primary brain tumours account for just 2% of all cancers diagnosed in adults in the UK
(Mirimanoff, Gorlia & Mason, 2006). In the UK, only 4,987 people were diagnosed with a
primary brain tumour in 2009 in comparison with 40,000 women diagnosed with breast
cancer and 25,000 men diagnosed with prostate cancer (2009, CRUK). With the annual
incidence rate of primary brain tumours being 7 in 100,000 (McKinney, 2004) primary brain
tumours are relatively rare. However, the prognosis for this group is extremely poor (Wang &
Jiang, 2013).The most common primary brain tumour in adults, and comprising 87% of those
diagnosed are High Grade Gliomas (Grade 3 and 4) or HGG. The majority of these are
identified as glioblastomas (Guilfoyle, Weerakkody, Oswal et al., 2011).
Although HGG affects adults of all ages, the incidence of this tumour rises after the age of 30
years, with a diagnosis of HGG most commonly made in those 65 and over (Chakrabarti et
al., 2005). A reduced incidence rate has been observed for those aged over 75 years, although
this may be due to less investigation in elderly patients where symptoms could be attributed
to other comorbid conditions e.g. stroke (McKinney, 2004). Primary brain tumours also
demonstrate gender disproportion, with males more likely to be diagnosed then women with a
ratio of 1.5:1 (McKinney, 2004).
HGG is an incurable disease and less than 5% of patients survive 5 years from diagnosis
(Shaw et al., 2004). Despite intensive biological research, prognosis has not improved
significantly over the last decade. Survival, and its quality, is dependent on age at diagnosis,
pathology, grade of tumour and presenting symptoms (McKinney et al., 2004). Elderly
patients (Mirimanoff et al., 2006) or those with poor performance status (Keime-Guibert et




                 
                 
                
               
                
              
 
    
             
              
             
            
             
 
                
             
          
           
       
            
           
              
                 
      
 
treatment is 12 to 14 months (Stupp et al., 2005), though few patients survive 3-4 years from
diagnosis (Catt, et al., 2008). Although HGG is rare, HGG is the third leading cause of cancer
related death among men aged 15-54, and the fourth leading cause of cancer related death for
women aged 15-34 (Kesari & Stiles, 2006). Reflecting on these statistics in a different way,
the average years of life lost (AYLL) for cancer patients is 12.5 years, brain cancer patients
suffer the highest AYLL at just over 20 years (Burnett et al., 2005).
2.3.1. HGG Treatment
Following initial presentation with symptoms of a brain tumour, treatment is often initiated
rapidly; the intent of treatment is palliative. Clinical management of HGG often depends on
the extent of the tumour mass, but those diagnosed will frequently undergo surgery,
radiotherapy and chemotherapy before dying from their disease (Guilfoyle et al., 2011).
Owing to the infiltrative growth of HGG, a relapse is inevitable (Salander 2009).
Surgery to excise the tumour is the first therapeutic modality for most patients but a complete
resection of high grade tumours is not possible. Radiotherapy and chemotherapy are then
subsequent forms of therapy (Salander, 2009). Despite improved technologies, effective
therapies for substantially improving life expectancy remain elusive (Keime-Guibert et al.,
2007). Radiotherapy has been the principle adjuvant modali 
addition of chemotherapy demonstrating only modest benefit until recently (Stupp et al.,
2005). The introduction of radiotherapy and combined chemotherapy has improved the
prognosis for some HGG patients, particularly in younger patients who are otherwise fit and
well (Mirimanoff et al., 2006). As commented by Guilfoyle et al. (2011), there is a clear need




              
               
 
           
     
 
              
              
              
               
                
 
        
            
               
             
              
              
               
              
                
 
             
             
             
Current treatments therefore can only extend survival, not provide a cure. In some centres,
and for some patients, doctors may perceive treatment to be unwarranted due to the adverse
However,
many patients who respond to treatment experience temporary improvement in their
symptoms (Catt et al., 2008).
After initial diagnosis, primary treatment will continue for six to twelve months. After this,
patients will only return to hospital when initial symptoms begin to re-present, signifying a
re-growth of the tumour. Treatment options at this time are often significantly less active,
attending more to symptom control. If patients survive to this point, their needs start to
diversify depending on their abilities as they return to daily activities (Janda et al., 2006).
2.3.2. Support needs of people with HGG
Following initial presentation with symptoms, treatment is rapid with patients admitted for
surgery as emergencies or electively as urgent cases (Guilfoyle et al., 2011). This has several
care challenges. When taken into surgery as an emergency, the time available for pre-
operative counselling and exploration of the impact of a diagnosis of HGG is diminished.
After surgery confirmation of a diagnosis is not possible until pathology results have been
returned. This period of time is critical as patients and relatives responses and experiences of
the time period before formal diagnosis is predictive of future adaptation to illness (Weisman
& Worden, 1977). However, few studies have explored this time point with regards to HGG.
Three qualitative studies that have undertaken research in this area are Salander, Bergenheim,
Hamberg and Henriksson, (1999); Halkett Lobb, Oldham and Nowak (2010) and Cavers et




             
            
              
              
                
                 
 
              
               
            
 
              
              
           
            
              
         
 
                
              
              
             
               
       
retrospectively about their experiences of symptom onset to the moment of diagnosis. Using
sensorial dysfunction and mental dysfunction, and barriers to seeking help included the
patient normalizing symptoms or avoiding them. A passive role by a spouse further mitigated
help seeking. Such delay in seeking assistance supports the earlier work of McKeran &
Thomas (1980) who reported that time from first symptom to diagnosis was nine and a half
months. Later work by Salander et al., (1999) found this time period to be six months.
Halkett et al., (2010) interviewed 19 people diagnosed with a HGG about their information
and support needs, utilising purposive sampling to capture a range of stages in the disease
process (during treatment, at disease recurrence). Using a grounded theory approach, the
me
needed for pathology results to confirm a diagnosis. Patients reported this waiting period as
difficult and wanted additional information to be provided. It should be noted that interviews
were conducted retrospectively and therefore were based on recollection of experiences.
There is also suggestion that surgeons preoperatively reassure patients and families that
information about the outcome of surgery will be available immediately, while the reality is
that this is impossible (Lobb, Halkett & Nowak, 2011).
As part of a larger exploratory serial interview study with HGG patients (n=26), Cavers et al.,
(2013) conducted 13 patient interviews (n=10 jointly with a relative) prior to a confirmed
diagnosis of HGG. These were conducted either immediately before surgery or in the week
after but before diagnosis. Utilising a grounded theory approach, findings identify a high
level of emotional distress and immense uncertainty about the future at this time. This time




              
           
               
              
          
            
                
             
                
             
           
            
            
             
              
                 
               
     
 
                 
              
               
            
            
               
unknown. Drawing on the same data Cavers et al. (2012) mapped the physical, social,
psychological and existential trajectories from diagnosis through to post-treatment for people
diagnosed with HGG. The physical trajectory began, as in the Salander et al. study (1999),
when patients presented with varied problems from a sudden isolated seizure to more gradual
symptoms including headaches and nausea. The social trajectory illustrated substantial
disruption immediately post-surgery at the same time as a reduction in psychological
wellbeing. Following surgery, anxiety was at its most acute, and the sense of uncertainty at its
peak with caregivers feeling great stress during this time. Existential distress was noted pre-
diagnosis of HGG when some participants could not find a sense of meaning in their lives.
Some participants became more spiritually aware whilst others turned to friends, family and
professionals for support. Whilst waiting for confirmation of their diagnosis, participants
reported seeking procedural information about what would happen next in order to
compensate for the lack of information about investigation tests (Cavers, 2012). This
challenging time following surgery and whilst waiting for a diagnosis is reflective of
experiences in the general cancer population where the period from the first suspicion of
cancer to the confirmation of the disease is described as a period of great stress (Sægrov &
Halding, 2004). One common theme running through all this empirical work is the need for
patients to have more information.
What is clearly highlighted in the literature is that living with a life limiting diagnosis such as
HGG, is characterised by profound distress and anxiety. One survey with 52 primary brain
tumour patients in the UK (Keir et al., 2009) demonstrated that high reporting of emotional
concerns correlated with increased distress scores. When compared to the general cancer
population, Keir et al. (2009) reported that this population reported significantly more




              
             
 
 
            
                
              
              
                 
              
               
                
       
 
      
          
            
            
               
              
     
              
        
 
experience more intense and enduring distress. In a systematic review it was shown this
distress extends to other family members and the pat upport network (Sterckx et al.,
2012).
Living with on-going physical symptoms such as memory loss and communication problems
describing how their initial reaction of coping with HGG and holding onto life, later turns to
more realistic awareness of the inevitability of death (Molassiotis et al., 2010). However, for
others, coping with a HGG diagnosis has been associated with a positive reappraisal and
redefinition of life (Strang & Strang, 2001). This often occurs as a result of the existential
reflection that occurs in patients during their HGG cancer experience. However, the ability of
health care staff to support patients in discussions about these areas has been questioned with
patients perceiving staff to be too busy, stressed, afraid or unskilled in this area (Adelbratt &
Strang 2000; Strang & Strang, 2001).
2.3.3. Improving HGG support through information
Evidence-based and clinical guidelines to inform information sharing with patients
recommends that communication with patients with primary brain tumours and their families
should include discussion of diagnosis, prognosis, treatment options, recurrence and end of
life care (NICE, 2006) and that clinicians should inform patients of the type of information
available, elicit how much information a patient wishes to receive and then individualise the
he importance of revisiting this
discussion at multiple time points, rather than believe this to be a one-off communication




              
                
              
             
               
               
              
               
                
              
             
             
             
              
             
            
           
 
              
          
              
            
             
           
Whilst this may appear relatively straight forward to achieve, it is clear that information
sharing with HGG patients is complex. In a study by Lobb et al. (2011), single interviews
were conducted with HGG patients (n=19) and their caregivers (n=21) within one year of
diagnosis. All interviewees described their shock and disbelief at being given the diagnosis.
They also reported that following diagnosis, they found it difficult to absorb and make sense
of prognostic information. Many could not recall the details of the diagnosis or prognosis, or
they believed they had not been given complete information. These issues are supported by
Halkett et al. s work (2010) who found patients valued the presence of a caregiver in
consultation to minimise the burden of recall. All spoke of the need for hope and reassurance
and the fact that hope was often taken away on receiving the prognostic information.
Reassurance by health care staff that participants would not be abandoned, and that
everything possible would be done, motivated patients to continue with treatments. Lobb et
al. (2011) noted that patients often coped with the distressing prognostic information by
rationalising that average life expectancy statistics did not apply in their case. Caregivers in
particular did not believe doctors could predict individual survival and preferred to stay
positive. Participants wanted clinicians to be more compassionate and empathic, and include
some positive messages in their delivery of such bad news.
Spetz, 2000). Through serial interviews throughout the course of their disease HGG patients
(n=25) reported they required concrete information about treatment schedules, future
appointments and the practicalities of dealing with everyday life (Salander & Spetz, 2000). In
their study Salander & Spetz (2002) found patients expressed satisfaction with information
but posed few questions about prognosis and were satisfied with simply knowing their




                 
             
               
              
                 
               
            
     
 
               
            
            
              
             
               
             
     
 
             
              
                
             
               
the early stages of coming to terms with a diagnosis of cancer, Cavers et al. (2012) report
participants were torn between wanting clear, direct and honest information and being unsure
if they could assimilate and cope with the impact of information about their diseases (Cavers
et al., 2012). However, in contrast other studies report how information helps participants to
cope with the uncertainty inherent in this disease (Janda et al., 2006, Catt et al., 2008, Cavers
et al., 2012|). This highlights the paradox of collective patient need as portrayed by the
literature contrasted with the individual and subjective informational needs of each unique
individual person with cancer.
In one of the few quantitative studies reporting the information needs of HGG patients (Diaz,
et al., 2009) twenty-six patients reported their information preferences: 50% wanted all
possible information, 23% wanted only important aspects, and 27% wanted only critical
aspects. Fifteen percent of patients expressed a wish to ask their HCPs more questions.
Younger patients (aged 65 years) wanted more information than older patients. Anxiety was
found to be lower in patients who wanted to know everything about their illness, understood
is supported by Cavers et al., (2012) who reported that having appropriate information
reduced anxiety for many people.
Differences in information preferences may be partly explained by the individual appraisal of
the need for information. Patients often fluctuate between wanting to know and not wanting
to know (Halkett et al., 2010). Interviews with carers (n=21) suggest this shift in need often
corresponds to the unique illness trajectory and rapid shifts in disease status (McConingley,




                
              
              
              
                 
       
 
            
           
              
              
             
                
               
           
            
              
      
 
             
              
               
               
            
            
care to patients, note that patients often prefer information adapted to suit their needs and at
the same time wanted to urgently know what their treatment plan would be. Conversely
Lepola et al. (2001) interviewed patients pre and post-surgery (n=8) found patients report the
feeling of urge and haste in making treatment decisions should be decreased. Timing of
information was also felt to be an issue as often patients were not ready to absorb information
or discuss prognosis (Halkett et al., 2010).
Qualitative findings from a longitudinal interview study with 17 patients found higher
information needs and anxiety were reported prior to commencing treatment, significantly
decreasing after treatment begins (Halkett et al., 2012). They identified four time points
as critical for information needs; the first consultation, the planning appointment, the first day
of treatment and approaching treatment conclusion (Halkett et al., 2012). Patients were found
to appreciate the opportunity to ask questions of medical staff in order to prepare for the
future (Halkett et al., 2012). Through serial interviews over the course of the disease process
Janda et al. (2006) found patients wanted continued communication by healthcare
professionals about their prognosis throughout the course of treatment and beyond. Without
this, patients and partners described being unable to discuss the severity of the situation
openly together (Salander & Spetz, 2002).
Communicating bad news is demanding and a significant source of stress for clinicians,
patients and caregivers (Ptacek & McIntosh, 2009). A review of the literature between 2000
and2007 revealed that no studies clearly identified what best practice is in breaking the bad
news of HGG or discussing poor prognosis (Catt et al., 2008); this highlights the challenge
clinicians face. Clinicians seek to strike the difficult balance between truth telling,




               
              
                
               
             
   
 
                
                
            
             
                 
                
                  
        
 
              
            
             
              
             
                
    
                
          
What can be concluded is the need for clinicians to be competent in communicating bad
news, receiving appropriate training in order for these skills to be practiced (Ptacek &
McIntosh. 2009), and for any information sharing to be customized in the way it is provided
(Halkett et al., 2010). Written information at the time of discharge following surgery has been
reported as one particularly helpful resource to improve recall of information (Paul, Hendry
& Cabrelli, 2004).
The value of written information as a record has been qualitatively explored in a study with
high and low grade brain tumour patients and caregivers by Janda et al. (2006). Data were
collected in focus groups (patients n=12, caregivers n=10) and telephone interviews (patients
n=6, caregivers n=8). Participants reported high need for both verbal and written information
at the time of diagnosis in order to make sense of their situation and enable understanding of
HGG, its treatment and side effects. This research is supported by a review of the literature
(Catt et al., 2008). Janda et al. (2006) call for further research to develop strategies to meet
on-going unmet information needs in patients and caregivers.
Molassotis (2010) in their small (n=9) serial interview study found that patients needed better
information, particularly preparatory information on what to expect throughout the course of
their disease, as well as regular assessment of their understanding. Good quality information
was found to raise awareness of available services and enable carers to advocate effectively
for the patient and support important treatment decisions (McConingley et al., 2010). Often
carers were noted to have a higher need for information than the patient (Salander and Spetz
satisfaction with information
was often greater than that of their spouse (Catt et al., 2008). Participants in Janda




               
         
 
            
               
              
               
             
                
   
 
     
            
            
            
           
               
    
 
              
              
                
                
           
              
relieve pressure for patients and carers alike (2006) whilst Halkett et al., (2011) called for
information to be tailored to the individual receiver.
Two literature reviews have been undertaken to examine the literature concerning the
experience of living with HGG and the resultant information and support care needs (Catt et
al., 2008; Davies & Higgingson, 2003). The first review examined literature up to 2000
(Davies & Higgingson 2003) whilst the second reviewed literature from 2000 2007 (Catt et
al., 2008) Both reviews conclude more research is needed to assess supportive interventions
to attend to patients unmet information needs and educate staff with regards to caring for this
population of patients.
2.3.4. Decision making in HGG
In addition to threatening life, HGG threatens mobility, cognition, perception and emotion
(Salander, 2009). Unlike patients from other cancer populations, HGG patients are more
likely to suffer with physical and cognitive impairments (Halkett, 2010). Patients often
present with features including cognitive decline, headaches, seizures and motor deficits
(Deangelis, 2001) which are often lasting, raising the need for decision making capacity to be
assessed and reviewed.
Medical decision-making capacity is relevant for patients with HGG as there are ongoing and
challenging medical decisions to be made whilst coping with a disease that rapidly erodes
cognition (Ford et al., 2012). The issue of capacity and personal autonomy can be a sensitive
area for patients when, due to risk of seizure and cognitive deficits, they require 24 hour
supervision (Pelletier 2002): this occurs whilst attempting to maintain independence where




              
           
 
              
              
              
            
               
              
                
              
           
               
                 
  
           
 
                
             
              
               
             
              
the humiliating process of patients no longer being recognised as a complete person (Strang
& Strang 2010) with carers becoming overprotective (Sterckx et al., 2012).
Against this backdrop, the importance of enabling patients to be involved in decision making,
whilst capacity exists, is important. This was explored in an early qualitative study conducted
in the UK (Davies, Clarke & Hopkins, 1996). Seventy five patients and sixty-six caregivers
experiences of diagnosis and prognosis. Whilst the majority of patients (71/75) understood
they had a brain tumour, three levels of awareness about the prognosis were identified. A
quarter of patients were fully aware of their prognosis, characterised by recognition of little
chance of cure and expressing thoughts and fears about dying. Less than one third of patients
were categorised as partially aware of their prognosis expressing some fear of dying whilst
anticipating a reasonable chance of cure. Overwhelmingly 43% (24/75) conveyed no
awareness of prognosis and the outcome of death although relatives in the study were three
times more likely than the patient to be aware of the prognosis (67% vs 21%). Although this
understanding
of their disease and the impact on their decision making.
some options. In their work they used a survey with 75 brain tumour patients to explore
unmet supportive care needs. Specific areas highlighted by patients where more support and
understanding was required included: coping with the physical side effects of the tumour and
treatment and changes in mental thinking or ability, feeling like a different person before the
brain tumour, information on the latest developments in research and treatment in brain




              
                 
            
               
              
                 
             
               
              
              
          
            
           
              
 
             
                 
            
             
                
             
             
               
 
 
patients identified uncertainty about the future and not having one identified member of staff
to talk to as problematic. The prognosis for HGG is certain, but the length of survival is
unavoidably uncertain. Uncertainty is shown to obstruct comprehension and increase a sense
of chaos and anxiety (Stang & Strang, 2001). This sense of uncertainty often leaves patients
feeling frustrated, unclear about what to expect from treatment and the future (Halkett, 2009).
Often this can lead to patients feeling out of control and unable to plan their life (Halkett,
2009). As a result uncertainty can lead to difficult doctor-patient communication, as concrete
facts about the future and success of treatment are absent. Davies reported that doctors in
some medical settings may perceive treatment to be unwarranted as it may diminish quality
of life further by the adverse effects of treatment (Davies, 1996). Treatment provides the
possibilities of extending life post-surgical morbidity. Although treatment provides the
possibility of extending life, side effects such as post-surgical morbidity, effects of
radiotherapy on the normal brain, chemotherapy-induced toxicity, high dose steroids and
anticonvulsants can all negatively impact quality of life (Remer & Murphy, 2004).
When considering decision making in HGG, many patients in qualitative reports of support
care needs (Janda et al., 2006) identify that having an assigned member of staff who can help
patients manage their emotions, answer medical questions, and mediate between carer and
patient is important. Patients and carers clearly want support in understanding not just
technical and medical knowledge, but also someone to listen to their views about care (Catt et
al., 2008). Patients with HGG and carers who report having higher needs, consistently
expressed greater interest in services that could provide greater support and improve their





                   
                
             
                 
               
              
             
          
 
   
                
            
               
            
              
            








With time to adjust to a diagnosis some people may begin to try to regain an internal locus of
control, and this may result in a shift away from their initial willingness to defer decision
making to professionals (Shaha et al., 2008). Information seeking is an effective strategy
when combined with an internal locus of control and may assist patients to accept cancer as
part of everyday life (Ramfelt, Severinsson & Lutzen, 2002). Rutten et al. (2005) in a
systematic review of 122 articles found that when the provision of information was adequate
and knowledge is therefore needed to develop patients cope with unfamiliar situations, such
as coping with cancer (Nanton, Docherty, Meystre & Dale 2009).
2.3.5. HGG: Summary
HGG is a rare disease, but one that holds catastrophic consequences for the patient and their
family. With current treatments focussed on palliative rather than curative outcomes, the
nature of the information to be exchanged between doctor and patient, and the types of
questions raised , require the utmost sensitivity. Despite understanding the information needs
of this patient population, and guidance on how to deliver distressing information clearly, and
over time, people with HGG continue to report overall dissatisfaction about their




         
              
              
                
           
 
             
               
             
           
              
               
              
    
 
   
              
        
            
             
           
           
               
2.4. Support needs of the general cancer population
The previous sections of this chapter have detailed the experiences and needs of cancer
populations specific to this thesis, those being patients with CRC and HGG. In concluding
this introductory chapter, a brief discussion is offered on where this sits with regards to what
is known about the needs of the wider cancer population.
Research about people diagnosed with cancer consistently reports that the majority of people
want and expect to be involved in decision making about their treatment (Davidson & Denger
2002; Coulter & Jenkinson, 2005) with patient involvement in decision known to improve
patient understanding, satisfaction and confidence in the treatment decisions made (Edwards
& Elwyn, 2006). However, many cancer patients do not achieve the involvement they desire
in treatment decisions, often leading to decisional regret (Brehaut et al., 2003). The success of
communication skills of both the doctor and the patients to engage in communication that
meets these needs.
2.4.1. Information needs
Information needs in the cancer consultation can be defined as a recognition that knowledge
& Rees, 2002, p.5). In general, patients are
interested in receiving information that will help them understand their cancer, relieve
uncertainty, make decisions and cope with treatment (Squires et al., 2005). This is
challenging for both patient and clinicians when uncertainty features prominently throughout
the situation can be anxiety provoking (Gaudine, Sturge-Jacobs, & Kennedy, 2003).




              
            
       
 
                
            
                 
              
   
 
 
                
               
              
                
                
                
               
                   
            
             
          
in the general cancer population, there is an unfulfilled need for security and certainty
(Halldorsdottir & Hamrin, 1996). Information about cancer treatment can bring certainty and
a sense of control for patients.
There is a strong body of evidence reporting that cancer patients wish to know all information
(Fallowfield & Jenkins, 2004), although many social, personal, and emotional factors impact
on this (Leydon, 2000). In one of the largest UK studies, a sample of 2331 patients of
multiple cancers across 34 hospitals in the UK, 87% preferred as much information as
2001). When reviewin 
In contrast, a qualitative study conducted in the UK with 17 cancer patients, within 6 months
of receiving a diagnosis of cancer, identified that patients wished to be given only basic
information regarding diagnosis and treatment but were content with no more (Leydon et al.,
2000). They suggest patients may engage in avoiding information or using silence as a way of
maintaining hope (Leydon et al., 2000). This was found to be more common among men who
preferred not to ask questions to avoid information about death (Leydon et al, 2000). In this
respect, efforts to maintain hope impeded the drive find out further information (Leydon et al,
doctor to do all that is necessary (Leydon et al, 2000). In contrast, in a qualitative study with
advanced cancer patients, clear communication about prognosis and curability was not found
to decrease hope (Smith, Dow, Khatcheressian & Lyckholm, 2010). Hope is an important




             
            
 
             
                 
        
 
               
              
           
            
           
            
 
             
               
            
             
requires that clinicians balance information provision to address the uncertain and certain in
treatment options, realism and optimism, hope and fear (Leydon, 2008).
Differences in information preferences may be partly explained by the individual appraisal of
either be a risk (loss of hope) or a reward (strengthen coping through a sense of knowing)
needs, is key to providing personalised care.
cope with the disruption of quality of life associated with a cancer diagnosis (Arora, Johnson,
& Gustafson, et al. 2002). Information seeking is a recognized and often used coping
mechanism that increases comprehension and manageability (Strang & Strang 2001). It
appears information needs and information seeking behaviour cannot be explained purely by
coping strategy (Wilson, 1997). This is evident in circumstances when gaps
knowledge are clear and yet information is not sought (Leydon, 2000).
Wilson (1997) suggests if we assume, for whatever reason, a person experiences an
information need, there must be an attendant motive to actually engage in the behaviour of
seeking. The stress/coping perspective offers a useful basis for further understanding this




             
           
 
            
               
              
               
            
             
               
             
                
 
             
            
               
                  
              
            
            
 
cancer an individual may be looking for the factual information about treatment or
information to enable dealing with the problem emotionally (Wilson, 1997).
Bensing and Verhaak (2004) contextualise this stress coping perspective into the medical
encounter in their model. They propose patients in general have two needs when they enter
the medical consultation with their doctor: a cognitive need; the need to know and
understand, and an affective need; the need to feel known and understood. The cognitive need
is met by appropriate information provision from doctors to, for example, enable
interpretation of symptoms or set expectations about treatment. The affective need is fulfilled
cognitive one, often not articulated by the patient, it requires the doctor to elicit concerns
through the use of adequate communication skills. If this is completed successfully they
when clinicians acknowledged them as a unique human being, distinct from their disease.
In exploring literature from the wider cancer population, there are common themes that
emerge and resonate with the CRC and HGG population-specific literature. The importance
of decision making, the impact of uncertainty and patient coping, and the role of information
in bringing a sense of control to cancer patients, is reinforced. This not only adds to what is
known about the information needs and experiences of people with CRC and HGG, but
further extends our understanding as to the importance of information in medical




   
              
               
                
             
           
              
                
        
 
2.5. Conclusion
This chapter has given a broad overview of the distinct disease trajectories and decision
making need of patients with CRC and HGG. In undertaking this, it has detailed the
challenges for the two cancer populations that will be the focus of this thesis. Through further
understanding gained from research of the general cancer population, the challenges for both
populations are contextualised and emphasised. It has been reported that communication
could be improved when talking with, and giving information to CRC and HGG patients.
Chapter 3 will present a more in-depth explanation of what is known in the literature about




        
  
             
              
              
               
            
                
                 
 
              
             
          
                 
                 
             
   
               
             
   
 
Chapter 3: Shared decision making - from policy to practice 
3.1 Overview
This chapter will explore current understanding of shared decision making (SDM) in health
care, the substantive area that underpins this thesis. To undertake this, the health policy
context of shared decision making in this study, the conceptualisation and models of SDM,
and the benefits and outcomes of shared decision making will be presented. The barriers to
SDM and the interventions developed to overcome these difficulties thereby enabling SDM
to occur, specifically with people who have cancer, will then be examined. This will lead to
the introduction of the Navigation intervention that is the main focus of this evaluation study.
The literature review undertaken to inform this chapter was exploratory in nature. As for
chapter 2, a structured narrative approach was undertaken, rather than a systematic review
methodology. Relevant literature was identified by searching Pubmed, PsycINFO, Cochrane
library and Web of Knowledge for publications from 2000 to 2013, and revisited in 2015. In
addition the work of key authors in the area and reference chaining were used. In order to
ensure all relevant studies were identified, broad search terms were used and included:
were used including:
finally full paper review. The literature is presented here using a structure that explores the
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Bowyer, 2000). Whereas patients
were once seen as passive recipients of medical care, patients are now increasingly positioned
-framing came with new patient rights to
expect standards of care that included being fully informed in discussions and involved in the
decision making about individual treatment plans (Mead & Bowyer, 2000). Indeed, this
position of incorporating patient perspectives into care pathways was been described as the
biopsychosocial paradigm of the 21st century (White, 1988). Reflecting on health policy since
that time it is clear that what was once an innovative move towards shared information and
SDM in health care, has now become firmly embedded as mainstream policy features
(Coulter & Collins, 2011).
Sharing decision making in health care constitutes the active discussion between, and sharing
of, expert information by the doctor, for example the risks and side effects of treatments, and
by the patient, for example, patient values and preferences for treatment (Charles, Gafni, &
Whelan, 1997). This information exchange is then used to reach a jointly agreed treatment
plan. With the emergence of SDM in English health policy already noted, such values are
clearly visibly in the United Kingdom (Department of Health (DH), 2011; DH, 2012), a
similar integration of SDM in Scottish health policy is evident (Scottish Government, 2012).
In seeking to map health care provision through to 2020, the ambition for mutually beneficial
partnerships between patients and health service deliverers and care that is anchored on clear,
compassionate communication and shared decision-making is transparently made clear
(Scottish Government, 2012). It can be concluded therefore, that as a mechanism for




              
     
 
             
              
                
              
              
    
 
             
            
             
          
             
             
             
    
 
                 
             
             
               
              
               
achieving safe and effective care (DH, 2011) and is firmly embedded into National Health
Service (NHS) policy (NHS, 2013).
Given the central policy impetus for increased consumer involvement in health care decisions
per se, it is unsurprising that strategy directing clinical specialities reflect a similar emphasis:
cancer care being one of these areas. Indeed, SDM is seen as key to improving patient
experiences of cancer care, cancer treatment and cancer support. This is evidenced by SDM
being one of the core principles in a recent UK cancer strategy document (Independent
Cancer Taskforce, 2015).
The clinical event most frequently requiring information to be exchanged between patient and
doctor is the medical consultation. Consultations between oncology clinicians and the person
with cancer shares features common to medical consultations in other medical specialties, for
example, discussion about presenting symptoms, diagnosis and treatment options. However,
there is an additional emotional burden in cancer consultations caused by: fear associated
with a cancer diagnosis; complexity of the medical information involved in cancer diagnosis;
uncertainty regarding the trajectory of cancer disease; and concern about efficacy of cancer
treatments (Arora, 2003).
It is clear that whilst can be SDM achieved by enabling patients to raise concerns with both
patients and clinicians recognising patients as equal partners in care (British Medical Journal,
2011), there are significant challenges in realising this when delivering health care. Within
the complex cancer care arena, it is often difficult for patients to understand and articulate
their treatment preferences and come to terms with existential matters of life and death




                
                
           
           
   
 
        
           
              
              
            
           
 
               
             
               
              
                
             
 
                
               
treatment, health care staff are often perceived by patients to be too busy, too afraid or
unskilled to discuss matters (Strang & Strang 2001). This is a failing of the current health
system where patients with cancer clearly recognisethe importance of health care
ability to tailor information to their individual information needs (Halkett
2010).
3.2 Shared decision making a conceptualisation
The conceptualisation of SDM initially arose from acknowledgement that traditional health
communication and decision making models needed to be more flexible in order to integrate
patients preferences and values. This is especially important in clinical encounters such as the
medical consultation where clear and effective communication between the patient and the
doctor is required to formulate an individual treatment plan.
When beginning to consider SDM there are some key issues (Clayman & Makoul, 2009) to
critically considered. Are some clinical contexts more appropriate for SDM? Can SDM only
exist in cases with medical equipoise, or should SDM be appropriate and feasible in every
patient/clinical situation? Should the patient always accept the position of SDM or can the
process of how the patient wants decisions made be discussed and agreed on, even if this
includes the patient wanting medical staff to make the decision for the patient?
While a number of SDM models have now been developed, one of the earliest papers to




                  
         
                
               
       
                 
             
               
  
              
         
                
               
               
              
             
              
              
              
              
(1997). Although nearly two decades old, it is still one of the most cited models in this area
defines the three key characteristics of SDM as being:
(1) At least two people are involved recognising that the medical encounter is not just limited
to doctor and patient, but may include other members of the medical team and relatives,
participating through complimentary roles, expectations and behaviours.
(2) The doctor must be able to establish a conducive environment that values the views of
the patient and elicits patient preferences, transfers technical information to the patients, and
assists the patient to conceptualise risk versus benefit in order to share a jointly agreed
recommendation.
(3) The patient must be willing to engage, disclose preferences, ask questions, balance the
information shared, and formulate treatment options with the doctor.
This model suggests it is the process of decision making that is shared, although it does
indicate that in turn this will impact the decision outcome. Furthermore the model does not
that the patient should always share equally in the information exchange but that this should
be facilitated through the doctor creating an environment that values the sharing of
information. This model therefore focuses on a SDM concept whereby expertise is shared
throughout all the stages of decision-making process. The doctor, as the expert in the
information clearly. The patient is the expert in their own medical history, lifestyle and
circumstance, personal attitude to risk, and their values and preferences. For SDM to occur,




              
  
 
       
              
    
                
      
      
 
  
             
             
             
             
           
    
 
            
              
              
             
expertise are used to guide the deliberation and subsequent consensus, where possible, of a
decision.
3.3 Why shared decision making in cancer?
The medical consultation provides a unique setting for information exchange. Doctors do not
problems and of the
problematic. It is likely that when these areas are ignored in the context of decision making,
lues or information preferences, and there
(Silverman, Kurtz & Draper, 2005).
onfidence in
the decisions made (Edwards & Elwyn, 2006); greater involvement in decisions can also
improve health outcomes. In one longitudinal study conducted in Canada, women with breast
cancer reported greater satisfaction with care and improved quality of life, higher physical
and social functioning scores and fewer reported side effects when actively involved in
choosing treatment than women who indicated passive involvement (Hack, Degner, Watson
& Sinha, 2006).
In recognising the principles of SDM during medical consultations, it is generally
recommended that clinicians should: inform patients of the type of information that can be
provided; elicit how much information a patient wishes to receive; and tailor the clinical




               
                
    
 
              
              
             
              
                
              
             




         
 
             
          
            
            
             
             
            
            
of individuals may change, this is not seen as a one-off communication event but rather as an
area to be revisited and explored at multiple time points during a series of interactions with
the patient (Clayton, 2008).
In acknowledging the potential for patients to refine and change views held about treatments
over time and during medical consultations, it is clear that clinical conversations between the
doctor and the patient in this setting can be demanding encounters (Stacey, Henderson,
MacArthur & Dohan, 2009). One review (Hack, Degner, & Parker, 2005) suggests that both
patient and doctor must be confident to engage in the medical encounter: the patient must be
confident and not feel vulnerable, while the doctor must be confident in confronting the
limitations of what medicine can offer. Effective communication is more likely when doctor
and patient can articulate their needs, and respond in a manner that results in both parties
feeling und 
2005).
3.4 Barriers to Shared Decision Making
Despite support from health policy and research for the application of SDM, the
implementation and normalisation of SDM into medical consultations remains challenging
(Lloyd, Joseph-Williams, Edwards, Rix & Elwyn, 2013). Findings from one American
qualitative study interviewing older people who had colorectal cancer (n=73) and their
oncologists (n=19), identified that interactions between the doctor and the patient remain still
largely paternalistic, reinforcing a passive role for patients (Elkin, Kim, Casper, Kissane, &
Schrag, 2007). Given that cancer patients continue to report dissatisfaction with poor




                
            
             
              
     
 
                 
            
              
            
            
                
             
           
            
            
            
           
    
              
              
            
             
               
suggested that clinicians need to recognise the extent to which patients wish to be involved in
understanding their health problems (British Medical Journal, 2011). Doctors also need to
make realistic assessments about the nature and amount of information needed by patients,
and possess the developed communication skills to give information in a clear and accessible
way (Kinnersley et al., 2007).
There are no parameters or variables that can be used by medical staff to predict how much
information patients may want. Patient preference for information and SDM involvement is
often difficult to accurately predict with regards to correlation of age, education and gender,
often with conflicting evidence in this area. One American study prospectively investigated
decision-making preferences in a cohort of cancer patients (n=78). Results demonstrated that
49 patients (63%; 95% CI 0.51 to 0.74) preferred a shared approach with physicians and that
patient age or sex did not significantly alter decision making preferences (Bruera, Sweeney,
Calder, Palmer & Benisch-Tolley, 2001). In another American study (Matsuyama, Kuhn,
Molisani & Wilson-Genderson, 2013), the information needs of 138 newly diagnosed cancer
patients were studied over nine months using the Toronto Informational Needs Questionnaire.
Information needs reduced over time, although gender (women), age (younger), race (African
American), education (lesser), and marital status (married) were significantly associated with
higher information needs.
There are also practical difficulties that impinge on medical staff engaging in SDM. These
have been detailed in an updated systematic review on the barriers to implementing shared
decision making into practice from the perspective of health professionals (Légaré, Ratté,
Gravel, & Graham, 2008). Using a structured search strategy with quality review processes,




           
                 
             
             
               
               
                 
               
              
      
 
 
   
              
                 
                
                
               
          
                
              
                
content analysis using a pre-established taxonomy. Physicians were the dominant group
reported in the papers (n = 3231, 89%). Concerns about not having enough time was the most
frequently cited barrier for doctors when implementing SDM across a number of clinical
encounters (22/38). Characteristics of the patient and the clinical setting not conducive to
SDM were noted as the second most frequently cited barrier (18/38). Clinicians in favour of
SDM only engaged in this process when SDM was perceived to have positive impact on
patient outcomes or the processes of care As such the authors of this study call for the
challenging to achieve if clinicians fear that allowing patients to make decisions that may be
against best medical advice and practice, would be incompatible with their medical duty of
care (Swenson, Settler & Lo, 2006).
,
Higginson, & Hearn
particularly with regards to decision making and this may influence the choices they make.
There is a latent tension in patients wanting to sustain hope and not feel fearful or anxious
and yet wanting to be fully informed with all available information (Leydon et al., 2000).
Control and autonomy is central to SDM and yet, at times, patients may wish to avoid
information and relinquish control to medical staff as a way of avoiding any decisional regret
(De Haes & Koedoot, 2003; Beaver et al., 2005).
Patients may have many valid reasons for not wanting to engage in SDM and to leave
medical staff to make decisions. In cancer where uncertainty about the outcome of treatment




            
              
 
 
               
          
             
           
            
         
          
          
             
            
 
                
   
              
       
 
              
  
                 
When illness is literally life- threatening, patients may regard clinicians as having the
expertise and power to provide safety (Salander, 2002) and this situation is often reinforced
2008).
A further influence hindering SDM in health care may be the pervasiveness of the traditional
believe that they do not have the expertise or experience
to make, or to contribute to, medical decisions about treatment decisions in life-threatening
diseases, due to the complex information used during consultation (Joseph-Williams ,
Edwards & Elwyn 2014). A European study conducted with women with gynaecological
cancers (n=53) examined information needs and decision-making preferences using
structured interviews together with measures of information needs (Information Needs
Questionnaire) and decision-making preferences (Control Preferences Scale) (Beaver et al.,
2005). Results were compared across previously conducted studies using the same tools with
breast (n=150) and colorectal (n=42) cancer patients. Participants identified that the doctor
was relie 
information involved (Beaver et al., 2005). In addition, participants did not wish to be seen to
ient role was
adopted. Older patients have particularly been reported as holding this view (Bastiaens, Van
Royen, Pavlic, Raposo, & Baker, 2007).
Frosch, May, Rendle, Tietbohl, & Elwyn, (2012) in their focus groups (n=6) with patients
(n=48) from primar 




              
                 
                
              
                  
 
             
                
       
             
            
               
              
               
              
 
               
             
            
             
          
             
               
the perceived benefits of behaving in a passive manner would make the doctor more
sympathetic to needs (Frosch et al., 2012). From this it is clear that having trust in the
clinician can act as both barrier and facilitator in SDM. Trust can make patients more willing
to ask questions, share information and discuss concerns (Fraenkel & McGraw, 2007) whilst
enabling the patient to take a passive role as they are in safe hands (Cohen & Britten, 2003).
Patients have also expressed concern about time being a considerable barrier to asking
questions, and thereby SDM. Patients were sensitive to the high workload of doctors and felt
et al., 2012). Other practical barriers have
been highlighted in a recent systematic review of patient-reported barriers and facilitators to
SDM (Joseph-Williams, Elwyn, & Edwards, 2013). Lack of continuity with medical staff
seen at clinic was perceived as disruptive and left patients feeling unknown as an individual
(Belcher, Fried, & Agostini Tinetti, 2006). Lack of time to adjust to devastating information
before making a decision was also noted as a barrier because the consultation could be
eclipsed by the shock of receiving a life-threatening diagnosis (Beaver et al., 2005).
The reasons why cancer patients seek or do not seek information from medical staff are
complex and cancer patients' attitudes to their disease and their coping strategies can
influence their information seeking behaviours and engagement with SDM (Leydon et al.,
2000). This results in patients feeling unprepared for consultations with medical staff and
patients leaving medical consultations with unanswered questions or inadequate information.
Whilst some system-based and practical challenges e.g. lack of consultation time, are difficult




            
               
             
              
         
 
          
            
         
            
              
             
              
              
           
          
         
             
              
 
               
      
           
health care decisions could be overcome by promoting self-efficacy (Bandura, 1997) in
patients. In order for patients to recognise their contribution to, and potential to gain from,
involvement in the medical encounter, patients need to be supported to acquire and
understand complex medical knowledge and be assisted in being part of the medical decision
making process (Joseph-Williams, Elwyn, & Edwards, 2013).
3.5 Interventions to Facilitate Shared Decision Making in Cancer
As previous sections have explored, improving information giving and SDM within medical
consultations is challenging. Many developed interventions to facilitate patient-doctor
interaction have, to date, focussed on developing the communication skills of doctors
(Fallowfield et al., 2002). These have been met with variable success. Such communication
training is often based on the traditional assumption that the health professional determines
the type, amount and content of information provided to patients and based on understanding
of what information patients want. This results in a standardised approach being taken which
can have erroneous assumptions when faced with patient populations with potentially
heterogeneous information needs. Whilst medical training in communication may inform
clinicians of specific communication strategies, communication skills performance remains
highly case specific (Baig, Violata, & Crutcher, 2009), implying that the transfer of
communication skills from one patient encounter to another is neither obvious nor easy.
Hack et al. (2005) in their examination of communication goals and the needs of cancer
patients direct a critical lens on




                
          
              
         
               
             
           
             
           
    
              
              
            
            
           
            
 
 
               
             
             
              
potential to result in patients being less reliant on the clinician and more able to satisfy their
goals. Enabling patients to effectively communicate personal values, priorities and
expectations to healthcare providers and to participate in SDM are of importance here and
indeed, are essential elements of patient-centered care (Hibbard, 2003).
Theories of decision making suggest an appropriate decision is one based on the evaluation of
the consequences of all options, appraising the likelihood and desirably of these choices
accurately and making trade-offs between these evaluations (Bekker, 2009). Janis and
individuals experience uncertainty about the decision to make especially when there is risk,
From this perspective, successful decision making consists of vigilant decision making,
ormation, careful consideration of
all viable alternatives and the unhurried, non-impulsive making of the final decision (Janis &
Mann, 1997). Without this, patients are likely to overreact and experience regret and even
anxiety and rage if undesirable consequences e.g. treatment side effects are experienced
(Janis, 1984). Key factors contributing to decision conflict in medical consultation therefore
relate patient perceptions of uncertainty, feeling uninformed, decision unaligned with patient
values and feeling unsupported in treatment decision making (Stacey, Samant, & Bennet
2014).
One patient-centred strategy to facilitate SDM and to optimise decision making is the use of
decision support technologies that can help patients to remember information, focus on points
of concern and consider issues for discussion in the consultation (Barnard, Cradock, Parkin,




          
        
    
              
            
             
               
              
                
 
 
               
             
 
              
   
            
           
              
             
              
             
              
                
cancer patients navigate their healthcare, share decisions and improve communication with
their doctors, and these are now discussed.
3.5.1 Decision Aids
Decision aids are evidenced based tools designed to prepare clients to participate in making
specific and considered choices about healthcare in ways that they prefer (International
Patient Decision Aids Standards (IPDAS) Collaboration, Elwyn et al., 2006). In this way,
decision aids are used to supplement and not replace clinician consultations, with the aim of
improving the quality of decisions made. Decision aids are intended to bring doctors and
patients together in a model of SDM enabling a mutual outcome to be reached that includes
Decision aids are informed by normative theories of decision making and as such provide a
framework for reaching the optimal choice (Bekker, 2009). Expected utility theory, the most
widely recog -
off between the probability of a consequence occurring and the utility placed on that
-off through the
goals of: increased question asking in the consultation; increased recall of information
discussed in the consultation; and increased satisfaction and confidence with treatment
decisions and decision aids. Often a difference is drawn between decision aids and decision
support tools. Most decision aids are self-administered tools, and can be paper or computer-
based. Decision aids provide specific and often visual data about the available options to
support patients in making an informed choice, for example when a preference sensitive
decision has to be made (Stacey et al., 2014). Decision aids present balanced information




              
              
             
      
 
              
             
            
               
              
             
               
            
   
            
              
             
               
               
                
 
                
              
informed judgement (Coulter and Collins, 2011). This is in contrast to decision support tools
that aim to provide patients with greater information, advice and support for treatment and
treatment decisions through the use of question prompt sheets, coaching, and recording and
summaries of the medical consultation.
A recent Cochrane review of decision aids (Stacey et al., 2014) identified high quality
evidence that concludes when compared to usual care, decision aids improve knowledge
about treatment options and reduce decision conflict. Moderate quality evidence was reported
on demonstrating that decision aids stimulated patients to take a more active role in decision
making and improved accuracy of patient perception of risks, when compared to usual care.
Low quality evidence was reported to show decision aids improve congruence between the
decision and values held by the patient (Stacey et al., 2014). Similar results have been
demonstrated in randomised controlled trials using decision aids with cancer patients (Stacey
et al., 2008).
Whilst acknowledging the strengths of decision aids, a well-recognised weakness is that
decision aids disregard the longitudinal (i.e. over time) and multifaceted nature of health care
decision making (Ferrer, Hambridge, & Maly, 2005). Patients, especially cancer patients, are
confronted with multiple decisions to make over time, and in the context of developed (or
choices is an important and valuable component of SDM itself (Alston et al., 2012) and
integrating this into the decision-making process is often beyond the scope of a decision aid.
Rather than using decision aids as a single use tool with a specific aim, an alternative




                
              
   
            
              
                
              
            
               
                
             
                
              
             
        
 
    
              
                
              
              
             
             
            
process (Ferrer & Gill 2013). This is more in line with the approach taken in decision
support tools. Epstein & Gramling (2013) develop this thinking further in their recent work
that describes the conc 
decisions are best reached through an iterative process with dialogue involving the
perspectives of people important to the patient. Decision aids are often created for situations
when there is no clear evidence in favour of one treatment decision over another. In such
situations, it is important to consider what current best practice guidelines exist together with
the patient preferences (Epstein & Gramling, 2013). Where decision outcomes have high
impact, patients often want control over the timing and delivery of the information and are
concerned that their values and preferences will be taken into account, but they may not want
to make the actual decision themselves (Charles, Whelan, Gafni, Willan, & Farrell, 2003).
Whilst it is challenging to ensure all these variables are accounted for in the medical dialogue
(Epstein & Gramling, 2013) it is important to develop technologies further to support this
outcome. In acknowledging the inherent limitations of decision aids, the evidence base for
use of decision support tools is now explored.
3.6.2. Questions Prompt Sheets
patient- centred questions during consultation. However, this is an area known to be difficult.
Patients are often unaware of what information they require and how much they can ask of
their clinician. One way to facilitate patients having more control over the flow of
information, is to encourage the asking of questions. Question prompt sheets are effective and
inexpensive interventions used in cancer care, enabling patients to become more involved in
medical consultations (Kinnersley et al., 2007). In a recent meta-analysis of the empirical




           
           
           
              
              
                  
              
    
 
              
            
      
          
            
            
          
            
               
               
             
            
            
          
    
 
significant increases in patient satisfaction (Kinnersley et al., 2007). Question prompt sheets,
further supported by other reviews (Dimoska, Tattersall, Butow, Shepherd & Kinnersley,
2008), were originally developed from observation of the medical consultation. Butow,
Dunn, & Tattersall (1995) examined 142 interactions between the doctor and patient in the
initial oncology medical consultation. Patients were observed to speak for only 24% of the
time, and asked a mean of 5.6 questions that took up 0.07% of the total consultation time. In
contrast, physicians spoke for 44% of the consultation time, 5% of which was spent
answering patient questions.
Low rates of patient questions-asking behaviour results were found in very early work by
Roter (1977) when examining the consultation behaviours of 250 general practice patients.
-asking behaviours could be influenced by
addressing enabling, predisposing, and reinforcing factors. Applying this, a coaching
intervention was developed to encourage patients to ask questions. In a randomised
controlled trial, the experimental group of patients asked more direct questions when
compared to controls. However, this concomitantly resulted in increasing negative
interactions between the experimental group and the doctor, with lower patient satisfaction
report of care received (Roter 1977). Butow, Dunn, & Tattersall (1995) built on this study
utilising a randomised controlled trial to investigate the effect of a question prompt sheet to
encourage cancer patients to ask questions. No significant difference was identified in the
number of questions asked between the control and intervention group, although patients
using the prompt sheet group asked significantly more questions about prognosis. These





            
               
         
           
               
              
             
      
 
               
               
            
              
              
             
              
             
             
  
             
                 
                
 
Learning from previous trials, Brown, Butow, Boyer, & Tattersall, (1999) ensured the prompt
sheet used in their study was discussed with and endorsed by the clinicians, and added
individualised coaching to train patients in question-asking behaviours. Research
psychologists worked with patients immediately before their consultation on the importance
of asking questions, guided them to generate a list of questions, explored benefits and barriers
to questions asking and, using coaching techniques, invited them to role play asking their
questions. Results demonstrated that the intervention groups did ask more questions, but this
outcome was not statistically significant.
In a more recent trial, although still not current, a heterogeneous sample of cancer patients
(n=318) were randomised to receive a question prompt sheet or not (Brown, Butow, Dunn, &
Tattersall, 2001). Oncologists were also randomised to either actively address the prompt
sheet or passively respond in their consultation. Patients in the intervention group and who
used the prompt sheet asked more questions about prognosis when compared with the control
group and this resulted in oncologists offering more prognostic information to these patients
(p=0.058). Patients who had a prompt sheet and a proactive doctor recalled significantly more
information and had significantly shorter consultations. Patients with the prompt sheet and a
passive doctor were reported as significantly more anxious than the two other groups,
ting a
negative reaction. Conclusions from this study are difficult as the sample was heterogeneous
and although large, there may have been a large variance in the nature of topics discussed.




               
            
                
                 
             
            
            
            
          
              
          
           
           
             
          
       
 
                
                   
             
             
                  
               
        
A recent cross over trial based in primary care in Australia, aimed to test the effectiveness of
just three generic questions hypothesised to elicit the minimum amount of information
needed to make a decision (Shepherd et al., 2011). These questions included: What are my
options? What are the benefits and harms? And, how likely are these? (Shepherd et al., 2011).
This study utilised two standardised patients, one delivered the intervention whilst the other
provided the usual care condition by not asking the prescribed questions. Thirty-six
unannounced standardised patient visits (18 intervention, 18 control) to primary care were
conducted. The transcripts of each consultation were then analysed using a non-standardised
measure of patient involvement (Assessing communication about evidence and patient
practice, ACEPP) and the well validated coding tool OPTION (Elwyn et al., 2005) to
measure clinician involvement. Rater analysis demonstrated within the intervention group
consultations, there was improved information provided by the clinician and increased
consideration of patient preferences in regards to treatment decisions thereby enhancing
patient involvement (Shepherd et al., 2011). This study presents powerful effects of three
simple questions on communication behaviour, however the reliability of the
ACEPP tool is not well established.
From this review of question prompt sheets, it is clear that encouraging patients to ask as
much as they wish or do not wish, supported by the clinician, is integral to their success. The
negative impact on patients when using prompt sheets is a worth consideration. Salmon
(2005) cautions that prompt sheets could disempower patients by inducing them to participate
more than they may have initially wanted to. It is postulated that there is a fine line between
empowering patients to achieve their goals and training them to fit with current thinking of




   
                
           
                
             
 
              
            
              
         
          
           
             
            
             
               
              
               
           
                   
            
 
3.6.3. Patient Coaching
The focus of coaching techniques as a decision support tool are in line with the core patient-
centred SDM principles outlined previously. Therefore coaching focuses on enabling patients
to speak up about their concerns, question what is important to them, recognise their right to
be equal participants in care, and to seek and use high quality information.
A Cochrane review has assessed the evidence of impact from interventions to help patients
address their information needs before their consultation, using a narrative synthesis and
meta-analysis (Kinnersley et al., 2007). This review identified 33 eligible RCTs, of which the
most common interventions were checklists and patient coaching. Meta-analyses
demonstrated these interventions were statistically significant in increasing question asking
and patient satisfaction. Interestingly, although not significant, the authors found anxiety
decreased before the consultation and again afterwards. Notably the addition of coaching to
an intervention before the consultation produced a larger non-significantly increase in patient
satisfaction when compared to the prompt sheet alone (Kinnersley et al., 2007). Furthermore,
the use of coaching and written materials such as question prompt sheets produced a smaller
increase in the length of the consultation when compared to question prompt sheets alone
(Kinnersley et al., 2007). In further support of this finding Belkora et al. (2008b) interviewed
because of my work [coaching], the doctor can learn key things
about a patient in five minutes [by reading the prompt sheet] that I've learned in an hour and a
half 




             
               
             
             
            
             
             
           
              
         
 
      
             
               
                
                
    
 
                 
            
             
               
            
Several rationales were conceived from a review (n=96) of the theoretical and empirical
evidence to inform the use of coaching alongside tools of decision support (Stacey et al.,
2013). These rationales included the ability of coaching to; achieve higher quality decisions,
avoid decision pitfalls, improve the quality of two way communication between patient and
clinicians, enhance learning and manage emotional distress (Stacey et al., 2013). When
compared to usual care the authors found coaching improved knowledge, however all other
variables (participation in decision making and satisfaction) were no different, and no worse,
than interventions without coaching. The authors concluded that the theoretical evidence
justifies the use of coaching to enhance decision support for patients and facilitate their
involvement in shared decision making (Stacey et al., 2013).
3.6.4. Recordings and Summaries
Whilst the provision of information in different formats is recognised as important (Halkett,
2010), the most effective way for providing information for cancer patients is as yet unclear
(Catt et al., 2008). Evidence suggests that while cancer patients with a good prognosis find a
taped or written record of the consultation helpful, cancer patients with a poor prognosis do
Guidance Subgroup, 1998).
It is often difficult for any patient to remember all the information that is presented in a
consultation (Kawabata, Konishi, Murakami, Kisa, & Maezawa, 2009). For this reason, many
patients access information outside of the medical consultation, for example at home, through
use of internet. Whilst some of these resources can be high quality, others may contain




              
            
              
                
 
             
            
           
              
             
              
            
            
              
             
           
               
          
             
             
               
      
            
            
inappropriate or confusing material. One way to circumvent this problem is to provide only
information that is applicable and specifically tailored to meet the individual patient's
information needs. This can be achieved by providing patients with a recording of their
medical consultation that can then be taken home for review in their own time (Butt, 1977).
Reviews of the empirical evidence support the conclusion that recordings and summaries of
oncology consultations are valued and utilised by patients, improve patient information recall
and potentially enhance patient satisfaction (Pitkethly, MacGillivray & Ryan, 2008; Tattersall
& Butow, 2002). As a Cochrane review, the results of 16 randomised controlled trials
involving use of recordings or summaries of consultation were studied. There was no
evidence of increasing anxiety and depression in patients following the use of recordings or
summaries, with indication that recorded information was used to later initiate treatment
discussions with family members (Pitkethly et al., 2008). This Cochrane Collaborative Group
concluded that although more research was needed to improve understanding in this area, the
provision of recordings of key consultations may benefit adults with cancer, and that
practitioners should consider offering consultation recordings to patients (Pitkethly et al.,
2008). Indeed, this has been supported by SIGN guidance (2011) for treating patients with
colorectal cancer, recommending that healthcare professionals should consider giving written
summaries or recordings of consultations to those who have expressed a preference.
Providing recordings or even sending patients their clinic letters is not standard medical
practice in some health care systems, such as in Scotland. Whilst no studies have reported
, work is this area is
outdated and non-UK based. Two surveys in Australia (Tattersall, 1994; Stockler 1993)




             
            
               
           
               
               
             
             
              
             
             
 
          
             
             
          
               
            
            
               
          
         
       
           
legal consequences of providing patients with a recording. Differences in the benefits of
providing recordings and/or providing summaries has not been widely or recently studied
(Pitkethly et al., 2008). Two studies have reported that a recording was more effective than
written information (Tattersall Butow, Griffin, & Dunn, 1994; Bruera Pituskin, Calder,
Neumann, & Hanson, 1999) but further work is required in this area to determine whether
one medium is more effective than another, or if both are required. Furthermore, the majority
of studies investigating the usefulness of audio-recordings for patients have focused on the
initial meeting between patient and doctor, specifically bad news consultations. Given that
treating patients for cancer can be a long process with multiple decisions throughout the
disease course, at each appointment, new information and options may be presented. This
needs appreciation in the design of studies evaluating use of such recordings.
3.7. Consultation Planning, Summarising and Recording (CPRS): Navigation
Navigation is a decision support and communication tool designed by Belkora (2005) to
facilitate breast cancer patients make decisions about their treatment options. As a complex
intervention Navigation brings together key elements described above, namely: question
prompt sheet, coaching, and provision of a recording, in addition it also provides a written
summary of the consultation. The intervention was derived from original work undertaken
about consultation planning, recording and summarising (CPRS) and the first evaluation of
the intervention in full was published in 2008 (Belkora et al., 2008). CPRS follows guidance
from the Ottawa Decision Support Framework, an evidence-based, practical, mid-range
theory that guides patients making health or social decisions
(https://decisionaid.ohri.ca/odsf.html). The framework proposes that decision support




          
  
           
              
       
                
         
              
              
              
              
 
             
            
           
           
            
          
          
   
 
           
         
outcomes including decision self-efficacy, decisional conflict, and decisional regret, among
others (O 
The CPRS intervention identified patient needs for asking questions and remembering
responses during medical consultations (Hack et al., 2005; Rutten et al., 2005) and combines
evidence-based interventions (question-listing, note-taking, and audio-recording) with
coaching to address these needs (Kinnersley et al., 2007; Pitkethly et al., 2008). As it
addresses common patient information and communication needs using evidence-based
strategies, CPRS has been transferable to distinct contexts. Studies have found the CPRS or
Navigation intervention to be effective in breast cancer (Belkora et al., 2015); prostate cancer
(Hacking et al., 2013); and orthopedics (Bozic et al., 2013). These prior experiences with
CPRS established its feasibility and effectiveness across a broad range of clinical conditions.
CPRS has a strong evidence base of facilitating communication and decision making in
breast cancer consultations in America, specifically aiming to increase question asking by
patients during treatment consultations, improve patient knowledge and recall of treatment
information provided by the physician, and significantly increase confidence in and
satisfaction with the final treatment decision (Belkora 2008a; Belkora 2008b; Belkora 2009).
Furthermore, it has been demonstrated to significantly reduce patient reported
communication barriers in the medical consultation (Sepucha, Belkora, Mutchnick, &
Esserman, 2002).
The intervention consists of three evidence-based practices combined into one patient-centred




      
                
                
             
             
               
   
            
             
               
          
 
              
   
                
            
             
            
          
           
            
              
               
               
, guide patients through the process.
Navigators meet with patients over the phone and help them to generate a list of questions
and concerns. This is known as a consultation plan for use in their medical consultation. This
list is generated using a neutral non-directive approach to question listing (Belkora 2008a;
Belkora 2008b, Belkora 2009), known as SCOPED; Situation Choices Objectives
People - Evaluation Decisions. Patients are encouraged to think of questions which are then
organised into a li 
clinician to review before the consultation occurs. The Navigator then accompanies the
patient to their consultation. Consultation recordings consists of the Navigator creating a CD
audio-
consists of the Navigator creating a word processed written summary of the key advice and
information presented by the doctor during the visit.
Navigation was first trialled in the UK with newly diagnosed prostate cancer patients in
Edinburgh, Scotland from 2008-
et al., 2013). The feasibility and efficacy of this trial was tested utilising a concurrent mixed
two arm methods randomised controlled trial. The quantitative analysis from patient pre-
post- questionnaires revealed that Navigated patients (n = 62), compared with usual care
patients (n=52), had significantly higher scores in decision self-efficacy (p=<0.05) in addition
to significantly less decisional conflict (p=<0.05) about treatment decisions post-consultation.
Navigated patients further experienced significantly less decision regret (p<0.05) 6 months
after intervention, where higher levels of self-efficacy were maintained in favour of
Navigation (Hacking et al., 2013). Effects on mood or anxiety were not found, suggesting
that Navigation did not impact on this area. This study is currently the only randomised




             
           
             
               
              
            
               
             
             
               
                  
               
   
 
              
                
            
             
              
               
              
             
                
This study also had a qualitative component where six intervention patients were interviewed
regarding their experiences of Navigation (Hacking, Scott, Wallace, Shepherd & Belkora,
2014). Findings demonstrated that Navigated patients felt enabled to prepare for the medical
consultation, and used the question list to help them focus on their concerns in the
consultation. They reported that the doctor was prepared for them and presented them with
individualised information. All six participants reported utilising the CD and summary and
found them useful to help with recalling information and facilitating the choice of treatment
options. Patients also reported they felt supported by their Navigator, although the definition
of what this support encompasses is not provided. These findings suggest Navigation with
prostate patients was well received and benefitted the patient in a SDM process. The small
sample (6 from 63 intervention trial patients) is acknowledged as a limitation and with no
control sample for comparison it is difficult to draw conclusions from this qualitative study in
isolation.
By including a qualitative component in their randomised controlled trial Scott et al., (2014)
were also able to evaluate Navigation in terms of its effectiveness from the perspective of the
specialist doctors (2 oncologist, 2 surgeons). From this, doctors reported that Navigation
patients were more prepared for their consultation meetings and doctors reported being more
prepared to see patients, having reviewed their consultation plan. Doctors reported using the
consultation plan as a checklist at the end of the consultation to ensure concerns were
addressed. These findings are consistent with previous studies (Belkora et al., 2008b) in that
Navigation helped patients organise and clarify their medical questions and ensure these were




            
              
              
               
           
            
        
 
               
             
           
             
           
        
 
   
              
           
             
             
          
           
             
              
 
s information needs. This latter point support is also noted as an
advantage for clinicians in a review paper on health care consumer support by Hibbard
(2008). Whilst medical staff supported the use of Navigation into the UK healthcare system
with prostate cancer patients (Hacking et al., 2014), the implementation cost of this was seen
to be prohibitive, with alternative ways of implementation suggested, including utilising
Clinical Nurse Specialists or volunteers. Currently, in America the program is delivered
through a less costly premedical internship programme.
In this short introduction to Navigation, it can be seen that previous research has only
undertaken Navigation with two oncology patient populations, and at one time point within
their medical journey. Consequently, to progress learning about this intervention, its
effectiveness, credibility and sustainability, this thesis is designed to trial Navigation with a
more diverse oncology population and follow patients over consecutive consultations, over
time as medical choices and decisions evolve.
3.8. Summary
This chapter has reviewed the health policy drivers and current literature based on shared
decision making demonstrating the increased focus on shared decision making, particularly
with regards to cancer care. The empirical evidence exploring patient needs for information
and the practical, professional and social barriers in achieving this have been explored.
Finally patient-centred interventions, specifically decision support aids, designed to facilitate
patient involvement in their consultations have been described and the Navigation
intervention evaluated in this thesis was introduced. The next chapter will present the




       
 
   
               
             
              
             
           
              
              
       
 
    
          
              
            
            
              
       
                
         
 
          
            
            
            
Chapter 4: Study design, Navigation intervention and protocol 
4.1. Overview
The previous chapter set the scene for this study by exploring literature relevant to shared
decision making in an oncology context. This chapter outlines the study design, the
intervention and the sample populations for this thesis. The study design describes the
approach taken to evaluate the Navigation intervention. The intervention model will then be
described in-depth using the template for intervention description and replication (TIDieR)
checklist and guide (Hoffman et al., 2014). The chapter concludes by presenting an overview
of the evaluation time points across both samples and within the two empirical studies
conducted that evaluated the Navigation intervention.
4.2. Study Design
A mixed-methodology design employing a parallel group, pragmatic randomised controlled
trial (RCT) with nested qualitative studies was utilised to evaluate Navigation. The study was
longitudinal in nature with six measurement points over nine months evaluating serial
exposure to the intervention, repeated three times. Whilst the RCT evaluation was
longitudinal, the qualitative evaluation occurred at one time point, at the end of treatment.
The qualitative evaluation included participants and their clinician 
rationale for this design is presented below. Details relating to the RCT will be described first
followed by separate description of the qualitative evaluation.
4.3. Evaluating a complex intervention: a mixed methods approach
The UK Medical Research Council (MRC) (2000) proposed a framework for the
development and evaluation of complex interventions, subsequently updated by Craig et al.




            
             
          
             
              
               
        
              
            
             
              
                 
         




types of decision support interventions. Navigation therefore is a complex intervention, as
defined by the MRC framework (Craig et al., 2008). When evaluating complex
interventions, methodological design is driven by establishing effectiveness in everyday
practice (Craig et al., 2008). The older MRC guidelines (2000) provided guidance for
evaluators to ensure a logical and systematic progression of evidence was built through the
design of research studies. This guidance was used to steer the methodological design of this
evaluation of Navigation. As istence and with a
body of supporting literature that has undergone exploration and testing through use of mixed
methodology; sequential controlled trial (Sephuca et al., 2002), case study (Sepucha, Belkora,
Aviv, Mutchnik & Esserman, 2003) qualitative evaluation (Belkora et al., 2009, Hacking et
al., 2013), quasi-experimental (Belkora et al., 2013) and RCT (Bozic et al., 2013; Hacking et
al., 2013) studies. The MRC guidance suggests that this body of work is currently at a Phase
III, exploratory trial, of the evaluation trajectory as show in Figure 4.1. 




          
             
                
                
            
             
            
             
               
             
           
              
 
           
              
              
              
             
               
              
             
              
               
To comprehend which methodological design will best meet aims of this study an
understanding of the paradigm stances is first needed. Distinction is often made between
philosophical views about the nature of knowledge in the social world and the ways in which
social reality should be studied (Guba & Lincon, 1982). The terms are also used to describe
different ways of conducting social investigations described as a technical position (Bryman,
1992). Academics continue to argue the merits and demerits of positivism (which equates
with quantitative and objective methods) and of naturalistic inquiry (which equates with
qualitative and subjective methods). Furthermore, they are often seen as being in competition
with each other. Within health care this competition has arisen as a consequence of the
evidence based medicine approach and the search for evidence that is reliable and
generalisable to a population (McPherson & Leydon, 2002). Quantitative methodology has
secured a dominant role in the provision of evidence within the health system.
Quantitative methodology generally emphasises theory testing and an external perspective of
a single tangible reality (Lathlean, 1995). In contrast, qualitative research is marked by a
concern with the discovery of theory rather than the verification of theory (Filstead, 1979).
The qualitative paradigm argues that social settings are complex, made up of individuals with
different perspectives, behaviours and intentions and can only be understood by studies that
that actors attach to their behaviour (Burgess, 1984). The aims are to analyse and describe
experiences, values and attitudes of people in their natural contexts (Burgess, 1984) with an
understanding of the role of the researcher within the data collection process. Qualitative
methods in health care are becoming widely used and increasingly accepted (Mays and Pope,




              
             
                
    
 
             
              
             
             
              
             
           
             
            
            
            
               
     
       
 
            
           
       
           
              
hierarchy of methodologies due to its small sample size and therefore lack of generalisability
(McPherson & Leydon, 2002). To reject this methodology, which aims to understand the
lived experience of cancer in favour of a reductionist approach is limiting in the pursuit of
providing patient-centred care.
The MRC guidance suggests a combination of qualitative and quantitative methods is likely
to be needed, for example to understand barriers to participation and to estimate response
rates (Craig et al., 2008, p10). Mixed methods investigations involve the integration of
qualitative and quantitative data collection and analysis in a single study (Creswell, Plano
Clark, Gutmann & Hanson, 2003). The concept of using mixed method research is gaining
popularity within the social science and health field (Gutterman, Fetters & Creswell, 2015).
This integration of methods is particularly important when studying oncology as
understanding the psychosocial aspects of living with a cancer and the related increasing
complexity of providing appropriate and timely cancer care is increasingly being developed
across Europe (McPherson & Leydon, 2002, p.225). Silverman (2001) suggests that when
considering methodologies, the common goal of both methodologies in detecting patterns in
data based on the analysis of the data body, should be recognised. Sandelowski (2000) states
that it is that should
influence how they are utilised.
Mixed methodology to evaluate an intervention is characterised by concurrent use of
quantitative and qualitative data collection to facilitate data triangulation and evaluate
p p14). Mixed method evaluation aims to
assess program acceptability, application to daily life, cultural specificity, integrity and




            
              
             
      
 
              
              
              
            
              
             
              
            
              
            
             
              
          
               
   
 
      
            
              
           
& Varjas, 2004). The use of multiple paradigmatic approaches is particularly useful in the
evaluation of the effects of complex health interventions, such as Navigation, as this involves
behavioural processes that can be difficult to explore or capture using quantitative methods
alone (Lewin, Glenton & Oxman, 2009).
The motivations of early mixed methods work were driven by the pursuit of a cross-
validation of results; conducting two different studies with the goal of reaching the same
conclusions (Campbell and Fiske 1959, Glantz, Halperin & Hunt, 1998). This aim however is
both expensive and time consuming. Complementarity has since consistently been a strong
motivation for combining research methods. Here the strength of one method is used to
enhance the performance of the other method. The mixture of qualitative and quantitative
evaluation is often needed in the evaluation of complex interventions to gain further insight
into barriers to participation or counter-intuitive findings (MRC, 2008). This thesis utilises
the convergent design model to guide the quantitative and qualitative approaches of this study
(Gutterman, Fetters & Creswell, 2015). This model involves collecting qualitative and
quantitative data concurrently (Gutterman, Fetters & Creswell, 2015). The two forms of data
are then be integrated through merging the quantitative with the qualitative results in the
discussion (Gutterman, Fetters & Creswell, 2015). The quantitative and qualitative
approaches chosen for this study, steered by the revised MRC guideline are discussed in the
following section.
4.3.1. The Qualitative and quantitative design
The MRC revised guidelines (2008) on complex interventions suggest that the parallel-group
randomised controlled trial is the optimal study design to minimise selection bias and provide




            
              
      
 
             
             
               
             
                
              
             
             
            
              
            
         
 
              
             
              
              
             
             
            
statistical power of chance to evenly distribute potentially confounding variables among the
trial arms (Craig et al., 2008). Where confounders are minimal and participant numbers high,
this strategy should be adequate.
For this study, a parallel-group randomised design with the colorectal cancer population was
feasible. However, this design was not feasible within the population of people diagnosed
with a High Grade Glioma due to the rarity of this cancer type. Furthermore, longitudinal
RCTs are particularly difficult to implement in trials of interventions within this population
because of high rates of attrition due to death (Catt et al., 2008). Within the colorectal
population it was estimated, based on previous evaluation trials of Navigation, that the study
would be sufficiently powered to reliability identify any difference between the trial arms
(intervention vs. control). The advantage of utilising randomisation ensures the effects of any
external factors such as environment / demographics, which may influence outcomes, were
minimised thereby reducing any selection bias that may have been present. However, it is
possible for confounding factors, especially if uncommon but significant, to be more
prevalent in one arm over another (MRC, 2000).
As noted previously the MRC guidelines (2008) suggest a qualitative element of evaluation is
integral to the understanding of how the intervention is experienced and implemented from
the perspective of its users. Within this evaluation qualitative data from trial participants and
consulting clinicians were gathered to triangulate the RCT results. By gathering both forms of
data, the study aimed to provide a comprehensive and complete understanding of the
intervention. Furthermore, for the evaluation of the intervention from the perspective of the




          
            
 
              
              
              
              
               
              
    
 
         
               
           
             
                  
             
               
            






comparison of experiences with the intervention across populations. Justification and
elaboration on this qualitative design is discussed in-depth within chapter 7.
A review of RCTs which utilised qualitative approaches by Lewin et al. (2009) emphasised
the importance and contribution of qualitative studies to RCT designs. This review found 19
out of 100 trials published qualitative work and only four of the qualitative investigations
were conducted after the trial (Lewin et al., 2009). Utilising the critical appraisal skills
programme to review the quality of the qualitative studies the review found no integration of
the two approaches (qualitative and quantitative) in the analysis or interpretation in 13 trials
(Lewin et al., 2009).
This study is guided by the convergent design model
integration of the results meets the necessary aims of the evaluation. As such, the study
structure and methodology will present quantitative data collection, analysis and results
(chapter 5 and 6) separately from the qualitative data collection, analysis and findings
(chapter 7, 8 and 9). Integration of this data will occur when the results of the study are
discussed (chapter 10), thereby presenting an enhanced understanding of the impact of the
intervention on the treatment for cancer, a feature found lacking in a previous review (Lewin,
Glenton & Oxman, 2009). Further justification for the specific methodologies will be




   
            
               
               
               
            
    
 
              
              
                 
             
             
             
 
           
              
               
             
               
         
           
              
           
4.4. Study Setting
As detailed previously, a mixed methods evaluation of Navigation was conducted by
undertaking a RCT with a cohort of CRC patients alongside and a qualitative evaluation with
a cohort of HGG patients. This evaluation was conducted in a tertiary cancer centre in
Scotland. The centre is a regional cancer centre and the sole provider of specialist cancer
services to a geographically defined population of approximately 1.5 million people (Strong
et al., 2007).
The RCT took place between November 2010 and December 2013 in the colorectal cancer
clinic. This clinic is staffed by colorectal oncologists and typically diagnoses 190 new cases
of CRC each year, and of these five to six people are referred for further oncology treatment.
The qualitative evaluation took place between November 2010 and January 2013 in the
neuro-oncology clinic. This clinic is run by medical staff from neurology, neurosurgery and
oncology specialities and typically diagnoses 100 new cases of HGG each year.
4.5. Ethical Approval, data management and study funding
Although typically ethical approval is explored later in the methods chapter, due to the
complex design of the study, the ethical arrangements are made clear at this point. NHS
ethical approval was obtained from the South East Scotland Research Ethics Committee 03
REC reference number; 10/S1103/47; see Appendix 1. The study was also approved by the
Queens Medical Research Institute, Research and Development, project number;
2010/W/ON/19 and Coventry University Registry Research Unit. All data records were
anonymised and held according to the requirements of the Data Protection Act (1998) and




             
        
 
      
              
            
              
               
                
           
 
              
             
               
             
            
              
          
              
            
            
             
locked cabinets. Recordings, consultation plans and summaries were stored in a NHS secure
electronic database with no identifying details included.
4.6. The Navigation intervention
To give structure to the reporting of Navigation, the complex intervention that is being
evaluated in this thesis, the Template for Intervention Description and Replication (TIDieR)
checklist and guide (Hoffman et al., 2014) is utilised. Making transparent the structure and
nature i.e. their form may not always be the same (Pawson, Greenalgh, Harvey & Walshe,
2005). In a review of complex interventions by these authors, it was suggest there would be
fas 
acknowledgement and reporting of the changes to intervention delivery and content.
The reporting of complex interventions often lack the detail needed to enable replication. An
analysis of 137 RCTs of non-pharmacological interventions published in 2009 in leading
general medical journals identified that over half (61%) did not provide the level of detail
needed to enable replication of the complex intervention in practice (Hoffman, Erueti &
Glasziou, 2013). This may be unsurprising given the guidelines for reporting interventions
have only recently been developed. One approach often used to report and describe complex
interventions is the CONSORT checklist for reporting non-pharmacologic RCT evaluations
(Boutron, et al., 2008). As a reporting structure, the CONSORT checklist identifies four key
areas to guide the description of interventions including: trial arms, intervention components,
standardisation and adherence. In contrast, the TIDieR checklist is more focussed on




          
    
 
             
              
                
                
             
              
               
                
            
 
              
              
              
         
 
  
          
          
              
              
             
sufficient explanation with an illustrative example sufficient to enable replication (Hoffman
et al., 2014).
The TIDieR checklist was developed through using results from a literature review for
pertinent checklists, followed by a Delphi survey of an international experts to guide item
selection, and a face to face panel meeting to agree the final checklist structure and content
(Hoffman et al., 2014). The resultant 12 item TIDieR checklist includes details of the name
of the intervention, the materials used, the procedures, planning and delivery of the
intervention. It is in fact an extension of the previously developed CONSORT 2010 statement
(item 5) and the SPIRIT 2013 statement (item 11). The strength of utilising the TIDieR
checklist is that it is specific to detailing the design and procedures of intervention studies, as
opposed to the CONSORT guidelines which provide structure for reporting on trials.
In using the TIDieR framework to report on the intervention, sufficient detail is therefore
provided within this thesis to enable replication. The remainder of this chapter uses the
TIDieR checklist to detail reporting on the complex intervention. This thesis also includes a
completed copy of the TIDieR checklist (Appendix 2).
4.6.1. Navigation
The intervention is called Navigation and comprised three evidenced-based processes:
consultation planning (Kinnersley et al., 2007), audio recording, and summarising
(Pitkethley, MacGillivray & Ryan 2008). In publications, the intervention has been referred
to as CPRS an acronym for consultation planning, recording and summarising (Belkora et




               
               
 
 
       
           
            
            
              
            
            
              
                
                
               
               
               
              
            
    
 
             
as it did not appear reflective of all the components of the intervention. The term
previous studies (e.g. Hacking et al., 2013). Participants were invited to take part in the
4.6.2. Theory essential to the Intervention
The Navigation intervention follows the underpinning principles of the Ottowa decision
support framework (ODSF) (O'Connor et al., 1998). This framework proposes that decision
support interventions should assess patient decision needs; address those needs and measure
outcomes (O'Connor et al., 1998). The framework was designed to guide the development of
shared decision making interventions and is a combination of several decision making
theories; the expectancy value model, decision analysis, prospect theory, conflict theory of
decision making and theory of reasoned action (described in Chapter 3, section 3.6.1)
(O'Connor et al., 1998). In essence, the framework is based on the premise that when making
decisions an individual is more likely to opt for the option with the highest expected values
and success; choices are made based on the probability of consequences (and the utility of
this consequence); the choice may be influenced by how it is framed; uncertainty in choosing
can be relieved by the gathering and evaluation of information, and decisions are made based
on our attitudes and subjective norms. The ODSF is organised according to determinants of
decisions, with different elements of the intervention addressing each determinant and its
r et al., 1998).




             
        
           
              
          
             
             
         
 
             
               
            
             
              
   
 
     
            
             
    
 
  
              
              
involved, their personal and external resources to make and implement a choice and personal
to improve decision making quality by influencing the
al., 1998). The Navigation intervention specifically focuses on addressing the information
needs and recall abilities of oncology patients when making decisions (Hack et al., 2005;
Rutten et al., 2005). It combines evidence-based interventions (question-listing, note-taking,
and audio-recording) with coaching to address these needs (Kinnersley et al., 2007; Pitkethly
et al., 2008). In this way, the intervention addresses the determinants of inadequate
knowledge, inadequate support, unrealistic expectations, unclear values and inadequate
personal reso 
theoretical underpinnings of the ODSF, and the specific conceptual goals of Navigation were
used to inform the outcome and process measures using in this evaluation of the Navigation
intervention. The specific research questions and outcome measures will be further explored
when discussing the variables evaluated in the RCT (Chapter 5), and also informed
development of the interview schedule used to collect data in the nested qualitative study
(Chapter 7).
4.6.3. Materials and procedures
The Navigation intervention was delivered by two trained Navigators who delivered the
intervention across both patient populations. The methods for each of the Navigation stages
are detailed below.
Consultation Planning
Consultation planning denotes the time that the Navigator spent with patients prior to medical




              
              
             
                
               
            
               
      
 
             
            
           
             
           
          
           
                
        
 
            
          
      
planning for the medical consultation was undertaken by way of thinking about questions and
concerns that patients want to raise with medical staff. The outcome of the consultation
planning appointment was a patient formulated consultation plan sent in advance to medical
staff for use in the upcoming oncology consultation. In the majority of cases, this meeting to
place with their Navigator over the telephone in order to avoid additional hospital visits.
Where patients expressed preference for a face-to-face meeting, the Navigators met with
patients in a quiet room in the hospital or local cancer support centres. Consultation planning
meetings lasted 30 minutes (approximately).
For the purposes of this evaluation, a maximum of three consultation planning meetings
occurred. That is a meeting with Navigators occurred before three consecutive outpatient
clinic appointments. At the first encounter of consultation planning, Navigators familiarised
participants with the process and procedures of the consultation planning session and set
appropriate expectations for the duration of the evaluation. This conversation was audio-
recorded, with permission, thereby enabling Navigators to listen to the
conversation and ensure all pertinent information was delivered. This audio-recording was
also used for quality assurance procedures. It was stored securely on a shared drive in the
hospital system, only accessible by the research team.
Navigators began each consultation planning by asking participants to explain what had
their current and upcoming situation, Navigators used neutral, non-directive interviewing




             
             
   
               
          
             
              
              
             
              
             
                
                
            
 
             
           
 
              
            
 
              
1. Scribing: Participants were guided to freely talk about their situation and what had
happened while the Navigator typed brief notes/ bullet point list on a computer/laptop.
2. Laddering:
scribing step, leading to more specific, concrete statements. The outcome of this step was to
make explicit any implicit thinking of concerns or fears.
3. Checking: Using a specific, structured question prompt sheet known as SCOPED,
developed by Dr Jeff Belkora at UCSF (see appendix 3), Navigators guided participants in
key questions, concerns and objectives relating to the six categories of the SCOPED model:
their current Situation, the treatment Choices available to them, their personal goals and
Objectives for treatment and their quality of life, the People involved in supporting them,
Evaluating the impact of their choices against their personal objectives, and finally the
Decisions that they have made or will need to make in the future regarding their care.
4. Triaging: In the final step participants were guided to prioritise issues according to their
level of importance for their next clinic appointment with their consultant.
During consultation planning, the Navigator made typed notes about the content of the
consultation, to ensure all the patien ere recorded. At the end
of
concerns, and took verbal permission from the patient to forward this information, known at
the consultation plan, to their oncology consultant prior to the appointment.
Outcome




              
             
              
                
                
         
 






consultation plan can be found in Appendix 4 and below in figure 4.2. Consultation plans
were securely emailed (using NHS email accounts with encryption) prior to the appointment
for the attention of the consultant. Participants received an email copy of the consultation
plan with all questions highlighted in bold text to make them easier to identify during the
consultation. In addition, reception staff were provided with a hard copy of the plan to attach






    
            
                
          
            
                
                
 
 
             
          
              
           
              
             
              
            
          
            
            
      
 
               
   
Recording and summarising
Navigators attended the oncology clinic appointment with the patient. They met participants
at reception and provided them with an additional hard copy of their consultation plan for that
clinic meeting. All medical consultations were, with permission, audio-recorded. All
discussions in the clinic appointment were between the patient/participant and clinician. The
Navigator did not input. Navigators sat at the back of the consultation room and made notes
using a laptop, of the key information relayed to the patient by the consultant and the
Once the medical consultation had concluded, Navigators used the audio recording to edit
containing information communicated during the consultation. Summaries were kept concise
and documented only key points discussed by the consultant with the patient. The six
SCOPED categories were used to organise this information. Navigators emailed the
consultation summary to the Consultant for the document to be checked for accuracy. Once
any required changes were made, a consultation summary document was posted to the
participant, their general practitioner and the consultant within a week of the consultation. An
audio-CD copy of the medical consultation appointment was also made available to
participants. This was either available immediately after the medical consultation
appointment or it was posted to participants via recorded delivery. Where possible,
Navigators followed the same patients through their cancer treatment, and therefore through
the stages of the evaluation study.
Outcome





     
               
               
             
             
            
           
               
             
               
              
     
 
   
           
            
             
  
            
              
            
           
            
 
4.6.4. The setting and sample
When evaluating a complex intervention there is potential for any difference in outcome to be
due to a range of factors including: the intervention itself, aspects of the healthcare systems
within which the intervention is delivered, aspects of the interactions with the research
process (Wells, Williams, Treweek, Coyle & Taylor, 2012). Whilst study design can attempt
to mitigate against these, problems can remain when drawing conclusions about the
applicability of an intervention in other healthcare settings. Oncology clinic appointments
were integral to the evaluation to the Navigation intervention, and yet these were provided in
diverse clinic settings with different consultants using a range of different skills and
consultation processes. In noting this, every effort was made to standardise the delivery of the
intervention used by Navigators in this study. The training undertaken by the Navigators is
described below.
Navigators
Two Navigators delivered the intervention across both patient populations. Both Navigators
were research psychologists. One had previous training in using the Navigation intervention
with prostate and breast cancer patients. The other was newly appointed. Neither had
with
repeated engagement of the intervention. Both were recruited as research assistants and
neither had a medical background or were familiar with the sample population care pathways.
To ensure standardisation in approaches, both were given training in Navigation and
observational time was spent in the respective oncology out-patient clinics observing




            
       
           
                
              
                
             
           
              
            
              
            
               
          
         
 
            
           
         
             
        
               
            
Navigators were trained to be supportive and non-directive (Stacey, Murray, Légaré, Dunn,
ardise the procedures and delivery of the
intervention, a protocol, manual and training programme developed by Belkora and
previously used to train Navigators in a study conducted by Sepucha et al., (2000) was used.
A 3-day intensive training course delivered by an experienced Navigator who was not a
member of the evaluation research team, was delivered to the two Navigators in this research.
This training described the theory underpinning the intervention, how to use the SCOPED
question prompt sheet to el uestions and concerns, it used case examples
to illustrate how to produce an accurate summary of the consultation using the SCOPED
framework and create the consultation audio recording. Remote supervision was provided by
Belkora and team from the University of California, regularly throughout the study to both
Navigators to ensure the quality of the intervention was maintained. Although supervision
was often conducted in pairs the option to engage in individual supervision was always made
available. During supervision, cases were discussed anonymously and constructive feedback
provided on consultation planning techniques and the documents generated.
charged situations, Navigators faced the potential for emotional distress resultant from being
present in medical consultations where patients were receiving difficult and emotionally
challenging information. De-briefing sessions were therefore important for Navigators.
Navigators engaged in formal monthly sessions with a clinical psychologist based in the
. Whilst clinical supervision provided a safe and
confidential environment for Navigators to reflect on and discuss their work and is in line




         
            
 
  
               
               
             
                 
               
               
      
            
             
     
             
              
       
 
    
              
               
                 
       
 
 
supervision when using decision support interventions has not been previously reported. In
addition, time was also set aside fortnightly for informal team de-briefing sessions.
Oncology clinicians
Oncology clinicians were not trained in any aspect of Navigation but were involved in the
planning stages of the trial evaluation. Clinicians were made aware of the evaluation plan and
the intervention, highlighting specifically the ways in which it would impact their provision
of usual care i.e. a consultation plan to attend to, an audio-recorder in the room. The study
was conducted in the same clinic as a previous RCT evaluation of Navigation (Hacking et
2013) and so all clinicians were familiar with the intervention. Prior to (usually the day
before) each Navigated clinic appointment, clinicians
consultation plan. Clinicians were aware that participants would then have the consultation
recorded, that a Navigator would be attending the appointment, and that a consultation
summary would be produced. Clinicians
consultation plan prior to beginning the appointment. Verbal or written (via email) agreement
for recording consultations and for the Navigator to attend the appointment was taken from
each clinician prior to each appointment.
Clinical Nurse Specialists (CNS)
Throughout the trial it became apparent that the CNS attached to the cancer specific out-
patient clinics would benefit from a copy of the consultation plan and therefore these were
provided. The impact of this was not evaluated as it was a practice that evolved during the









               
                
              
             
        
 
        
 
              
          
          
              
              
       
    
 
              
               
              
General Practitioners (GP)
intervention group, r 
summaries.
Research Team
The research team included five members. One member, the author of the thesis, was active
in recruitment and data collection. Two were trained as Navigators and as such did not take
part in any data collection. One member was a consultant clinical psychologist and could
provide guidance for working effectively with the clinics. Another was a senior research
member able to provide methodological advice.
4.6.5. The Navigated patient pathway and evaluation protocol
Important in this evaluation was to identify key appointments within the CRC and HGG
treatment pathways where consultations involved the information sharing of significant
clinical updates and where significant questions and decision-making about treatment
direction were to be made. These were identified as the most relevant and significant
consultations to be used in evaluating the intervention. All such appointments were to be
during : spanning a time period of
approximately six months.
To identify the key consultations points informal discussions were held with consulting
clinicians, clinical nurse specialists and a focus group held with a small cohort of patients




             
          
              
              
            
               
      
             
              
 
             
 
           
               
             
               
              
           
              
               
 
             
              
                
               
           
not be reported here). Across the CRC and HGG patient treatments, key discussions were
identified that were held with oncology consultants about patient treatments.
Two flowcharts are below map the medical consultation for each population, and as outlined
in the TIDieR checklist, these are important diagrammatic methods that depict the nature and
chronology of the intervention (Perera, Heneghan & Yudkin, 2007; Hooper, Froud, Bremner,
Perera, & Eldridge, 2013). The medical consultations highlighted in blue in Figure 2 and 3
next sections describe these appointments in
more detail. For each key appointment, an intervention participant engaged in the process
described earlier i.e. Navigation consultation planning, and provision of a summary and CD.
4.6.5.1. Colorectal cancer (CRC) appointments and evaluation time points in detail
Colorectal cancer participants were randomised to receive the Navigation intervention or
usual care. After each key appointment, all CRC trial participants were sent a battery of
outcome measures, described in Chapter 5, to evaluate their experiences, annotated in Figure
2. These were sent to all participants once all Navigated materials (Summary and CD) had
been distributed. Outcome measures were taken at five time points (with an additional time
point for Navigated participants). Qualitative evaluation through use of interviews occurred
after treatment had ended with a sample of participants recruited and interviewed from both
trial arms i.e. Navigated and control groups who had completed three consultations.
The number of appointments each participant attended varied according to their needs and
treatment pathways. The minimum was one (if treatment was not accepted) and the maximum
was four (if more time was needed to deliberate about treatment). It was decided that the
intervention would be applied to all the appointments required by a participant during the first




            
          
 
              
            
           
              
             
              
            
 
             
            
            
               
    
 
               
              
            





participants were sent outcome measures evaluating their experiences of care three months
after their final clinic appointment as shown in Figure 4.3.
Appointment 1: This was the initial oncology consultation in clinic where chemotherapy was
discussed following the results of bowel surgery. Discussions with the patient included;
formal diagnosis from the pathology of tissue/tumour removed during surgery, treatment
options with provision of information about side effects, and the availability of clinical trials.
Next line treatment included eight weeks of chemotherapy. Due to a concurrently running
clinical trial (SCOT trial) patients could have either eight or four cycles of chemotherapy.
Some participants needed two initial appointments to finalise their treatment decision.
Appointment 2: This occurred three months after the initial appointment. For patients
receiving eight cycles of chemotherapy this was a mid-treatment appointment, where side
effects of treatments were discussed and chemotherapy adjusted / discontinued if necessary.
For patients receiving four cycles of chemotherapy this was an end of treatment review, as
described in appointment 3.
Appointment 3: This was six months after the initial appointment. This appointment was an
end of treatment review for those who had received eight cycles of chemotherapy. It
reviewed post staging scans, discussed management of any lingering treatment side effect





          



























   
    
  
     
 
    
     
   
          
            
  
      
 
  
      
   
   
    
 
     





    
    
    
     











Figure 4.3 Colorectal cancer treatment pathway. Flowchart to present the treatment





summary and recording for
intervention participants.
Evaluation point for all.
Post-surgical staging CRC, deliberation
about: receiving chemotherapy, entering the
available clinical trial.
Follow up: review post treatment scans and decided next steps
i.e. to go to nurse led follow up or commence second line
treatment.
No further treatment.Standard chemotherapy: 8
cycles
Chemotherapy (RCT)
trial: 8 OR 4 cycles
Mid treatment: Side
effects discussed, chemo
adjusted or stopped if
needed.






Study evaluation follow up
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4.6.5.2. High Grade Glioma (HGG) appointments and evaluation time points
As previously presented, the CRC cohort were involved in both the RCT and the nested
qualitative evaluation study. However, a HGG cohort was also Navigated and interviewed as
described.
All HGG patients who were diagnosed during the time that this study was conducted were
invited to take part in the intervention. No randomisation occurred due to the small sample
size available and the exploratory nature of the qualitative evaluation. Whilst participants in
the study engaged in three Navigated consultations from baseline to follow up, this thesis
only presents analysis from the final interviews undertaken after the end of treatment. This
facilitated the comparison of experiences across both CRC and HGG populations, and builds
an evidence-base for understanding potential applicability of the intervention for the HGG
patient cohort. Further details of the qualitative methods utilised will be described in Chapter
7.
The following paragraphs details the content of the appointments for which the intervention
was utilised, as represented in Figure 3. This care pathway is similar to the CRC care
pathway. The number of appointments for patients on this pathway ranged from one to four,
as displayed in the Figure 4.4.
Appointment 1: This appointment was the diagnosis consultation. In contrast to the CRC
care pathway for the majority of HGG participants this initial appointment informed them of
their diagnosis. The first clinic appointment for HGG patients occurred at the point of




             
            
               
               
      
 
            
              
              
            
          
 
               
     
               
                 
               
     
 
               
         
           
           
              
         
of their surgery. Within this appointment, patients were also offered treatment options of
radiotherapy, plus or minus chemotherapy, and the inclusion into on-going clinical trials.
Patients were expected to make treatment choices on the day and trial choices within two
days. Due to the poor prognosis, it was expected patients would demonstrate a range of
emotions at during this consultation.
Appointment 2: This consultation occurred after radiotherapy treatment. At this point,
patients were seen by the oncologist to discuss symptoms and the possibility of adding
chemotherapy into their treatment regime. As scans undertaken at this time are unable to
differentiate between the tumour progression and effects of radiotherapy, no information can
be given as to how well treatment is working.
Appointment 3: This occurred at a three month follow up appointment. Three months after
the end of radiotherapy a
and information given to the patient about either the progression, stability or a reduction in
the tumour size. The result of this scan guides the next steps of treatment, if required. If
participants do not require/do not elect to undertake chemotherapy, this is the end of their
treatment review appointments.
Appointment 4: This appointment occurred at end of treatment as a review consultation for
patients completing chemotherapy treatment. Following chemotherapy, patients attend this
consultation with their consultant oncologist to discuss treatment side effects, symptom
management and future disease management. This may include possible treatment options
should the tumour progress in the future. Information is given for signs of disease




           


























    
    
     
 
       
     
    
     
   
    
    
   
   
 
  
    
















    
   















Figure 4.4. HGG treatment pathway. Flowchart to present the treatment pathway for
patients being treated with a High Grade Glioma.
Results from surgery (diagnosis)
provided, treatment plan deliberated:
radiotherapy vs radiotherapy plus chemo
Radiotherapy
End of radiotherapy review: decision to stop
treatment or include chemotherapy
End of treatment review:








End of treatment review;


















             
              
               
              
              
              



















This chapter has described the study design used to evaluate Navigation, a complex
intervention that aims to improve decision making in the context of the medical consultation
in this case with CRC and HGG patients. In detailing the intricate Navigation procedures and
data collection time points across both samples and within the RCT and nested qualitative
evaluation study, the complex nature of this evaluation study has been described. Chapters 5
and 7 will provide detailed descriptions of the methods used and provide further justification




         
   
           
            
           
            
               
                 
               
  
 
           
              
                
             
              
               
          
              
             
                
            
             
               
             
Chapter 5: Randomised Controlled Trial with CRC patients; the methodology 
5.1 Introduction
This chapter describes the Randomised Controlled Trial (RCT) conducted with colorectal
cancer (CRC) participants. The chapter includes the study design, participant recruitment and
consent, randomisation and blinding, outcome measures and statistical analysis. This chapter
utilises the CONSORT checklist for non-pharmacological trials (Boutron et al., 2008) and
pragmatic trials (Zwarenstein et al., 2008) to report the methodology and findings of the trial.
This checklist can be found in Appendix 6. The study setting and a detailed description of the
intervention has already been detailed in Chapter 4. Results of this RCT are reported Chapter
6.
5.2. Evaluating a complex intervention: utilising a pragmatic randomised controlled trial
One of the first cited RCTs was published in the mid-1940s (Stuart-Harris, Francis &
Stansfeld, 1943). The RCT is now regarded as the gold standard in clinical trial design to
produce unbiased results for health care interventions (National Institute for Health and Care
Excellence (NICE, 2006). In the search for reliable evidence to inform decision making, more
emphasis is placed on the results of randomised controlled trials than any other form of
evidence when making recommendations for healthcare (Medical Research Council (MRC)
2000). The rationale for utilising a randomised controlled trial, as guided by the MRC
guidance to evaluate complex interventions has been outlined in Chapter 4, section 4.3.
Consequently, this section will justify the use of a pragmatic RCT in this evaluation.
RCTs are experiments designed to achieve high internal validity, controlling where possible
for most confounding variables through exclusion criteria and randomisation. However, it is
this high internal validity which can ultimately result in a low external validity. The RCT




               
            
 
          
           
         
                 
           
          
                
  
 
               
                  
                
             
               
               
             
                
               
               
               
 
for the trial. Schwartz and Lellouch (1967) were the first to consider how applicable and
translatable RCT results actually were to everyday practice. Accordingly, they formulated the
CT
RCT design. The explora aim to evaluate the efficacy of an
intervention in a well-defined and (Patsopoulos, 2011, p.218). In contrast,
determines the effects of an intervention under the usual
(Thorpe et al., 2009 p. 464). Pragmatic trials are part of the solution in the aim of
producing generalizable results from RCTs. The investigation within a pragmatic trial
explores whether an intervent (Patsopoulos, 2011, p218). In
this way, it aims to evaluate the intervention within the usual clinical setting to capitalise the
generalisability.
The distinction between an exploratory and a pragmatic trial is not binary. In reality many
trials have aspects of the two designs as such the distinction between the two trials exist on a
continuum (Thorpe et al., 2009). This has led to the development of a framework of domains
to enable evaluation of whether a trial is pragmatic or exploratory (Gartlehner, Hansen,
Nissman, Lohr, & Carey 2006, Thorpe et al., 2009). The framework by Gartlehner et al.,
(2006) consisted of eight domains each with a yes/no dimension to evaluate the trial. Thorpe
et al., (2009) subsequently developed the PRECIS tool to distinguish between the pragmatic
and explanatory trial based on ten domains. The domains are used to determine the level to
which a trial is pragmatic or explanatory. Although this is an intriguing idea, the framework
is difficult to apply and quantify as judgement of the domains appears subjective in nature.




           
              
              
              
               
       
 
                 
  
                
                
              
              
            
          
               
            
               
           
            
            





A pragmatic design is highly applicable to non-pharmacological trials where outcomes are
based in patient-report measures of experience and not biological markers. For this trial, the
evaluation of the intervention within the everyday clinic settings was integral to the nature
and quality of the intervention and its evaluation. Through utilising the pragmatic trial, this
trial is able to evaluate the intervention in its natural setting whilst maintaining a robust
approach to the collection of data.
In questioning the validity of the RCT results, one of the areas highlighted as a weakness is
Nicholl 2010).
The importance of recognising patient preferences for a trial arm i.e. preference to be part of
the intervention or control arm, has been highlighted by Coates (2010). It can be assumed the
main incentive to participate in this study (apart from altruistic reasons) is for the
intervention, since the usual care is available to patients without the need to participate
(Relton et al., 2010). As this intervention depends on participant involvement and co-
the study trial arm needs to be considered. Where a
participant is allocated to the least preferable arm of the intervention they may withdraw from
the trial or display disappointment bias when completing evaluation measures (Torgerson &
Torgerson 2008). However, to take account of such preferences within the design of the study
would not necessarily solve problems of attrition or disappointment bias (Preference
Collaborative Review Group, 2008) and would compromise the robustness of the considered
research design. Although it is important to acknowledge preferences, in this study





    
             
            
             
           
             
      
 
     
              
     
 
            
     
 
             
            
          
             
    
    
            





The selected trial design is an open parallel-group pragmatic RCT. Participants were openly
randomised after completion of baseline measures to receive the intervention (Navigation) or
usual care (no intervention). The study is longitudinal in nature with the intervention
administered three times per participant. Participants completed outcome measures prior to
baseline, post each consultation (x3) and at follow up (three months following last
appointment at the clinic).
5.3.1. Primary Research Question
To address the information and decision making needs of people with colorectal cancer this
study asks the following question:
people with colorectal cancer for their clinic appointments during first line treatment
for their cancer, on
This primary research question is answered through the self-report of people with colorectal
cancer, who experienced or did not experience the intervention, completing measures of
Decision self-efficacy (DSE), Decision Conflict (DCS), Decision regret (DRS) and
Preparation for Decision Making. The outcome consisted of changes in reported scores over
time between groups.
5.3.2. Secondary research question
Does the intervention impact on the anxiety or depression experienced by people




   
            
              
      
 
           
              
       
 
      
    
                
             
            
                 
           
           
                  
              
        
              
           
  
           
5.3.3. Hypothesis
Null Hypothesis: Using the intervention with people with colorectal cancer during their
cancer treatment will result in no differences in the perception of decision quality between
intervention and usual care groups.
Alternative Hypothesis: Using the intervention with people with colorectal cancer during
their treatment will result in an improved perception of decision quality for the intervention
group when compared to usual care.
5.4. Recruitment and Participants
5.4.1. Eligibility criteria
Eligible participants were adults aged 18 or over with a new diagnosis of CRC (curative or
palliative), who were attending the colorectal cancer clinic, from December 2010 - March
2013 for their first oncology treatment discussion and subsequent treatment regimen. Patients
with a diagnosis of colon cancer or rectal cancer were invited into the study as both followed
a similar pathway of care managed by the same clinical team.
All patients considering adjuvant chemotherapy following surgery were the study population.
Due to the nature of the CRC treatment pathway, this included all Stage 2, 3 and 4 patients
and eliminated all stage I patients from the study population. The following exclusion criteria
were applied to the recruitment selection process:
- People with a previous diagnosis, in order to minimise bias when evaluating the
Navigation intervention from the perspective of first time oncology treatment decision
making.




             
        
 
   
             
               
            
              
              
              
               
              
                
                  
      
 
                 
               
            
          
 
                
                
              
- People with identifiable severe psychiatric morbidity or with a limited capacity to
understand or engage fully with the intervention.
5.4.2. Recruitment
Eligible patients were identified at the multi-disciplinary team meeting (MDT) (see Figure 1).
disease were invited to the cancer centre for an appointment with the oncologist to discuss
further treatment (chemotherapy). Those who needed no further treatment were not eligible
for the study. This first clinic appointment acted as the first Navigated appointment.
Patients were notified of their initial clinic appointment via a telephone call with the clin 
Clinical Nurse Specialist (CNS). The telephone was a standard method of contact utilised by
the clinic as patients were usually at home recovering from bowel surgery (undergone 1 week
prior). In this phone call the CNS would briefly explain that the upcoming appointment
would be about the need for further treatment, often chemotherapy, due to the results of the
surgery. The study team were notified by the CNS if a patient was eligible and when they had
been made aware of their appointment.
Patients were invited to participate in the study via a separate phone call from the study team.
This approach was selected following an initial poor recruitment rate when the CNS made the
initial recruitment approach. Specific ethical approval was given to approach the patients
without first being introduced by a member of the patien .
In the recruitment telephone call made by the study team, a description of the study was
provided and permission was sought to post a study pack to the potential participant, and then




                  
             
             
              
              
                
                  
              
             
     
 
               
               
                   
            
              
              
 
               
            
            
              
 
              
in the study were thanked. No further contact was made. The study pack (Appendix 7, 8 & 9)
included: invitation letter, information sheet, consent form (one for participants to keep and
one to return to the study files), the baseline questionnaire (including three measures
described below) and a stamped addressed envelope. The follow up phone call ensured
participants had received their study pack, gave opportunity to provide more detail about the
study, and answer any questions about the study. At the end of the follow-up telephone call
participants were asked if they would like to take part in the study, or not. Again, those who
declined were thanked and no further contact was made. Reasons for refusal were not
requested although some information about this was volunteered and examples of these are
presented in Chapter 6.
Participants who agreed to take part in the study were verbally taken through the consent
form items over the telephone: this verbal consent was audio recorded. Participants were also
asked to complete and sign the consent form and asked to bring it back to clinic or return in
the post using the stamped addressed envelope. In order to undertake randomisation
participants were then requested to complete their baseline questionnaire and post this back in
the stamped addressed envelope provided as this was the most time efficient method.
The time between initial study contact and clinic appointment was one week giving time for
participants to complete the recruitment and consent process, complete baseline measures and
for intervention participants to take part in their consultation planning appointment as
described in Chapter 4, section 4.6.3. Consequently, it was impractical within the timeframe
at




             
    
 
             
    
  
             
             
           
              
            
          
 
               
                 
                
              
             
               
             
            




Participants were then randomised and informed which group they had been allocated to
(Intervention or Control).
The numbers of eligible and consented participants are represented in the CONSORT flow
chart in Chapter 6.
Control group
Participants in the control group were informed via telephone conversation before their clinic
appointment that they would not be receiving the Navigation intervention. This group of
participants completed five separate questionnaire packs over nine months: baseline, after
each of three key clinic appointments (initial, mid-treatment and end of treatment) and three
months following the last appointment. Every set of questionnaire included a stamped
addressed envelope for participants to return their completed measures.
A weakness often discussed with regards to RCTs is that information about standard care is
seldom given for the control group (Hoffman et al., 2014). The usual care for patients in this
control arm was usual care provided by this clinic. This is a morning clinic where consultants
and registrars meet with people diagnosed with colorectal cancer to plan or review their
treatment. Clinical Nurse Specialists (CNS) are available for support but do not provide
formal appointments within this clinic time. This trial arm received no input from the study
with regards to their appointments at the clinic. Communication between the study and
control participant was limited to questions about and delivery of questionnaires and




   
              
            
            
              
             
               
         
                
    
             




               
   
           
    
        
      
              
       
 
        
  
Follow up phone call to check baseline measure complete and inform of group allocation.
Intervention Group
Participants who consented to participate in the study and who were randomised into the
intervention group, i.e. receiving the Navigation intervention were contacted by the Navigator
at an arranged time for their initial consultation planning appointment. Participants were
consultation and end of treatment consultation. This occurred over a six month period.
The intervention arm completed the same five separate questionnaire packs over nine months
as the control arm. In addition, the intervention group completed one extra measure after their
baseline measure and prior to their clinic consultation.
A flow chart of the appointments attended and evaluation points taken can be seen in Chapter
4, Figure 5.1.
Figure 5.1. Recruitment and Consent Procedure. Flowchart to present the consent and
recruitment procedure for patients with colorectal cancer.
Navigation Control
Follow up study phone call to answer study questions and gain consent 
Verbal consent audio recorded
Patient asked to complete baseline by specified date
Decline - no further contact made
Patient Identified at MDT CNS phones patient to inform him/her of clinic appointment
Research team notified patient is aware of
appointment.





    
            
            
                
           
                
         
             
          
              
            
           
              
         
  
   
    
 
                
              
              
             
          
             
5.5. Outcome Measures
The outcome measures were informed by the Ottawa Decision Support Framework (OTDSF)
goals of the Navigation intervention to; encourage confidence and reduce confusion and
regret in decisions that have been made (Belkora et al., 2008). As proposed by the OTDSF,
decision support interventions should measure indicators of quality decision making as
opposed to the outcome of the decision, as it is suggested good decision making can still
result in bad outcomes, particularly in the uncertain context
1998). The authors suggest these indicators include such things as; knowledge, clear values,
expectations, low decision conflict, decision implementation and satisfaction with the
decision and the process of making the decision , 1998). In this study, the
quality of the decision implementation was measured using the Decision Self-Efficacy Scale
(DSE, evaluate the personal resources a participant had to implement the
decisions. Satisfaction with the outcome of the decision was measured using the Decision




It is hypothesised based on the review of the theoretical evidence for coaching by Stacey et
al. (2013) that the intervention may improve the feelings of confidence through the discussion
and deliberation with another who provides support and validation Stacey et al. (2013).
Furthermore the review also indicates the intervention may also improve the likelihood that
ns are considered by the clinician throughout the process, through




             
               
           
              
             
 
 
              
               
          
 
              








   
      
   
     
  
      
  
     
          
      
  
     
 
         
  
of decision making the provision of information tailored to the individual through the
consultation summary and record could also result in a reduced feeling of uncertainty in the
decisions. Furthermore, the Ottowa framework postulates that through the identification of
information and decision making needs (via in this instance the consultation planning part of
the intervention) the participant is enabled to achieve higher quality decisions in turn
The DSE, DCS, and DR have been used previously to evaluate the Navigation intervention
with breast (Belkora et al., 2008) and prostate cancer populations (Hacking et al., 2013). All
measures used were self-administered and all are validated research instruments.
Table.5.1. Demonstrates the evaluation and determinant factors of the measures used
according to the Ottowa decision support framework.
Measure Evaluation Determinants
DSE Quality of decision and decision Resources to make and implement
making process decision
DCS Quality of decision and decision Perception of the decision
making process
DRS Outcome of decision Perception of the decision
PfDM Quality of decision and decision Resources to make and implement
making process decision





   
            
              
          
            
             
    
 
    
       
             
  
               
     
            
                 
              
              
             
                 
     
 
      
              
5.5.1. Baseline demographics
Basic demographics (Appendix 10) taken included; age (self-reported on a continuous scale);
gender (male or female) ethnicity (White, Mixed ethnicity, Asian or Asian British, Black or
Black British, Other), marital status (Married, Divorced, Separated, Widowed, Single)
educational background (Left before 15, Secondary education to 16, Secondary education to
18, College, University, Other) and employment status (working full time, working part time,
retired, unemployed, other).
5.5.2. Primary Outcome Measure
5.5.2.1. Decision Self Efficacy (DSE)
The primary outcome measure was decision self-efficacy (Appendix 11). This scale was used
to measure
implement a decision. The Decision Self Efficacy (DSE) is an 11 item scale which measures
self- in decision making, including shared
decision making. This scale has been shown to demonstrate high internal consistency
meets a core principle of shared decision making. The DSE has been used to evaluate the
Navigation intervention before and was found to be sensitive to this intervention (Belkora et
al., 2008). Belkora et al. (2008) found although participants (n=38) reported a relatively high
baseline of decision self-efficacy meaning limited room for improvement at, the standardised
effect size for the scale was large at 0.85, indicating this scale may be responsive to the
impact of the intervention.
To this measure was taken at




           
                
            
                  
                  
                 
             
                
 
                    
           
                
              
 
    
       
             
             
              
           
            
              
     
 
participants completed DSE after their consultation planning appointment with the Navigator
and prior to the clinic appointment (T2) to measure any change in DSE attributable to the
consultation planning part of the intervention. Control participants did not complete this
measure at this point as the baseline measure of DSE was taken a minimum of five days prior
and it could be assumed there was no reason for this score to have changed. DSE was not
measured at follow up as it has been suggested that the validity of this measure weakens as
time away from the consultation increases. A measure of personal resources three months
after the event (the consultation) may not be reflective of the experience at the time.
Participants were asked to report on a scale of 0 4 (0 not at all confident to 4 very
in response to eleven items. To create a total score
per respondent all 11 items were summed, divided by 11 and multiplied by 25, therefore total
scores for DSE ranged from 0 (not at all confident) -100 (very confident).
5.5.3. Secondary outcome Measures
5.5.3.1. Decision Conflict Scale (DCS,
To measure uncertainty in decision making the Decision Conflict Scale (DCS) (Appendix 12)
was selected (O'Conner, 1995). Decision conflict is defined as an emotional state involving
commonly occur within the context of health decisions. This 16 item scale measured personal
perceptions of uncertainty in choosing options, modifiable factors contributing to uncertainty
such as feeling uninformed, unclear about personal values and unsupported in decision
making, and effective decision making, such as feeling the choice is informed, values based,




                
                
              
            
  
 
              
                  
              
  
 
        
              
                
               
             
   
 
               
 
                
            
           
The DCS was administered after each consultation (T3, T4, & T5) and at three month follow
up (T6). Respondents were directed to think about a choice they had made and rate how
strongly they agreed to or disagreed with the 16 statements. Decision conflict rating was
completed immediately after each consultation to evaluate recent decisions made in the
consultation.
Responses to each statement were rated from one (strongly agree) to five (strongly disagree).
Total scores were summed and divided by the number of items. A total score of 1 indicated a
participant had reported low decisional conflict where five indicated a high level of decision
conflict
5.5.3.2. Decision Regret Scale (DRS, O'Connor, 1996).
To measure the regret a participant experienced in regard to their treatment decision, the
Decision Regret Scale (DRS) (Appendix 13) was selected (O'Connor, 1996). This is a 5 item
self-
(Brehaut et al., 1996, p283). A low regret score indicates positive feelings about the decision
made. This measure has good internal consistency (Cronbachs alpha 0.81 - 0.92) (O'Connor,
1996).
The decision regret scale (DRS) was administered once at follow up (T6), so that participants
w
up was 3 months after a participant had been discharged from the clinic following either; the
decision to not have treatment, ending treatment earlier then standard guidelines suggest(6




             
         
                
                
                
           
 
       
                
      
              
               
              
                  
                
             
                
                
                 
                
             
          
      
  
 
The DRS measure asked respondents to reflect on the treatment decision and rate their
agreement on a scale of 1-5, on a scale
Items 2 and 4 were reverse coded so that for each item a higher number indicated
more regret. Item scores were converted to a 0-100 scale by subtracting 1 and multiplying by
25. Total scores were obtained by summing each item and averaging. A score of 0 indicated
no regret, a score of 100 indicated high regret.
5.5.3.3. Preparation for Decision Making
To measure preparedness to make a decision four of the ten items were taken from the
, (Appendix 14). These items were
selected pragmatically as they have been used in the evaluation of the intervention previously
and so this facilitates comparison (Sepucha et al., 2002; Belkora et al., 2015). It was
acknowledged the battery of surveys over several different time points was quite a large
demand on participants as such the use of only four of the ten items helped to reduce the
participant burden. The four items were chosen based on the most relevant items to assess the
components of the intervention, the six items not used asked about preparation for;
recognising a decision needs to be made, making a better decision, thinking of the pros and
cons and then which are most important to you, know the decision depends on what matters
most to you, an, follow up visits. The selected items are presented in table 5.2 Using single
items from the Preparation for Decision Making scale has been used in this way in other
studies (Winterbottom et al., 2015). Validation studies found this scale was sensitive to
decision support interventions (Pitkethly, MacGillivray & Ryan, 2008). Validation studies





             
            




          
          
         
           
             
             
 
 
       
            
            
                
            
 
            
            
                 
              
             
             
             
The Preparation for Decision Making scale was administered after each consultation (T3, T4,
the services in the run up to your appointment help you
for the four items. Respondents rated their agreement from 1-5, on a scale anchored at 1
Table 5.2. Items measuring preparation for consultation
Did the services in the run up to your appointment 
Help you organise your own thoughts about the decision?
Help you identify the questions you want to ask your doctor?
Help you think about how involved you want to be in this decision?
Prepare you to talk to your doctor about what matters most to you?
5.5.3.4. Satisfaction with the intervention
Intervention participants were asked to rate their satisfaction of the consultation planning
stage of the intervention Please indicate how satisfied you are with the
question-listing support you received anchored on a scale of one not at all satisfied to ten
extremely satisfied. This was administrated after each consultation T3, T4 and T5.
5.5.3.5. Hospital Anxiety and Depression Scale (HADS, Zigmund & Snaith, 1983)
The Hospital Anxiety and Depression Scale (HADS, Zigmund & Snaith, 1983) (Appendix
15) is a 14 item scale which provides separate brief state scores of anxiety (seven items) and
depression (seven items). In a systematic review of screening for emotional distress in cancer
patients, ten studies showed the HADS demonstrated adequate internal consistency for each
subscale (anxiety or depression) and was sensitive to change (Vodermaier, Linden & Siu,




                
              
      
 
                 
               
                    
             
     
 
    
             
              
                
            
            
             
      
 
            
                
             
            
was shown to be sensitive in its detection of a clinical disorder of anxiety or depression,
furthermore it was deemed more sensitive in this detection than the single item Distress
Thermometer (Patel et al., 2010).
In this RCT, the HADS was administered twice, once at baseline (T1) and again at follow up
depression at the point of diagnosis and end of treatment/ three months following the decision
to not have treatment. Each item is scored on a four point scale (0-3). A total score of eight to
(Zigmund & Snaith, 1983; Patel, Sharpe, Thewes, Bell & Clarke, 2010). It takes
approximately 2-5 minutes to complete.
5.6. Procedure
Data was collected at six time points. Table 5.3 demonstrates which measures were
completed at each time point. The time points for measurement included: baseline (T1) which
was pre randomisation, after each consultation T3, T4, & T5, and 3 month follow up after
discharge from the clinic (T6). In addition intervention participants completed the Decision
self-efficacy (DSE) measure post consultation planning prior to consultation (T2). Once the
Navigation materials (consultation summary and CD) had been sent all participants were sent
their outcome measures via post.
The evaluation was longitudinal. Participants would complete three clinic appointments and
evaluation would be taken after each one was attended (as discussed in Chapter 4); the initial
consultation to plan treatment, a mid treatment review appointment and end of treatment




               
              
            
         
           
 
               
   
 
      
         
 
    
     
 
  
          
            
            
         
  
    
 
    
 
 
     
              
          
                
               
                
               
               
and a maximum of four. This impacted the evaluation time points. Where a participant had
two appointments for one time point (e.g. two initial appointments to decide treatment) they
completed measures after the second appointment. Final evaluation (T6) was taken three
months discharge from the clinic (from first line chemotherapy).
The amount of appointments attended was recorded for each participant.
Table 5.3 Timeline of evaluation to demonstrate the time points of outcome measures for
colorectal participants.
Timeline Navigation Control








DSE, DCS, PfDM DSE, DCS, PfDM
T4 Post mid treatment consultation DSE, DCS, PfDM DSE, DCS, PfDM
T5 Post end of treatment consultation DSE, DCS, PfDM DSE, DCS, PfDM
T6 3 months after discharge from the clinic
(follow up)
HADS, DCS, DR HADS, DCS, DR
5.7. Sample Size
A power calculation was conducted using the primary measure DSE and based on a
previously undertaken feasibility RCT Navigation study with prostate cancer patients
(Hacking et al., 2013). The Hacking et al., (2013) study measured DSE at three time points,
baseline, post first consultation and 6 month follow up. This study measured DSE at five
times points and so expected and planned for a higher attrition rate. For a significance level
of a=0.05, to achieve power of 80% and detect a clinical difference with an average




              
               
         
 
      
        
        
    
               
               
                
               
 
     
                
              
           
              
           
             
               
    
      
the primary outcome measure (DSE), 54 subjects per group at each measurement time point
was required (n=108). An attrition rate of 21.14% was estimated therefore a sample size of
132 participants, 66 participants per group, was needed.
5.8. Randomisation and Blinding
Participants were randomised using a web-based Randomisation Tool:
(http://www.healthbehaviourresearch.co.uk/research.aspx - no longer in use 23/03/16).
Simple randomisation was used.
number allocation for the participant; '1' (Intervention) or '2' (Control), in a random sequence.
Blinding of the participants and clinicians and during the analysis was not feasible within this
study. Patients who did not accept their group allocation were not able to proceed with the
study. A record of study withdrawals was recorded (see Chapter 6, CONSORT flow chart).
5.9. Monitoring non completers
If a participant did not return their questionnaire they were sent a reminder, along with the
same questionnaire two weeks later. If they failed to respond they were considered a non-
completer. Non-completion of questionnaires was not considered as withdrawal from the
study. Participants remained part of the study but the time point questionnaire was marked
non-completed. Some participants did not medically require all three oncology appointments
according to treatment decisions. In this instance participants did not receive the subsequent
measures but were asked to complete the follow up surveys three months after their discharge
from the clinic.




               
                 
             
               
              
  
 
   
              
            
             
                
              
        
 
               
              
          
 
       
             
              
              
Participants were free to withdraw at any time. The researcher was also able to withdraw a
participant if it was in their best interest or they were no longer eligible, for example, spread
of disease resulting in hospitalisation and referral to palliative care. When a participant
withdrew it was recorded. All previous data were kept unless requested by the participant that
they be removed, as detailed in the information sheet. No reasons were requested for
withdrawal.
5.11. Statistical analysis
Data were analysed using SPSS®, Version 22.0. Statistical significance was set at 0.05 and
nonparametric tests were conducted if normal distribution assumptions were not met. Where
data were missing due to participants not completing questionnaires no substituted data were
inputted. Missing data per item response was coded as 99. Where a participant took part in
two of the same consultations, (for example two initial consultations to decide treatment) they
completed their survey after the final consultation.
An intention to treat (ITT) analysis was also performed on all participants regardless of the
number of appointments attended, to ensure the evaluation does not over or under estimate
forward. This ITT analysis is detailed in appendix 16.
5.11.1. Characteristic between groups at baseline
Baseline between group (control vs. intervention) differences in age, DSE scores and HADs
were compared using an independent samples t-test. Where data did not meet the assumptions




        
         
 
        
               
                
             
                 
             
             
             
               
                
         
 
     
              
              
            
       
            
              
               
             
   
measurements: ethnicity, employment status, education, gender and marital status, were
tested using chi-squared as data gathered was categorical.
5.11.2. Primary Outcome Measure: Decision Self Efficacy
Means and standard deviations of the whole data set were calculated. DSE scores over time
(T1, T3, T4, and T5) per trial arm (intervention and control) were analysed using a mixed
ANOVA. Another mixed ANOVA was run to analyse scores across T1-T3 between groups,
as at this time point the main treatment decision was made, this is also comparable with other
current studies of the intervention (Hacking et al., 2013). Bonferroni adjustments were used
throughout to correct for multiple testing. The intervention only arm (for pragmatic reasons)
completed the DSE at an additional time points, post consultation planning and immediately
prior to the initial consultation (T2). A paired t-test was conducted to compare the difference
in scores from baseline (T1) to T2 for the intervention participants, to measure the effect of
the intervention (consultation planning) before the clinic appointment.
5.11.3. Secondary Outcome Measures
Decision Conflict scale: A mixed ANOVA was used to measure the interaction between
time and trial arm on the DCS measure. Bonferroni adjustments were used throughout to
correct for multiple testing. Independent t-tests were ran to compare differences between
scores at each time point (T3-T6).
Decision Regret Scale: An independent t-test was conducted to compare scores between
groups. As this measure was based on expectations for treatment it was considered the
number of appointments each respondent attended could be a factor in the DRS score. As





            
              
            
             
             
                
                
 
             
             
            
             
       
 
     
              
            
            
              
              





Preparation for Decision Making scale: This scale consisted of 4 separate items. An
independent t-test was conducted at each time point (T3, T4 and T5) between groups
(Intervention and control). Descriptive statistics were used to examine satisfaction with the
intervention from intervention only participants. Where data did not meet the assumptions of
normal distribution a Mann Whitney U test was conducted. Scores were reported by
participants using the scale: A great deal 1-2-3-4-5 Not at all, however for the purposes of
analysis scores were flipped to reflect a more logic progression: Not at all 1-2-3-4-5 A great
deal
Hospital Anxiety and Depression scale: A mixed ANOVA was used to measure the
interaction between time and trial arm on each subscale HADS-A and HADS-D. Bonferroni
adjustments were used throughout to correct for multiple testing. Descriptive statistics were
calculated to summarise the prevalence of borderline and clinical presentations of anxiety and
depression, from baseline to follow up.
5.12. Summary of methods
This chapter has described the trial design to test the Navigation intervention within a
population of participants with colorectal cancer. The challenges of evaluating a complex
intervention within a clinical setting with a population of people potentially experiencing
acute distress were acknowledged and a pragmatic RCT design was considered the most valid
approach. The evaluation of this study is supported by the framework for evaluating decision




          
   
              
             
             
                 
    
 
            
             
              
               
                
  
 
         
 
   
      
            
            
              
          
        







Chapter 6: Randomised controlled trial with CRC patients; the Results. 
6.1. Introduction
The previous chapter detailed the methodology utilised in this RCT. This chapter will present
the randomised controlled trial (RCT) results with colorectal cancer (CRC) participants. This
chapter reports on differences in outcome measures between the control and intervention trial
arms over time. All p values are reported as actual values, where SPSS noted p=0.000 this is
reported as p<0.001.
This chapter begins by outlining the trial numbers for a nrolment, intervention
allocation, follow-up, and data analysis. Baseline characteristics of each trial arm (control
and intervention) and any differences between the groups are then presented. This is followed
by the results of each outcome measure. The chapter concludes with a summary of the
results. The table below (6.1) serves as a reminder for the administered time points of
measurement.
6.1 Time points of measurement in the trial
Code Description
T1 Baseline prior to randomisation.
T2 For intervention participants only: Post intervention (consultation planning) prior to
oncology consultation this measure was taken in clinic waiting room.
T3 Post consultation once all summary items have been distributed (within one week).
T4 Post second clinic consultation (mid treatment review for most).
T5 Post end of treatment review appointment.




   
               
               
             
            
 
             
                
               
               
 
              
              
                












404 participants were assessed for eligibility and 300 were invited into the trial. 137 accepted
the invitation and consented into the study; a recruitment rate of 33.9%. At randomisation 68
participants were allocated to the intervention group and 69 to control. Subsequently one
intervention participant was withdrawn as ineligible prior to receiving the intervention.
The expected attrition rate used in the original power calculation, estimated from previous
research (Hacking et al., 2013) was 21.14%. The actual rate of attrition at follow up was
44.52% at T6. Figure 6.1 shows the CONSORT flow diagram (Moher, Schulz & Altman,
2001) of the enrolment, intervention allocation, follow-up, and data analysis of the trial.
Some examples of reasons provided for decline into the study were collected and included
participants feeling as though they; did not have enough information about their health care
situation, would like to join but only after the initial appointment was over, want to have




         




























     
   
        
        
        
        
      
       
       
        
    
       
       
      
      
    
    
    
     
     
     
       
       
      
   
     
     
       
    
        
      
        






Figure 6.1. CONSORT flow diagram of enrolment, intervention allocation, follow-up,
and data analysis.
Enrollment Assessed for eligibility (n= 404)
Excluded (n= 267)
Not meeting inclusion criteria (n=23)
Declined to participate (n= 163)
Other reasons (n=81 not invited)
Analysed (baseline n=65, t2 n=55, T3 n=60, T4
n=44, T5 n=35, T6 n=39)
Excluded from analysis: as did not return
questionnaire (baseline n=4, t2 n=12, T3 n=4,
T4 n=12, T5 n=13, T6 n=17) not measured;
(T4 n=5, T5 n=7)
Lost to follow-up: after one appointment (n=6;
no further treatment (n=5), died (n=1)) after
two appointments (n=13; no further treatment
(n=7), died (n=3) no appointment (n=1),
missed appointment (n=2))
Discontinued intervention (n= 8)
Allocated to intervention (n=68)
Received allocated intervention (n= 67)
Did not receive allocated intervention
(receiving treatment elsewhere) (n= 1)
Lost to follow-up: after one appointment (n=7;
no further treatment (n=5), death (n=2)) after
two appointments (n=13, no further treatment
n=11, died n=2))
Discontinued trial (n= 2 )
Allocated to control (n= 69)
Analysed (baseline n=67, T3 n=57, T4 n=46,
T5 n=33, T6 n=35)
Excluded from analysis as did not return
questionnaire (baseline n=2, T3 n=10, T4









      
            
          
 
                  
                  
                  
               
       
 
              
                 
           
               
             
              
             
               
               
          
 
              
          
6.2.1. Characteristics of participants at baseline
No significant differences were found in the baseline characteristics between groups. These
are discussed below and presented in table 6.4.
The overall age range of the participants was 35 92, with a mean age of 62.13 (SD11.66).
Intervention participants had an age range of 35 80 years, resulting in a mean age of 62.71
(SD11.35). Control participants had an age range of 36 92 years resulting in a mean age of
61.57 (SD11.99). No significant difference was found between when the mean age of the two
trial arms were compared (t=0.56, df=130, p=0.58).
The sample comprised 78 (59.1%) males and 54 (40.9%) females. In the intervention arm
there were 35 males and 30 females and the control arm comprised 43 males and 24 females,
a non-significant difference was found between groups (X2= 1.46, df=1, p=0.227).
reporting to be white (n=129, 97.7%) and no difference between groups was found (X2= 2.98,
df=3, p=0.395). The majority of participants were married (n=92, 69.7%) and no differences
in the marital status of the groups participants was found (X2= 2.943, df=4, p=0.567).
Participants education level was variable, a minimal number of participants left school before
the age of 15 (n=12, 9.16%), no difference was found between the groups education level
(X2= 5.65, df=5, p=0.342). Most participants in the sample had retired (n=69, 52.67%) and
again no differences between groups occurred (X2= 1.01, df=4, p=0.908).
At baseline prior to randomisation between group scores on the primary outcome measure of




         
  
 
              
              
            
             


















SD20.09) and intervention participants (M84.24, SD13.29) (U=1795.00 N1=62, N2=64,
p=0.36).
Baseline scores of anxiety were lower in the control (M6.41, SD4.21) compared with the
intervention group (M7.03 SD0.54) and scores of depression were lower in the control group
(M4.98, SD3.84) compared with the intervention group (M5.17, SD3.80). When baseline
scores were compared between groups no significant difference of mean scores occurred at




            
      
       
   
  
     
    
       
 
      
    
    
     
     
     
     
       
         
          
          
          
      
            
         
             
      
       
           
       
  
 
   
        
           
       
         
        
     
        
           








Table 6.2 Baseline characteristics of the study participants
Trial arm at Baseline
Control (n=67) Intervention (n=65) p value
Age (yrs) 61.57 (SD11.99) 62.71 (SD11.35) 0.417
[mean (SD)]
Gender 0.227








Married 49 (73.1%) 43 (66.2%)
Divorced 7 (10.4%) 11 (16.9%)
Separated 1 (1.5%) 2 (3.1%)
Widowed 2 (3.0%) 4 (6.2%)
Single 8 (11.9%) 5 (7.7%)
Level of education 0.342
Left before 15 5 (7.5%) 7 (10.8%)
Secondary ed to 16 29 (43.4%) 16 (24.6%)
Secondary ed to 18 3 (4.5%) 5 (7.7%)
College 10 (14.9%) 13 (20.0%)
University 18 (26.9%) 22 (33.8%)
Other 2 (3.0%) 1 (1.5%)
Missing 0 1 (1.5%)
Current employment 0.908
status
Working full time 19 (28.4%) 20 (30.8%)
Working part time 10 (14.9%) 6 (9.2%)
Retired 34 (50.7%) 35 (53.8%)
Unemployed 3 (4.5%) 3 (3.0%)
Other 1 (1.5%) 1 (1.5%)
Outcome Measures
Decision Self Efficacy 79.83 (SD20.09) 84.24 (SD13.29) 0.36
HADS-Anxiety 6.41 (SD4.21) 7.03 (SD 0.54) 0.45




   
              
                
               
            
             
   
 





     
 
 
   
 
         
       
       
           
 
       
            
              
  
 
           
              
             
 
       
              
       
6.2.2. Protocol Compliance
The number of appointments attended by the participants varied. This meant the number of
maximum of four - see table 6.2. As detailed in the previous two chapters, the pragmatic
decision was made to follow participants through all their required appointments to the end of
treatment review. No significant differences were found between the number of appointments
attended by the intervention group (M2.54, SD0.87) and the control group (M2.58, SD0.76;
t(133)=-0.11, p=0.79).
Table 6.3. Number of appointments attended at the clinic for all participants
Number of Control Intervention
appointments / n = 67 n = 66
Navigations (%) (%)
1 9 (13.4) 11 (16.2)
2 12 (17.9) 15 (22.1)
3 44 (65.7) 36 (52.9)
4 2 (3.0) 6 (8.8)
Full trial reasons for only one appointment:
Control: (n=9) Two participants died after their initial appointment. Five participants required
no further treatment. Two withdrew after the first appointment; one was being treated in
another hospital.
Intervention: (n=13) Five participants withdrew after their first clinic appointment. One
refused navigation for final two appointments but did not withdraw so was administered T6.
Six required no further treatment. One died soon after their initial appointment.
Full trial reasons for two clinic appointments
Control: (n=12) Eleven participants had to complete their treatment early due to side effects.




           
             
             
       
  
       
            
            
             
            
















Intervention: (n=11) Five participants finished treatment early due to side effects. Three
participants died before their next appointment. One participant did not have a mid-treatment
review appointment as decided by the clinic. Two participants had one appointment missed
by the Navigation due to staffing resources.
Full trial reasons for four Navigated appointments
Control: (n=2) Two participants had two initial appointments to decide treatment.
Intervention: (n=6) Four participants had two initial appointments in addition to their mid-
treatment and end of treatment review appointments. One participant had two mid treatment
review appointments. One participant had two end of treatment review appointments in




    
        
               
                
              
               
 
              
        
       
      
    
    
     
    
    
     
    
    
     
    
    
 
 
            
               
     
 
               
             
             
           
 
6.3. Results
6.3.1. Primary Outcome Measure: Decision Self Efficacy (DSE)
Whole group scores of decision self-efficacy were high and remained high over the four time
points of measurements for both groups, indicating a high level of confidence in the ability to
make decisions. The intervention group mean score at baseline was higher than the control
group, however as reported earlier this was not a significant difference, see Table 6.4.
Table 6.4. Mean scores of the Decision Self-Efficacy scale for all responders over







































DSE scores over time (T1, T3, T4, and T5) per trial arm
The mixed ANOVA across all four time points was underpowered due to high levels of
attrition and missing data.
There was a significant main effect of the trial arm F(1,43)=13.59, p=0.001, the rating of
DSE differed between groups. Bonferroni corrected post hoc test showed that the intervention
group (M90.26, C195% 86.44-94.07) overall scored higher on the DSE (Mdiff =11.03, C195%




             
              
             
            
 
            
                
               
           
       
 
 
              
             
        
      
    
    
     
    
    
     
    
    
     
    
    
 
There was also a significant main effect of the time F(3,129)=5.19, p=0.007, the rating of
DSE differed within groups over time. Bonferroni corrected post hoc test showed that rating
of DSE from baseline to T3 did significantly differ (Mdiff =6.88, C195% 0.51-13.25,
p=0.028). All other changes in DSE score across time were non-significant (p>0.05).
However, a non-significant time x trial arm interaction was found F(1,129)=40.90, p=0.826,
the rating of DSE over time did not differ between intervention and control groups, see table
6.5 and Figure 6.1. When applying the intention to treat principle to the primary outcome
measure of decision self-efficacy this non-significant interaction between Time and Trial
Arm is maintained (see Appendix 16).
Table 6.5. Mean scores of the Decision Self-Efficacy scale for all responders included
in the Mixed ANOVA over time T1-T5 and per trial arm.
Time Trial Arm n Mean Std. Deviation
Baseline T1 Intervention 27 86.11 11.98
Control 18 73.23 22.11
Total 45 80.96 17.73
T3 Intervention 27 92.17 8.53
Control 18 80.93 11.59
Total 45 87.68 11.22
T4 Intervention 27 91.75 11.60
Control 18 80.68 14.71
Total 45 87.32 13.90
T5 Intervention 27 90.99 10.13
Control 18 82.07 12.95









        
               
             
             
           
 
                
             
Figure 6.2. Mean group DSE scores by time included in Mixed ANOVA
DSE scores over time (T1-T3) per trial arm
There was a significant main effect of the trial arm F(1,103)=8.04, p=0.005, the rating of
DSE differed between groups. Bonferroni corrected post hoc test showed that the intervention
group (M88.31, C195% 85.18-91.44) overall scored higher on the DSE (Mdiff =6.49, C195%
1.95-11.02, p=0.005) when compared to the control group (M81.82, C195% 78.54-85.10)
There was a significant main effect of the time F(1, 103)=13.53 p>0.001, the rating of DSE




          
 
 
             
               
 
               
           
        
      
    
    
     
    
    
 
          
              
             
              
         
          








intervention group overall scored higher on the DSE (Mdiff =5.82, C195% 2.68-8.96,
p>0.001).
There was a non-significant time x trial arm interaction F(1,103)=96.81, p=0.392, the rating
of DSE over time did not differ in intervention and control groups, see table 6.7.
Table 6.6. Mean scores of the Decision Self-Efficacy scale for all responders included in
the Mixed ANOVA over time T1-T3 and per trial arm.
Time Trial Arm Mean Std. Deviation N
Baseline T1 Intervention 86.07 10.53 55
Control 78.22 21.70 50
Total 82.34 17.17 105
T3 Intervention 90.54 8.63 55
Control 85.41 13.29 50
Total 88.10 11.34 105
DSE scores over time (T1 and T2) intervention group only.
A paired t-test compared the difference in DSE scores from baseline to post consultation
planning, the first stage of the intervention, for the intervention participants only. A
significant difference was found in the scores of the DSE measure from baseline (M83.91,
SD13.29) to post consultation planning (M86.36, SD13.00, t(51)=-2.07, p=0.044).
Intervention participants rating of decision self-efficacy significantly increased after the




    
      
              
            
 
                
               
              
                
 
            
               
     
 
                
            
              
           
 
              
         
 
             
              
                
6.3.2. Secondary Outcome Measures
6.3.2.1. Decision Conflict Scale (DCS)
This measure was taken four times; post initial consultation (T3) post mid treatment review
(T4), post end of treatment review (T5) and follow up (T6).
Whole group scores of Decision Conflict Scale (DCS) were low (1 = low decision conflict, 5
= high) and remained low over the four time points of measurements for both groups,
indicated by no score going above 2). The intervention group mean score was consistently
lower than the control group, see Table 6.7 in the DCS scores between groups section.
DCS scores over time (T3, T4, T5, and T6) per trial arm
The mixed ANOVA across all four time points was underpowered due to high levels of
attrition and missing data.
There was a significant main effect of the trial arm F(1,34)=6.19, p=0.018, the rating of DSE
differed between groups. Bonferroni corrected post hoc test showed that the intervention
group (M1.58, C195% 1.42-1.73) overall scored lower on the DCS (Mdiff = -0.29, C195% -
0.53- -0.05, p=0.018) than the control group (M1.87, C195% 1.69-2.05).
There was a non-significant main effect of the time F(3,102)=0.19, p=0.996, the rating of
DSE did not differ within groups over time.
There was also a non-significant time x trial arm interaction F(3,102)=1.09, p=0.355, the
rating of DSE over time when intervention group and control group means scores were




                
     
 
                
           
       
     
    
    
     
    
    
     
    
    
       
    
    
 
              
 
 
time per group. The comparison of DCS scores at the individual time points will be analysed
further in the next section.
Table 6.7. Mean scores of the Decision Conflict scale for all responders included in the
Mixed ANOVA over time T3-T6 and per trial arm.
Time Trial Arm N Mean Std. Deviation
T3 Intervention 20 1.72 0.85
Control 16 1.77 0.57
Total 36 1.74 0.73
T4 Intervention 20 1.48 0.68
Control 16 1.98 0.57
Total 36 1.70 0.67
T5 Intervention 20 1.65 0.86
Control 16 1.80 0.47
Total 36 1.71 0.71
T6 Follow up Intervention 20 1.48 0.45
Control 16 1.94 0.54
Total 36 1.68 0.54




    
 
             
     
 
             
            
         
 
            
            
              
  
 
             
           
             
 
               
            






DCS scores between groups T3-T6 
Independent t-tests compared group mean scores of DCS between groups at individual time
points, see table 6.8.
Post consultation (T3) a non-significant difference was found between group mean scores of
DCS (t(106)=-1.40, p=0.164). Control participants score of DCS (M1.75, SD0.74) were not
significantly different to intervention participants rating (M1.96, SD0.78).
Following the mid treatment consultation (T4) a significant difference was found between
group mean scores of DCS (t(84)=-2.76, p=0.007), the intervention group (M1.60, SD0.73)
reported lower scores of decision conflict when compared with control participants (M1.99,
SD0.56).
Post end of treatment (T5) review a non-significant difference was found between group
mean scores of DCS (t(60)=--1.25, p=0.216), although the intervention group (M1.70,
SD0.78) scored lower on the DCS when compared with control participants (M1.91, SD0.54).
At follow up (T6) a non-significant difference was found between group mean scores of DCS
(t(67)=-1.76, p=0.082). Again the intervention group (M1.48, SD0.50) scored lower on the




            
     
 
    
   
 









        
       
       
        
       
       
        
       
       
         
       
       
 
 
     
               
     
 
              
              
           
               
                
               
 




         
        
      
Table 6.8. Mean scores of the Decision Conflict scale for all responders over time
and per trial arm.
95%Confidence Interval
Std.
Time Trial Arm n Mean Deviation p value Lower Upper
T3 Intervention 55 1.75 0.74 0.164 -0.49 0.08
Control 53 1.96 0.78
T4 Intervention 43 1.60 0.73 0.007 -0.67 -0.11
Control 25 1.99 0.56
T5 Intervention 32 1.70 0.78 0.216 -0.55 0.13
Control 38 1.91 0.54
T6 Intervention 35 1.48 0.50 0.082 -0.47 0.02
Control 34 1.70 0.54
6.3.2.2. Decision Regret
The decision regret scale (DRS) was administered once at follow up (T6). A high number (1-
5) indicated more regret.
An independent samples t-test was conducted to compare the Decision Regret score for the
intervention and control group at T6. A significant difference in scores was found between
intervention (M9.32, SD12.26) and control (M19.03, SD22.86; t(44.07)= -2.12, p=0.039) see
table 6.9. The magnitude of the differences in the means (Mdiff-= -9.71, CI95%: -18.92 to -
0.49) was moderate (eta squared = 0.064) see figure 6.11. These results indicate that those in
the intervention arm experienced less regret when compared with those in the control arm.
Table 6.9. Mean scores for the Decision Regret Scale at follow up (T6).
Mean score (SD) Mean difference p value
Control (n=31) 19.03 (22.89) -9.71 (1.02-18.39) 0.039




                
 
 
         
             
              
               
              
           
          
          
           
               
    
 
Figure 6.4. Mean changes in Decision Regret Scores between groups at follow up (T6)
Relationship between amount of oncology appointments and DR score
As previously reported, the number of appointments attended, and therefore the amount of
intervention exposed to, varied amongst participants from a minimum of one to a maximum
of four. To explore if there was a relationship between the number of appointments attended
and DRS score a scatter plot was generated which indicated some level of positive
relationship, however a non-significant correlation was reported (r(66)= 0.22, p=0.08). This
non-significance was maintained when exploring the relationship between number of
appointments attended within the intervention participant (r(35)=-0.05, p=0.74). However a
positive relationship was found for control participants r(29)=0.38, p=0.038, indicating for





              




       
                
               
                 
     
 
             





Figure 6.5 A scattergram to show the relationship between the spread of DRS scores and
number of appointments attended for control participants.
6.3.2.3. Preparation for decision making scale.
This measure was taken after each consultation (T3, T4 and T5) and consisted of four items
to assess how prepared a participant was for their consultation. Mann Whitney U tests were
used to explore the differences of scores between groups as all item scores at each time point
violated the assumption of homogeneit 
At T3 for all four items the intervention participants scored significantly higher (p>0.001)

















      
 
      
        
 
      
        
 
      
                
 




Table 6.10 Mean scores for the Preparation for Decision Making Scale at post initial
consult (T3).
Items scored Control Navigation U p
valueNot at all 1-2-3-4-5 A great deal n=52 n= 62
M (SD) M (SD)
Organise your own thoughts about the
decision
Identify the questions you want to ask your
doctor
Think about how involved want to be in
decision
Talk to your doctor about what matters most
3.98 (0.91) 4.60 (0.59) 752.00 0.00
3.84 (1.03) 4.67 (0.57) 952.50 0.00
3.92 (0.94) 4.50 (0.75) 920.50 0.00
4.10 (0.78) 4.69 (0.53) 878.00 0.00




             
          
 
               
 
   









      
 
      
        
 
      
        
 
      
                
 
 
                 
 
 
At T5 for all four items the intervention participants scored significantly (p>0.001) higher
than control participants, see table 6.11 and figure 6.7.
Table 6.11. Mean scores for the Preparation for Decision Making Scale at mid treatment (T4)
Items scored: Control Navigation U p
valueNot at all 1-2-3-4-5 A great deal n=29 n= 42
M (SD) M (SD)
Organise your own thoughts about the
decision
Identify the questions you want to ask your
doctor
Think about how involved want to be in
decision
Talk to your doctor about what matters most
3.52 (1.39) 4.57 (0.70) 318.50 0.00
3.41 (1.43) 4.57 (0.60) 305.00 0.00
3.45 (1.38) 4.55 (0.71) 309.00 0.00
3.59 (1.30) 4.64 (0.62) 878.00 0.00




            
         
 
                
   
 
  









      
 
      
        
 
      
        
 
      
                
 
 
                 
 
At T6 for all four items the intervention participants scored significantly (p>0.001) higher
than control participants, see table 6.12 and figure 6.8.
Table 6.12. Mean scores for the Preparation for Decision Making Scale at end of treatment
review appointment (T5).
Items scored:









Organise your own thoughts about the 3.84 (1.03) 4.71 (0.75) 169.00 0.00
decision
Identify the questions you want to ask your 3.67 (1.27) 4.60 (0.84) 206.50 0.00
doctor
Think about how involved want to be in 3.76 (0.93) 4.69 (0.63) 200.00 0.00
decision
Talk to your doctor about what matters most 3.68 (1.28) 4.80 (0.72) 168.00 0.00




       
             
               
    
 
    
               
                 
             
 
            
     
   
 
  
      
      












Summary of Preparing for decision making scores
Intervention participants reported overall higher scores on the four items from the Preparation
For Decision Making scale when compared to control participants at each time point (T3, T4
and T5) (p>0.001).
Satisfaction with Intervention
Intervention participants were asked to rate their satisfaction of the intervention on a scale of
one-ten (1 not at all satisfied 10 extremely satisfied) after each consultation T3, T4 and T5.
The majority of particiapnts were highly saisfied with their experience, see Table 6.13.
Table 6.13 Intervention participant satisfaction scores over three timepoints(T3, T4,T5).
Score Range
Timepoint Mean Standard Min Max
Deviation
T3 (n=62) 9.08 1.27 2 10
T4 (n=41) 9.37 0.83 7 10




       
               
             
                
       
        
 
































            
       
        
          
        
        
6.3.2.4. Hospital Anxiety and Depression Scale
Participants completed the HADS a 14 item measure at baseline (T1) and follow up (T6);
seven items measured anxiety and seven measured depression. Group mean HADS scores for
anxiety and depression for both trial arms decreased from baseline to follow up see table 6.14
and 6.15 and Figure 6.9, reporting of
anxiety and depression over the study period.
Table 6.14. Group mean anxiety scores by trial arm over time (T1-T6).
Mean baseline score (SD) (n) Mean Follow up score (SD) (n)
Intervention 7.03 (4.29) (n=64) 5.67 (4.13) (n=39)
Control 6.41 (4.21) (n=64) 5.94 (4.49) (n=34)
Table 6.15. Group mean depression scores by trial arm over time (T1-T6).
Mean baseline score (SD)(n) Mean Follow up score (SD)(n)
Navigation 5.17 (3.80) (n=63) 3.49 (3.30) (n=39)




              
 
        
               
             
              
          
             





Figure 6.9. Mean change in HADS scores from Baseline (T1) to follow up (T6) per trial arm. 
HADS-Anxiety scores (T1 and T6) per trial arm
There was a non-significant main effect of the trial arm F(1,71)=0.005, p=0.943, the rating of
HADS-A did not significantly differ between overall groups scores, disregarding time point.
There was a non-significant main effect of the time F(1,71)=2.42, p=0.124), the rating of
HADS-A did not differ over time disregarding Trial Arm.
A non-significant Time x Trial Arm interaction was found F(1,71)=0.38, p=0.541, the rating




             
   
 
      
  
 
     
    
    
     
    
    
 
    
              
               
       
 
             
            
             
 
              
              
         
 
               
              
               
    
 
 
Table 6.16. Mean scores for the HADS-A at baseline (T1) and follow up (T6) included in
the mixed ANOVA.
Std.
Time Trial Arm n Mean Deviation
T1 Intervention 39 6.62 3.92
Control 34 6.41 4.72
T6 Intervention 39 5.67 4.13
Control 34 6.00 4.46
Clinical thresholds of anxiety
Descriptive statistics were calculated using a clinical cut-off point of eight, to indicate a
borderline state of anxiety and ten to indicate a clinical presence of anxiety (Zigmund &
Snaith, 1983; Patel, et al., 2010).
At baseline, 128 participants completed the anxiety subscale measure. Of these, 24
participants (16 intervention, 8 control) (18.75%) reached the threshold of clinical anxiety
( 10), while 23 (17.97%) participants (10 intervention, 13 control) scored borderline ( 8-
.
At follow up 15 participants (8 intervention, 7 control) (20.56%) reached the threshold for
anxiety ( 10) out of 73 participants who completed the scale, 9 participants scored borderline
( 8- (4 intervention, 5 control) (12.16%).
Using a threshold of 8 on the whole data set, 36.72% (40.6% intervention, 32.81% control)
of this population were highly anxious at baseline; at follow up 32.43% (30.77% intervention,
34.29% control) at follow up. Table 6.17 shows the mean scores for all participants who




           
 
 
        
               
           
               
               
         
              
              
 
                 
   
 
      
  
 
     
    
    
     
    





    
     
          
         
          
Table 6.17. Frequency of clinical anxiety threshold 10) scores by trial arm over time. 
Baseline Follow Up
Range Range















HADS-Depression scores (T1 and T6) per trial arm
There was a non-significant main effect of the trial arm F(1,71)=0.01, p=0.920, the rating of
HADS-D did not differ between groups, disregarding the time point.
There was a significant main effect of the time F(1,71)=7.15, p=0.009, the rating of HADS-
D did differ over time. From baseline to follow up overall HADS-D scores, disregarding
Trial Arm, decreased (Mdiff =-1.20, C195% 0.31-2.10, p=0.009).
A non-significant time x trial arm interaction was found F(1,71)=0.34, p=0.564, the rating of
HADS-D over time did not differ between intervention and control groups, see table 6.18.




























   
              
              
          
 
             
            
             
 
              
            
           
   
 
               
               
              
       
 
                 
 
      
     
         
         
          
Clinical thresholds of depression 
Descriptive statistics were calculated using a clinical cut-off point of eight to indicate a
borderline state of depression and ten used to indicate a clinical presence of depression
(Zigmund & Snaith, 1983; Patel, et al., 2010).
From the 63 participants who completed the depression subscale at baseline 14 participants
(seven control, seven intervention) (22.22%) scored 10 indicating a potential diagnosis of
depression, 12 (19.05%) scored borderline ( 8- (7 intervention, 5 control).
At follow up, 74 participants completed the measure, of this sample 7 participants (9.46%)
reached the cut-off point indicating a borderline state of depression ( 8-
intervention, 2 control) while three participants (one control, two intervention) (4.05%)
scored 10.
Using a threshold of 8 on the whole data set, 20.31% (22.22% intervention, 18.46% control)
of this population were highly depressed at baseline; at follow up this reduced to 13.51%
(17.95% intervention, 8.57% control) scored. Table 6.19 shows the mean scores for all
participants who competed the depression subscale.
Table 6.19. Frequency of clinical depression ( 10) threshold scores by trial arm over time.
Baseline (T1) Follow Up (T3)
Range Range


















        
             
                
              
                 
               
             
              
             
             
              
           
            
             
           
 
               
              
           




6.4. Summary of the RCT results.
The primary outcome measure of this study was the Decision Self-Efficacy scale. No
significant difference was found in scores of DSE between Trial arms and over time. In the
secondary outcome DCS again no significant difference in the scores was found between
trial arms over time. When the DCS scores were analysed at each time point there were no
significant differences between groups for T3 and T5, however at T4 the intervention group
reported significantly lower decision conflict when compared to the control group. At follow
up a significant difference was found between the score of Decision regret between groups.
Intervention groups reported lower scores of regret. . In addition a positive correlation
between number of appointments attended and increasing regret score was found for control
participants only. At each time point after the consultation (T3, T4 and T5) intervention
participants scored significantly higher on the Preparation for Decision Making scale,
indicating a high sense of feeling prepared. Overall intervention participants rated their
satisfaction as high across the time. No significant differences were found between groups
over time on both the HADS subscales (anxiety and depression).
These results will be discussed further in the context of current knowledge and the qualitative
evaluation of the intervention in chapter nine, the discussion. The next Chapter (7) will
describe the qualitative evaluation methodology followed by the qualitative findings in




   
   
           
             
             
               
             
             
             
            
 
       
            
            
       
          
             
  
               
              
                  
        
 
Chapter 7: Q 
7.1. Introduction
Following the previous chapters, which outlined the randomised controlled trial methodology
and results of the intervention with colorectal cancer patients, this chapter presents the
methodology used to explore patient and clinician experiences of Navigation and usual care.
This was achieved through undertaking a qualitative study as part of this thesis. The chapter
begins by documenting the process of designing the qualitative component of this research
and subsequently outlines and provides rationale for the methods chosen. There then follows
a description of the qualitative research methods utilised with the sample population of:
colorectal cancer participants, high grade glioma participants and health care professionals.
7.2. Philosophical underpinning of qualitative inquiry
The philosophical foundations of naturalistic inquiry, undertaking study of a phenomena in
its natural setting, individuals create their own subjective realities, and thus the
(p 46, DePoy & Gitlin, ,
2011). Within this philosophy, interpretations are the lenses through
which they know the universe (DePoy & Gitlin, 2011). Qualitative research therefore is
characterised by;
methods sensitive to the context; the capture of detailed and rich data, utilising a mainly
inductive process; and developing explanations at the level of meaning (Spencer et al., 2003).
As such, qualitative research aims to answers questions such as what is X, how does it vary in




           
          
           
              
              
             
               
              
     
             
  
 
             
               
          
            
             
             
              
           





There is a recognised competition between qualitative and quantitative philosophies, with
quantitative methodologies, in particular the randomised controlled trial, residing dominant
within health-related research. Although quantitative research may be able to demonstrate
statistically significant and so generalisable results from a large population, it has limited use
in adequately exploring why or how a phenomenon occurs (Silverman, 2009), for example in
building understanding of the cancer experience. To understand meaning that people attach to
their experiences of the social world and how they make sense of that world, qualitative
research can provide the in-depth and exploratory tools needed to produce a clear depiction
(Symon & Cassel, 1998). As
and unpick the mechanisms which link particular variables by looking at explanations or
As this world view is constructed and interpreted by people themselves, naturalistic inquiry
proposes that the social world cannot be reduced to purely that which is observable and
manipulated (Holloway, 2005). Research conducted in this paradigm uses systematic
approaches to collect empirical data, organise and interpret such data usually obtained
through talking with people or through observation in the natural setting. Qualitative
methodology facilitates researchers to reveal a novel and insightful way of understanding the
perspective of the respondent, and has application in the context of oncology as increasingly
multi-disciplinary research teams attempt to tackle the psycho-social aspects of cancer




          
             
             
              
             
               
             
         
           
           
     
 
               
            
             
             
             
            
            
             
            
            
             
                 
7.3. Qualitative research in healthcare and complex intervention evaluation
A qualitative approach to inquiry has become accepted and established within health services
research (Mays & Pope, 2000) and increasingly within health care evaluation (Lewis, 2007).
Qualitative evaluation is operationalized as research which aims to appraise how a service or
innovation, in this thesis Navigation, is implemented, and whether it achieves its objectives,
with a view to understanding its effectiveness (Lewis, 2007). The field of using qualitative
research for evaluation purposes is relatively early in its development. Such evaluation within
interpretations of the social world examined with their natural
2003). Qualitative approaches in evaluation aim to holistically understand the phenomena
from the insider perspectives of participants (patients) and other stakeholders (clinicians)
(Abma & Widdershoven, 2011).
Qualitative research is now used in evaluation for a range of purposes. Ritchie and Spencer
(1994) propose evaluation research seeks to address four categories of objectives, namely:
contextual, identifying the form and nature of what exists; diagnostic, examining reasons for,
or causes of, what exists; evaluative, appraising the effectiveness of what exists: and
strategic, identifying new theories, plans or actions. More specifically, Spencer et al., (2003)
highlight qualitative evaluative research can: identify the factors that contribute to successful
or unsuccessful delivery; identify outcomes (intended or unintended) and how they occur;
examine the nature of requirements of different groups within the target population; and
explore organisational aspects of delivery. Within the evaluation of a complex intervention
Lewin, Glenton & Oxman (2009) recommend a qualitative element has many beneficial
functions according to when it is implemented; before, during or after a randomised




          
                
             
           
              
             
             
       
         
 
            
              
             
            
 
    
             
            
               
             
              
              
            
             
a engagement with the intervention therefore it corresponds with the functions
after a trial. After a trial, Lewin, et al., (2009) propose the qualitative approach contributes to
the overall evaluation through: exploring reasons for the findings of the trial, explaining
variations in effectiveness within the sample, examining the appropriateness of the
underlying theory, and generating further questions or hypotheses (p.2). In a review of the
literature of qualitative studies that evaluated RCTs for complex intervention Lewin et al.
(2009) found very few integrated the results of both paradigms. This thesis follows
el to integrate the findings at the
contextual level, within the discussion of this thesis.
For this evaluation, the study is primarily interested in understanding the acceptability,
impact and feasibility of Navigation, grounded in the experiences and views of patients and
clinicians. The qualitative methods utilised will thereby provide a more detailed and nuanced
information than the data generated through an RCT alone (Sandelowski, 1996).
7.4. Study design
A prospective qualitative design was used to evaluate the Navigation intervention from the
perspective of patients and their clinicians. Qualitative in-depth interviews were used to
collect data. The sample was drawn from patients with CRC involved in the intervention arm
(Navigated patients) and control arm (usual care). Participants were also recruited who had
HGG and received the intervention. Consulting clinicians involved in the care of HGG and
CRC patients were also recruited. Data was collected in a single face-to-face or telephone
semi-structured interview that explored the areas of decision making and communication in




           
      
 
       
                
             
  
               
              
             
             
            
               
            
 
          
               
             
             
                
              
                
             
           
patients and clinicians). Two interview guides (patient and clinician) were used to direct
interview questioning. Framework analysis was undertaken.
7.5. Study settings and sample
The settings in which this study occurred have been detailed in Chapter 4 section 4.4. In
summary, the qualitative evaluation was conducted in a regional, tertiary cancer centre in
Scotland.
Sampling in qualitative research is driven by a different set of concerns when compared to
quantitative research. As stated by Mays and Pope (1996) the purpose [of sampling in
qualitative research] is to identify specific groups of people who either possess characteristics
or live in circumstances relevant to the social phenomenon being studied (p.12). The
sampling strategy was purposeful in that participants were recruited based on having
experiences relevant to the aims of the study. Details of the recruitment of patient and
clinicians for the qualitative component of the evaluation are now presented.
7.5.1. Sample and recruitment procedures: Colorectal cancer (CRC) participants
In order to obtain a more detailed insight into the experiences of decision making and
communication within the consultation in usual care and with the intervention, a subsample
of the control and intervention participants from the RCT were invited to interview.
for interviews occurred over a four month period towards the end of the trial. The
study aimed to recruit ten control and ten intervention participants. The sampling frame for
this evaluation was formed by those who gave their consent to be contacted for interview at
baseline. The inclusion criteria included; trial participants who had consented for interview at




            
               
               
            
     
 
             
          
            
              
            
            
   
 
               
              
              
          
              
             
               
    
 
              
             
a mid-treatment review appointment and an end of treatment appointment. Exclusion criteria
included; participants who did not consent to be contacted for interview at baseline and those
who had attended two or fewer clinic appointments as the aim of the qualitative evaluation
was to gather experiences of repeated consultations and compare the longitudinal experience
of Navigation with usual care.
Qualitative interviews were conducted within one month of a participant completing the end
of treatment review appointment. Stratified purposeful sampling (Sandelowski, 2000) was
utilised to select participants within intervention and control groups, purposively chosen to
include those with palliative disease and curative disease. These groups were chosen due to
the different contexts of treatment decisions (curative and palliative) and the potential
comparisons between CRC and HGG. This type of sampling is informationally representative
(Sandelowski, 2000).
As this trial was longitudinal in nature the main researcher was very familiar with the
participants. To reduce any potential bias in the selection of participants e.g. those favourable
with the intervention, and in keeping with the evaluative nature of this research, an
independent and remote researcher selected participants for interview. All eligible
participants at the current time point were assigned number codes and grouped according to
trial arm and disease stage. The independent researcher randomly picked twelve from each
group, to account for decliners. This was an iterative process that ran concurrent with the
main study trial.
Selected participants were invited to interview via a telephone call. The telephone call




              
             
               
  
          
                
              
               
                 
      
               
       
            
     
            
      
        
 
             
            
                
               
            
              
              
convenience and availability. As the aim of this study was to develop a qualitative
understanding of the experience of the intervention, and generate ideas to further understand
the RCT findings, the sample size was deemed adequate for this evaluation and to achieve
data saturation.
7.5.2. Sample and recruitment procedures: High Grade Glioma (HGG) participants.
As previously highlighted, the number of people diagnosed with a HGG at the study site was
variable. Recruitment occurred over a 14 month period, and based on an assumed 30%
recruitment rate, the aim was to recruit 36 participants during that time. The inclusion criteria
were: all patients newly diagnosed with a HGG and all patients aged over 18. The exclusion
criteria were patients who had:
severe physical illness and considered too ill or distressed on assessment by the clinic
team to be involved in the study;
identifiable severe psychiatric morbidity or limited ability to understand and to
engage in the intervention;
diminished cognitive capacity and unable to make an informed autonomous decision
about taking part in the study;
inability to speak and comprehend English.
Recruitment for the HGG group was informed by a flexible, pragmatic sampling approach,
using purposeful sampling (Marshall, 1996). It was anticipated that recruitment from this
patient group would be challenging and time intensive as HGG is a rare cancer with patients,
at the point of recruitment, being generally unaware of their diagnosis. An initial sample of
seven patients was consecutively recruited. The demographics of these participants were then
reviewed and subsequent recruitment was then directed to ensure diversity by age and gender,




            
              
              
      
          
            
              
             
               
             
                
                 
              
             
                
                  
              
                 
         
 
              
              
               
              
            
became difficult and subsequently a convenience sample of participants were invited for
pragmatic reasons such as limited time left for the study to run. next of
kin/relatives/carers of patient wished to be present or take part in the interview, verbal
consent was obtained from both parties.
Potential HGG participants were identified through the weekly multi-disciplinary team
meeting and confirmed by the neuro-surgical team (including the consultants and specialist
nurse) according to the inclusion/exclusion criteria. Patients were invited to the study at one
of three time points; at pre-assessment clinic before their surgery, on the neuro-surgical
hospital ward before their surgery or a few days after their surgery in the neuro-surgical
hospital ward. Those invited at the pre-assessment clinic were re-assessed for eligibility after
their surgery and the study team met with them again on the ward post-surgery. Initial
contact was made by a member of the health team who then introduced the researcher to the
patient. At first contact patients were provided with a verbal explanation of the study
alongside an invitation sheet, information sheet and example consent form (see Appendix 17,
18 & 19). Opportunity for questions was made available. A second time for follow up contact
was arranged. A minimum of 24 hours was given for patients to decide if they would like to
participate. When a patient agreed to participate they completed the consent form. No repeat
approaches were made. Those who did not wish to take part in the study were not contacted
again. All participants who consented received the intervention.
At the first Navigated clinic appointment, patients received the results of their surgery and
were informed of their formal diagnosis, a high grade glioma, an incurable and severely life-
limiting brain tumour. The pre-diagnosis period is a critical time that can either preclude or
facilitate smooth and rapid transition from being a person with symptoms to becoming a




               
            
              
                 
               
               
             
              
                
              
         
 
                 
            
             
             
              
        
 
       
           
              
                
              
             
such, it was important the intervention be put in place before a patient had received their
formal diagnosis, in order to support participants for their first consultation appointment.
Therefore patients were invited into the study whilst on the ward recovering from brain
surgery for their HGG. At this point of invitation the majority of patients at this point were
not aware of the gravity of their condition. Furthermore, it was quickly discovered the
majority of participants were not aware they would need to attend a clinic appointment to
hear the results of their surgery. Through negotiation with the neuro-surgeons throughout the
study period, it was agreed patients would be informed earlier post-surgery that attendance at
clinic would be the next stage in their management and this was then highlighted to ward
staff. Participants were often very pleased to understand more about what would happen next.
All interviews were arranged and conducted at the parti 
As noted previously in this work, this thesis reports on part of a larger evaluation study. In
this, Navigation participants engaged in serial evaluation interviews throughout their first line
treatment (baseline, mid treatment and end of treatment). However, in order to enable
comparison with the experiences of other groups involved in this qualitative evaluation, this
thesis will only report on the final interview conducted with HGG participants within one
month of their end of treatment review.
7.5.3. Sample and recruitment procedures: Clinicians
To gain a multi-perspective approach about the intervention impact, consulting clinicians
were also interviewed about the experience of using Navigation. The aim of bringing data
from another appropriate source was to add richness to the context of the data, provide a
more detailed understanding from a different perspective, and use this to help inform relevant




             
              
           
 
           
          
             
           
             
               
                
            
               
  
 
        
              
       
              
       
              
              
             
             
              
Following the end of patient recruitment to the trials, all consulting clinicians who had first-
hand experience of Navigated patients were invited to a single face-to-face interview in order
to explore their views and attitudes about the Navigation intervention.
The potential sample was self-selected from four colorectal consultants and three neuro-
oncology consultants and one senior registrar. Inclusion criteria encompassed; consulting
with an intervention participant over the three consecutive appointments (initial, mid & end
time points) with three or more participants. Exclusion criteria included; consulting
intervention less than three participants for less than three appointments or consulting for
each appointment but fewer than three times. Invitations to participate in the interviews were
made via email. A convenient time and place for interview was agreed with those wishing to
participate. No follow-up emails were sent to non-responders or those who declined.
Clinicians were asked to sign a consent form (Appendix 20) prior to commencement of the
interview.
7.6. Research Methods: the qualitative research interview
Interviews form an essential part of qualitative data collection and provide a rich and
important contribution to understanding ). A semi
structured approach was used to conduct the interviews as the evaluation aimed to understand
and communication within the consultation and
the impact of the intervention on these experiences. Two interview guides (Appendix 21 &22
) were developed that outlined key areas for exploration with each group of participants
(patients and clinicians). The interview guides were important in building the language used
in interviews, thereby producing creditable and auditable data. These were informed by the




             
            
              
               
           
             
             
            
     
             
             
                 
            
          
            
            
            
  
 
             
            
            
                
              
The participant interview schedules were based on the determinants as proposed by the
Ottowa decision support framework (O'Connor et al., 1998). The questions examined a
resources and role in treatment decision making. This same framework was applied in the
selection of outcome measures for the RCT, this directed the interview to elaborate on topics
measured quantitatively. In developing the participant interview guides formal piloting was
not undertaken however the content and question formulation was shaped and explored in
consultation with expert patients. The same interview schedule was used for all participants.
However, for intervention participants there were prompts to further discuss the specific
elements of the intervention. The
materials (Consultation plan, audio recording, summary) and the impact on; their patient, the
consultation and their style of consulting, in addition it examined how relevant the
intervention was to their practice. The same schedule was used for both cohorts of clinicians.
Strategies employed during the interviews included use of different types of questions
including those that gathered information about experiences, explanations, opinions, and
emotions. Other techniques also included use of descriptive grand tour questions (Spradley,
1979) where broad overarching questions were used to explore general health consultation
and decision-making issues, through to funnelling down to specific questions (Kvale &
Brinkman, 2008).
Patients with cancer can be perceived as a vulnerable group (Hawryluck, 2004), with
qualitative research interviews having potential to evoke strong emotional responses. It was
therefore understandable that some patient participants wanted carers to be present when
talking with the researcher. Whilst this was not part of the original study design, a decision




              
            
              
     
 
    
               
             
             
                
 
      
            
             
              
               
              
              
 
            
                
           
        
 
 
collection about sensitive issues (Morris & Thomas, 2001), and indeed can bring a different
understanding. Therefore some interviews were joint interviews where both patient and carer
were present and where the researchers was responsive to the needs of both participants
(Morris & Thomas, 2001).
7.7. Data collection
As reported above, two interview schedules were developed as a guide for each interview (all
patients and clinicians). Any new issues identified in the early interviews were incorporated
into the schedule for subsequent interviews. All interviews concluded by asking whether the
participant had any questions or whether there was anything else to add to the interview.
primary study site, or over the
telephone. This was directed by participant preference and convenience. Prior to
commencement of the interview, participants were reminded of the purpose of the interview
and their right to withdraw at any time, whilst assuring confidentiality and anonymity during
the study processes. The interview schedules were used to guide the conversation and ensure
all topics were covered with each participant, whilst also remaining open to incorporate new
and emerging areas of importance to the participant and relevant to the study.
All interviews were recorded with the , using a digital audio-recorder to
obtain an accurate record of what was said. The recording provided a complete account of the
ind , thereby increasing data reliability by reducing the selective filtering of




     
            
              
        
 
           
             
            
             
       
 
              
                 
               
               
                 
             
      
 
            
     
            
           
            
             
7.8. Qualitative data analysis
A wide range of literature documents the underlying assumptions and procedures associated
with analysing qualitative data. For this work, the main approach used to manage, organise
and interpret the data was framework analysis.
Many established qualitative data analysis approaches are associated with specific approaches
or traditions, such as grounded theory (Strauss & Corbin, 1998), phenomenology (e.g., van
Manen, 1990), discourse analysis (e.g., Potter & Wetherell, 1994), and narrative analysis
(e.g., Leiblich, 1998). The framework methods sit broadly within a category of thematic
analysis (Pope, Ziebland, & Mays, 2000).
Framework analysis was used as it is suited to research with specific questions, a pre-
designed sample and apriori issues to be addressed, as was the case in this thesis (Ritchie &
Spencer, 1994). Although framework analysis can be used to generate theory, its prime use in
this study was to describe, organise and interpret what was happening in a particular setting.
In undertaking this, the process of analysis and the findings are set out to be accessible and
transparent to others outside of the analysis team, thereby enhancing study rigour (Pope,
Ziebland, & Mays, 2000).
Qualitative data analysis is essentially about discovery, in which the tasks; categorising,
theorising, explaining, exploring and mapping,
(Ritchie and Spencer, 1994). The framework analysis method facilitates the completion of
each task. Although framework analysis uses grounded and inductive analytic approaches,
the analysis starts deductively from pre-set study aims and objectives. The framework




             
             
               
              
              
            
           
              
         
 
               
           
              
            
               
                
                
           
               
             
              
            
               
       
ultimately used to produce structured summarised data. In this way, the method facilitates the
constant comparative technique (Strauss & Corbin, 1998) which was used to refine themes,
through the constant review of data across the matrices. As this study involved three cohorts
of data this method supported the comparison across experiences at the interpretation level.
Prior to the start of data analysis, all digital recordings were professionally and confidentially
transcribed. Transcriptions were re-read for accuracy and anonymised through the removal of
names and places mentioned throughout the interview. Transcribers were offered a de-
briefing session as transcribing interviews in this area is recognised as an emotional burden
(Kendall et al., 2007). Once transcribed, data analysis commenced.
analysis (1994). This is a five stage matrix method of familiarisation that develops a thematic
framework through indexing, charting and finally mapping and interpretation. All participant
data was analysed together (CRC and HGG). Clinician data were analysed separately with a
separate thematic framework. Two researchers conducted the analysis, the author of this
thesis and an independent researcher (MC) not familiar with the trial but with expertise in
qualitative analysis. The roles within the analysis are described in each of the five stages of
analysis. Details of how each of the five stages were accomplished in this study are now
given (exerts are also provided in the appendix 23 & 24):
1) Familiarisation: In this phase of the analysis all transcripts were read several times
and annotated thoroughly on encrypted word files. Key ideas, issues and possible themes
were noted and the relevant text highlighted. This was an immersive time which helped
develop an awareness of potential repeating patterns throughout the data. The researcher
became familiar with one data set at a time (HGG, CRC intervention, CRC control, and




           
          
    
             
              
              
          
           
            
             
            
 
             
              
            
             
             
            
              
              
             
             
              
           
              
2) Developing a thematic framework: Through familiarisation, gradual development and
clarification of the important common themes emerged. Through conversation with
another researcher , broad
key themes and subthemes were identified. These were numbered to create a thematic
framework, and applied to six patient transcripts (2 control and 2 intervention, 2 HGG)
and 2 clinician transcripts. In being responsive to the text, this process refined themes,
redefined categories and ensured all relevant issues and conceptualisations encapsulated
the experiences and attitudes of participants. Through this process of constant
comparison and checking to see if the theme categories accurately captured experiences,
researchers discussed, deliberated and agreed upon a final thematic framework to sort the
data. Two researchers (author and MC) were involved in this process.
3) Indexing: The finalised thematic framework index was systematically applied to all
transcripts. It was preferable to keep the same index for different patient groups (control
and intervention) as it facilitated the identification of common and divergent themes.
Text within the transcripts were highlighted and annotated in the margins with the
corresponding index number. Two researchers took part in this process. The process of
making judgements is subjective. However, in checking with another researcher (MC),
this made the processes visible to others and, through the annotation of transcripts and
charting of quotes, is therefore open to scrutiny. Five transcripts (1 control and 1
intervention, 1 HGG, and two clinicians) were indexed by both researchers who then
came together to compare coding. Again, a process of deliberation and further refinement
of the description of the categories took place. One researcher (author) then continued to
index the remainder of the transcripts. Multiple indexing [where single passages





               
               
            
             
              
              
             
             
        
 
              
              
           
     
 
          
            
             
              
              
             
           
      
                  
         
4) Charting: Within the charting stage for the participant date four charts were devised
for each of the major themes that emerged, informed by the thematic framework. For the
clinician data three main themes emerged and so three charts were created.
quotes were lifted from the corresponding transcript and entered into the relevant chart,
along with their assigned study code and the transcript line number. This stage resulted
in four tables of relevant quotes from all participants (HGG, CRC control and CRC
intervention) and three for clinician data. Two researchers reviewed the charts to further
ensure the quote represented the category. If there was no agreement about the
representativeness of a quote, it was removed.
5) Mapping and Interpretation Researchers returned to the key question of analysis
and systematically reviewed each chart to map and interpret the data as a whole.
Experiences and accounts were compared and contrasted, salient patterns were searched
for and explanations sought.
Although the analysis process employed the approaches of interpretation; identifying
patterns, constant comparison and the exploration of conceptual and thematic linkages, the
nature of different populations added a layer of complexity. A further complication arose
from there being no set procedures that supported the analysis of qualitative evaluation across
different sample populations. It was important for the rigour of the interpretation phase that
the data analysis was guided by principles to distinguish the similarities and differences
within and between groups (HGG, CRC control, CRC intervention). Consequently, a
(2007) framework for analysing longitudinal qualitative
data was applied to provide structure to the analysis (only stages 2 and 4 were relevant to, and




             
          
           
            
            
       
           
          
         
            
      
 
               
            
               
            
            
               
            
            





1. Isolated individual group analysis: looked at the cases within each data set in
isolation of the other groups (HGG, CRC control, CRC intervention).
2. Within population analysis: explored the experiences of receiving care for
colorectal cancer from the perspectives of the intervention and control groups.
Explored the experience of delivering care from the perspective of the CRC
clinicians separately from the HGG clinicians.
3. Within intervention analysis: enabled the exploration of the experiences of
Navigation between the two different populations (HGG and CRC intervention)
to explore similarities and differences in the different contexts.
4. Comparison across groups: to explore key issues, similarities and differences in
experiences across all the participant groups.
Within the comparison across groups it was important that the control group were fairly and
accurately represented and not swamped by the intervention data. Careful consideration of
this was utilised throughout the interpretation phase and guided the write-up of the themes to
represent the control experience first followed by the contrast with intervention participants.
When selecting quotes to represent experiences, it was important and integral to
the quality of the research to not use quotes that would only represent the interventions
qualities. This integrity was maintained through constant checking that identified quotes best





       
              
              
                 
              
             
              
              
             
            
            
              
           
         
           
           
               
 
               
              
              
             
          
               
             
7.9. Quality in qualitative research
Given the interpretative nature of qualitative methodology, it can be challenging to assess if
high quality research has been accomplished. A method that reliably assesses the rigour of
qualitative research has not been fully agreed upon. One of the main criticisms in this area of
rigour is that observations and interactions are open to the subjective interpretations of the
researcher, and thus are unscientific (Hammersley, 1998). Furthermore, it is argued that if
research cannot be replicated, then it is unreliable (Atkinson & Silverman, 1997). The
challenges of how a framework may reliably assesses the quality of qualitative research has
resulted in many approaches being developed and much debate over which approach holds
primacy (Shenton, 2004). Consequently, criteria used to assess the quality of qualitative
research is numerous, and often contrasting (Dixon-woods, Shaw, Agarwal & Smith, 2004).
Additionally, there has been concern that criteria to assess quality may stifle the
interpretative and creative nature of qualitative research (Schwandt, 1996). Debates about
whether criteria should exist are concerned with researchers resorting
comply with evaluators needs (Barbour, 2001) However, as qualitative methodology is
increasingly being regarded as an important method in furthering empirical understanding
(Greenhalgh et al., 2016), there is need to appraise the quality of qualitative research.
In this study, specific strategies were adopted to review the rigour of this research. Several
works that critiqued the quality of qualitative study and qualitative evaluation were used to
make assessment of study rigour. These combined the Dixon-Woods et al., (2004) paper that,
in appraising qualitative research, proposed a list of prompt questions, with the Spencer,
Ritchie, Lewis (2003) framework for assessing qualitative evaluation. From
Dixon-woods et al. (2004) work, a number of questions were applied to the design and




    
         
             
    
         
         
 
             
             
                
             
           
            
              
            
             
                 
           
 
            
      
          
          
 
Are the research questions clear? 
Are the research questions suited to qualitative inquiry?
Are the sampling, data collection and analysis clearly described? Are they appropriate
to the research question?
Are the claims made supported by sufficient evidence?
Are the data, interpretations, and conclusions clearly integrated?
These broad questions were integrated within the framework for appraising the quality of
qualitative evaluation by Spencer et al., (2003). This framework was created to appraise
published work, however it was also useful to apply to the design and conduct of this
research as the study progressed. Spencer et al. (2003) suggests four central principles
underpin the quality of qualitative evaluation: contribution to knowledge; defensible design;
rigour in conduct (through transparent collection, analysis and interpretation of data); and
credibility in claims. As there was some overlap between this framework and the framework
proposed by Dixon-woods et al. (2004), relevant items to specifically appraise qualitative
evaluation research were chosen. Four of the original eighteen questions proposed by Spencer
et al. were deemed relevant to the evaluative nature of this study and were applied to further
guide the rigour and trustworthiness of conclusions (2003, p.9-15):
How well does the evaluation address its original aims and purpose?
How credible are the findings?
How clear is the basis of evaluative appraisal?




           
             
  
 
              
              
             
            
              
             
                
             
            
          
          
 
               
             
              
              
               
             
  
 
These questions were used to address issues of trustworthiness: credibility, transferability,
dependability, and confirmability (Lincoln and Guba, 1985). These are now discussed in
more detail.
To ensure credibility of the study, the method was purposefully selected to best describe
experiences of participants in the key areas. Triangulation of data across and within the
groups, thereby cross-checking data sources, added to the credibility of the study. The
relationship with participants over time meant that re-visiting issues raised in earlier
credibility. Using a comparative method within the analysis to example multiple data sources
meant that developing analytical ideas could be tested (Silverman, 2013). Use of thick
description in the data and data write up was also important to allow assessment of whether
findings were reflective of the data presented. Peer review was regularly undertaken during
data analysis with another researcher, and when presenting at research seminars and
conferences. As highlighted by Shenton (2004), such opportunities provided valuable
feedback and fresh insights into the analysis and findings.
Although findings from this study do not claim to be representative to other populations and
settings, identifying the transferability of the research findings to wider audiences is an
important issue. However, it is for the reader to determine, based on the contextual
information provided, and the details of methodology and methods used, the extent to which
findings here can be applied to other settings. The in-depth detail regarding the context and





             
          
            
               
              
                
              
               
              
       
 
              
                
      
 
       
             
            
              
            
              
              
            
           
               
Confirmability addressed the extent to which the researcher has influenced the study. In
rigorous qualitative research, researchers must represent participants perspectives in a
credible and dependable way whilst acknowledging any possible influence of their presence.
In this study, this has been addressed in three ways: triangulation, audit trail, and reflexivity.
Triangulation is a means of reducing researcher bias and has been outlined above. Providing
sufficient detail for others to undertake the study and keeping records as audit trails assist in
making clear the research procedures and research decisions made. This was facilitated by the
use of framework analysis which provides a clear audit trail through the five stages of
analysis. Finally, being reflexive, as discussed in the following section is the final strategy
used to ensure confirmability of the study.
The detail and content given through all methods and findings chapters, and exploration of
this study in the discussion chapter has been provided to act as evidence to assess whether
these areas have been suitably addressed.
7.10. Reflexivity: The role of the researcher
Within qualitative research it is acknowledged the researcher is a central figure who
influences, if not actively constructs, the collection, selection and interpretation of data
(Finlay, 2002). The researcher therefore needs to reflexively recognise that they are part of
the social world being researched (Gobo, 2008). Undertaking such reflexive practice requires
the researcher to critically consider the nature of the relationship held between the researcher
and study participants and how the researcher role is made explicit during the research
ly, 2009). Reflexive practice also requires consideration of whether or how the
researcher has influenced study processes and the final written product (Bradbury-Jones,




              
            
              
 
             
                
           
              
               
                
              
             
              
               
               
          
               
              
              
             
                  
               
               
       
into the research interview or reporting on the impact of the Navigation intervention. Such
reflexive practice and making transparent the reporting of the research process were
perceived as integral to the rigour and validity of the study findings (Allen, 2004).
In recognising and upholding the principles of reflexivity, throughout the thesis, I recognised
the effect I could have on the research process, data collection and data analysis. Prior to
commencing this PhD, I had undertaken research requiring interviewing and collecting
survey data about information needs within a general oncology population. However, as a
junior researcher I had limited experience of research within a group of people acutely aware
of their mortality. In order to maintain a robust method of data collection, I recognised I
needed to be aware of how interviewing someone with a life-limiting prognosis affected my
questioning. As an interviewer, I grappled with the dilemma that participants were spending
their limited time talking with me about their experiences of the intervention. I recognised
this dilemma had the ability to negatively impact the collection of data, for instance making
me hyper sensitive to needs, and in the analysis of data whereby the pressure of
accurately representing a person now deceased, weighed heavily. Acknowledging these
thoughts, I sought advice and counsel early into my PhD from two senior researchers, expert
in end of life research and who had previously conducted research into how researchers
manage data collection in this area. The resultant conversations highlighted to me that often
such qualitative interviews were useful for participants (Kendall et al., 2007). I therefore
has happened up to now / since we last met. This gave the participants choice about what
they would like to tell me. This helped me to undertake the interviews respectfully but
maintaining focus on the aims of the research and to capture the experience of Navigation




             
                
              
          
 
         
 
 
            
                
            
             
            
              
              
            
               
              
           
               
  
 
                 
             
           
uncover the mechanisms of what was happening was challenging; compounded by the fact
this was a funded study. There is a tendency for the gathering of qualitative research to
become self-indulgent and so the frequent de-brief with others on the research team was
integral to maintaining an objectivity to the collection of data
7.11. Ethical considerations and Qualitative research: conducting ethically sensitive
research
Although qualitative research does not generally place participants at risk from procedures,
they may be exposed to data collection that is both intrusive on and invasive of sensitive
experiences. Ethical issues are potentially heightened in research with people who are
potentially vulnerable, and with a diagnosis that may be causing physical and mental
deterioration, such as HGG (Lawton, 2001). In interviewing about experiences of cancer,
awareness of ethical and sensitive issues is paramount and flexibility in technique is required
(Morris & Thomas, 2001). Balancing the benefits of discovery against the potential risks to
the informant was an integral consideration throughout data collection. Given that some
participants may not understand or wish to be confronted with their prognosis, Murray et al.,
(2009) suggests researchers should proceed as if people do not have awareness of their
disease and prognosis, unless explicitly acknowledged otherwise. Within the interviews cues
about willingness to discuss end of life issues were responded to rather than asked about
directly.
Full details of the consent and capacity issues in this study have been detailed in Chapter 4
section 4.5.: ethical approval, data management and study funding. The specific issues of




               
               
            
                  
              
             
               
               
               
     
 
             
               
             
           
             
                    
              
              
        
 
            
               
research interviews. It could be argued that the qualitative design of the study may render
informed consent impossible as the direction and content of the research interview is, to a
certain extent, unforeseeable. Participants were asked to re-confirm their consent at the
beginning of each interview (Kendall et al., 2007) and at the end of the study, to ensure that
fully informed consent for analysis on the data generated was gained. Capacity for consent
was continually assessed in collaboration with the patient's health care team. If capacity
decisions, carers were asked if they would like to continue using the intervention. Carers in
this instance were defined as someone who shared the experience of cancer with the patient
(Morris & Thomas, 2001). If any of these conditions were not fulfilled, the patient was
withdrawn from the study.
Researchers have responsibility for the safety of their participants whilst collecting data and
this is another important aspect of moral and ethical decision making. It was essential to
ensure that participants were not caused any distress by participating in the study.
Rescheduling interviews due to symptoms and/or carer gate-keeping was handled with
sensitivity, and opportunities to withdraw from the study were reiterated at several points
(Kendal et al., 2007). It was also important to know how to bring interviews to an end in a
manner that left participants in a safe emotional state with access to external counselling
support if needed (Kendall et al., 2007). Techniques such as normalising the situation and
bringing patients back to the prese for the rest
of
qualitative interviews is usually more intimate compared to that disclosed during normal




                
     
 
             
              
            
               
                 
                 
               
                
              
               
               
                
   
 
     
              
                 
           
               
  
 
such data is kept private or included as research data. All participants were assured of their
anonymity throughout the interviews.
The ability to establish trust, maintain a fine balance between objective and empathic
listening and taking of a non-judgemental stance were identified by Cowles (1988) as key
factors in eliciting information from participants during an interview; and these remain
relevant today. I reflected on one interview where a participant had talked at length about
losing her husband and her job. Reviewing the transcript, I wondered why I had not ended the
interview earlier as I had enough information. I reflected that I had let it happen because the
participant had provided information that was important for me, and having done that she was
entitled to talk about what was important to her. Although this approach was intuitive, it is
further justified by this quote which aptly speaks to the dilemma I faced: Egalitarian
research is more likely than researcher domination, to allow participants to talk about what is
important to them, express emotions in a spontaneous fashion and act in ways that have
meaning for them rather than in way perceived to be desired by the researcher. (Hall &
Stevens, 1991, p.25)
7.11.1. Researcher Welfare
In terms of researcher safety during the off-site interviews, the researcher informed a third
party of the time and place of interview. This offered protection to the researcher as a lone
worker, whilst preserving confidentiality of the participant. The researcher telephoned the





            
            
            
               
                 
              
               
               
            
            
   
 
  
              
           
               
              
     
The responsibility of the researcher for participant welfare was also significant, particularly
within this patient group. Relationships with the intervention participant group (CRC and
HGG) were inevitable, cultivated over time by multiple contacts and visits. While
professionalism was maintained at all times, there were times where it was difficult to switch
off from distressing events. As noted for the Navigators in chapter 4 section 4.6.4, the role of
de-briefing sessions were also important for the researcher. The use of an interview journal
helped me to reflect and provided a written outlet to express any concerns. Whilst such
responsibility cannot be taken lightly by researchers in this field, it should be noted that
interactions with this patient group, and conducting interviews which address sensitive and
distressing subjects, although demanding, can be satisfying, humbling and at times, inspiring
(Kendal 2007).
7.12. Conclusion
This chapter has described the qualitative study design to evaluate Navigation with CRC and
HGG participants and their consulting clinicians. The design utilised qualitative research
interviews to best answer the research questions posed by this thesis. Chapter 8 will present
findings from the patient interviews and Chapter 9 will explore the perspective of clinicians




    
    
              
             
          
                
             
            
      
 
    
      
             
            
                 
               
 
              
             
              
             
         
 
 
Chapter 8: Qualitative findin 
8.1. Introduction
The previous chapter has outlined the qualitative methods utilised in this evaluation study.
clinicians over the course of their treatment, particularly focusing on aspects of decision
making and information exchange. All participants retrospectively reported their experiences
of the three (in some cases four) consultations attended over the previous six months. In this,
comparison is made of the experiences of Navigated consultations between HGG and CRC
intervention participants. The experience of usual care as reported by CRC control
participants is also explored.
8.2. The sample
8.2.1. The colorectal (CRC) sample
Twenty-four trial participants were invited to take part in the interviews, seven declined.
Seventeen interviews were conducted with trial participants (8 intervention, 9 control). This
sample included 11 males (57.9%) and 6 females (54.54%), with an age range of 39 75
years (M 60.2, SD 9.2). Details of participant characteristics are shown in Table 8.1.
All interviews were conducted within one month of the treatment ending. At this stage
participants were mainly well, particularly those who had treatment with curative intent, and
their illness did not dominate their lives. All participants in the intervention arm were
navigated 3 times; the initial consultation to decide treatment, mid-way through to review




      






      
      
       
      
       
       
      
      
      
      
        
      
      
      
       
      





        
            
           
              
               
           
              
   
 
              
            
                 
Table. 8.1. Characteristics of CRC trial participants interviewed. 




John Navigation Male 61 Curative Phone
Amy Navigation Female 52 Curative Phone
Brian Navigation Male 66 Curative Face-to-face
Angus Navigation Male 69 Curative Phone
Daniel Navigation Male 59 Palliative Phone
Phil Navigation Male 61 Curative Face-to-face
Jan Navigation Female 75 Curative Phone
Rose Navigation Female 39 Palliative Face-to-face
Bill Control Male 51 Curative Face-to-face
Mike Control Male 57 Curative Phone
Ian Control Male 51 Palliative Phone
Barry Control Male 59 Curative Phone
Jill Control Female 52 Curative Phone
Susan Control Female 72 Palliative Face-to-face
Alex Control Male 70 curative Face-to-face
May Control Female 65 Curative Face-to-face
Jeff Control Male 65 Curative Face-to-face
(paired
interview)
8.2.2. The High Grade Glioma (HGG) Sample
Serial interviews (n=3) were conducted with each HGG participant to evaluate the
intervention. To facilitate the comparison of experiences across the oncology populations
(HGG and CRC) only the final interview, following end of treatment, with HGG participants
was included in this analysis. Final interviews were conducted at a similar time point as
colorectal participant interviews, within one month of ending initial treatment. HGG
participants who were interviewed at this time point were re-adjusting to life without frequent
hospital intervention.
Seventy three participants were assessed for eligibility, 51 were invited into the trial. Twenty
participants consented for the Navigation study. Eleven participants were interviewed at this




             
          
 
                
            
                
             
                
              
                
              
 
            
            
              










(n=4), experiencing a physical or mental decline (n=4), and discontinued participation in the
study due to geographical re-location for further care (n=1).
Participants interviewed included five males and six females, with an age range of 29 to 69
(M51.55, SD13.03). The majority of participants (n=9) were diagnosed with a Glioblastoma
(GBM), this is a grade four brain tumour with a prognosis of 18-24 months. Two participants
were diagnosed with an Anaplastic Oligodenroglioma, a stage three brain tumour with a
prognosis of 5 years. Both are categorised as High Grade Gliomas (HGG). In total 15 people
were interviewed as four participants opted for paired interviews, with their husband (n=2) or
wife (n=2). This was deemed useful and not limiting in the interview as discussed in the
methodology (Chapter 7 section 7.6). Details of participants are shown in Table 8.2.
Participants on average, took part in 3.09 Navigated appointments: initial treatment planning,
mid treatment review and post treatment consultation. Participants who received chemotherapy
in addition to radiotherapy required one more appointment mid treatment and so were offered




         
 
     
 
 




       
        
         
     
  
   
       
  
     
        
       
          
           
            
          
 
     
             
              
             
               
         
          
 
      
 
  
             
    
    
    
 
             
               
            
Table. 8.2. Characteristics of HGG participants interviewed
Pseudonym Gender Paired or Age Diagnosis Navigated Location of
single appointm interview
interview ents
Roy Male Single 53 GBM 3 Phone
Carrie Female Single 29 GBM 4 Phone
Harriet Female Paired 57 GBM 3 Face to face
Jen Female Single 39 Anaplastic 3 Phone
Oligodenroglioma
Donna Female Paired 59 Anaplastic 2 Face to face
Oligodenroglioma
Ted Male Single 69 GBM 3 Phone
Rod Male Single 68 GBM 3 Phone
Mick Male Single 47 GBM 4 Face to face
Claudia Female Single 34 GBM 3 Face to face
David Male Paired 56 GBM 3 Face to face
Pam Female Paired 56 GBM 3 Face to face
8.2.3. Total participant sample
The total sample of participants included in this analysis consisted of twenty-eight people,
sixteen males and twelve females, see table 8.3 for details. Nineteen of these participants
were exposed to the Navigation intervention, nine received usual care. Description of usual
care and the Navigation intervention are detailed in Chapter 4, however, a brief description of
the intervention is included in table 8.4 below.
Table 8.3. The demographics of the qualitative participant sample
Demographics CRC control (n=9) CRC intervention HGG (n=11)
(n=8)
Age M 60.25, SD 11.02 M 60.22, SD 8.14 M 51.55, SD 13.03
Gender
Male 6 5 5
Female 3 3 6
appointment at the clinic. The interview data generated from the two cancer population
cohorts (CRC & HGG) were analysed separately. Analysis of both data sets resulted in




              
             
           
             
   
 
         
 
     
            
        
   
 
         
         
        
   
 
         
         
 
 
   
              
           
              
   
            
          
     
            
     
         
          
interview findings of the CRC trial participants and HGG participants will be synthesised and
presented together. The findings from the control participant interviews will be used to
contrast against the intervention participants findings. Similarities in, and differences between
throughout to illustrate the findings, followed by the study participants pseudonym, age and
trial arm group.
Table 8.4. The Intervention, a brief description.
Navigation elements Details
Consultation Planning: Participant and Navigator create a list of prioritised questions
and important information for the consultation.
In the clinic Consultation plan used to ensure questions are covered.
appointment: Navigator attends the appointment with the participant to type
notes and set up the recording equipment.
Summary & audio Participants receive an audio recording of their consultation via
recording: CD and a written summary (approved by attending clinician).
8.3. Themes
Four overarching themes were developed from the data that described the experiences of the
medical consultation. These themes are each presented and the differences between
Navigated and usual care groups, and across the two cancer populations is discussed. The
four themes are:
1. Preparation for consultation: This theme describes how participants planned for the
medical consultation, what behaviours and activities were undertaken and the
he theme describes the differences
between usual care and intervention participants about how time was spent planning
for their oncology consultation.
2. Information exchange in the consultation: This theme describes




         
  
              
              
           
         
          
             
             
        
            
     
 
             
             
            
             
 
      
               
             
               
            
         
consultation and the differences between usual care and intervention participants 
experiences.
3. Recall and understanding of the consultation: This theme looks at the experience of
having a record of the medical consultation that gives information to help reflect on,
and comprehend details shared. Participant experiences of being provided with a
consultation summary and audio-recording are described and contrasted to
experiences of usual care in which neither are provided.
4. Decision making in the consultation: This theme explores how participants felt about
the decisions made and their participation in this, during the medical consultation and
during their disease management. Intervention participants who underwent
consultation planning and coaching and were provided with an information record, are
contrasted to usual care.
To give context to the differences in participant perspectives , findings from participants
receiving the intervention will be presented and then contrasted, within theme, to the
perspectives of usual care participants. This structure will thereby help qualitatively evaluate
the Navigation intervention in its use across and within the study cancer populations.
8.3.1. Preparing for the consultation
Preparing for a medical consultation appeared to be a new concept for all participants across
the study. This was particularly evidenced in the interviews with Navigated participants who
reflected that they would not have prepared for the consultation without the support of the
intervention. In addition, there was minimal data demonstrating preparation for the medical




             
             
 
  
           
               
             
             
             
            
       
                
   
 
               
                 
          
         
             
                 
               
            
 
             
             
feeling supported by the intervention to prepare for their upcoming clinic consultation. This
section is broadly structured into the areas of: (dis)ordered thoughts and managing anxiety.
(Dis)ordered thoughts
Intervention participants reported initially feeling unable to articulate and formulate their
questions prior to the consultation. The reasons for this were unclear but may have been
associated with the stressfulness of the situation. However, what was evident in the
interviews was that through reflection and deliberation with the Navigator in the consultation
planning stage of the intervention, participants could clearly identify the cause of their
concern and felt supported to verbalise their questions clearly with medical staff:
that really helped. Rose, 39, CRC Navigation
It is helpful to formulate what you want to ask beforehand or, you know, have some
Jen, 39, HGG
In addition to being able to clearly formulate their questions, participants felt they were able
to focus their mind to identify what the key issues were they wanted to understand during the
consultation. Acknowledging the time pressures of clinic appointments, participants felt
enabled to focus on the most pertinent matters:
It [Consultation Planning] helped me to focus my mind. Daniel, 59, CRC Navigation
It really made you focus beforehand on what it was that you wanted to talk about or
the information that you wanted from the clinician, instead of just going in blank and
the conversation not being focused enough and getting confused. Donna, 59, HGG
Through spending time with the Navigator reflecting on their situation and the information




              
              
            
                
            
            
 
   
   
 
              
              
             
     
               
              
  
                  
                  
                 
               
                  
             
situation more than they may have without the intervention: ( It just made me think about it 
[healthcare] a bit more. Brian, 66, CRC Navigation). This meant that while knowing results
of tests was very important, participants recognised the consultation provided an opportunity
to ask more about the concerns on their mind, for instance one HGG participant planned to
ask if his condition was hereditary. Asking these questions, which initially appeared
peripheral, wase acknowledged as some of the most important information gathered:
Partner of
Harriet, 57, GBM
The majority of participants receiving usual care had not given consideration to preparing for
the consultation. This suggests the usual care experience is to arrive at the consultation
without allocating time to preparing questions or important information to share with the
clinician. This lack of preparation
discussed in theme four later in the chapter. Two control participants reported preparing for
their consultation. The internet and their partners were valued sources of support in aiding
their preparation:
I found it difficult to ask because I found it difficult to phrase the question and I think
I had looked up a website that sort of gave you questions to ask; the type of questions
you might want to raise just to try and get the vocabulary right. May, 65, Control
I jotted down things I wanted to ask, because I realise sometimes you get bombarded
with information and I found it was quite good to chat it through with my wife and she




               
              
 
  
                
           
                
          
 
                 
              
 
             
   
 
            
              
    
      
             
                 
               
 
days ago'. Because your consultations are at a specific time, but things crop up in
your mind a week or a day or on the morning. Mike, 57, Control
Managing anxiety
The space to reflect on and talk about individual situations with the Navigator, without the
expectation of answers, appeared therapeutic for some participants. It provided participants
with the permission to offload their concerns to someone who was not involved in their care
This appeared to calm a mind that felt busy with
questions:
It's like, you're thinking about it a little bit more, rather than just going in there and
feeling that the questions are then building up in my head again Carrie, 29, HGG
their bed or going out for a meal whereas my husband would. Rose,
39, CRC, Navigation
The consultation planning appeared successful in enabling participants to prepare for their
consultation because it was a relaxed conversation, removed from the pressure and anxiety a
medical consultation could induce:
[Navigator] on the phone or whatever,
saying what kinds of questions we had, you'd get prompted, [Navigator] would prompt
you 'do you want to ask about this, what about holidays, do you want to ask any





       
 
               
              
            
   
                
               
                
              
                 
         
 
              
               
              
              
                
               
               
                
          
some idea of questions. Ted, 69, HGG
Over time, participants appeared to feel reassured in knowing they would have this time with
the Navigator to plan for their appointment. This pattern of preparation appeared to enable
participants to engage in their own preparation strategies independently for the consultation
planning appointment:
To me that was the most valuable, the preparation and I found that extremely helpful
knowing that [Navigator] was gonna phone, made me think about it and so I was
already thinking ahead, I jotted down ideas so that I felt like we had a meaningful
discussion, it just helped and [Navigator] would add things and clarify things so that
when I came to the meetings I felt very prepared so that above anything else was what
I found really, really helpful. Phil, 61, CRC Navigation
Present in the HGG participants account, but not the CRC intervention, was the involvement
of their partner in deliberation about the questions to ask at the upcoming appointment. For
HGG participants and their partners, having this conversation, about the questions to ask in
the consultation, was important to remove the risk of (primarily the patient) receiving more
information than they wanted at that time. This finding is further supported by a later theme
in which HGG participants report the need to pace the assimilation of information to which
they were exposed. In this sample this finding was unique to HGG. CRC participants who
had disease of a palliative nature did not relay this need. It was acknowledged without the




     
             
     
               
               
     
 
            
              
          
  
                 
       
 
           
            
             
               
          
              




[prior to intervention] articulate any
really serious questions to each other [partner] because it was the unthinkable, you
know. Mick, 47, HGG
If [Partner] says to me 'I don't want that question asked', you can tell her
[Navigator]. Whereas if you're sitting with the clinician it's out of your mouth and he
Partner of David, 56, HGG
Controlling the amount of information gathered in the consultation could be communicated
through the consultation plan and for some HGG participants this was important to ensure
they gathered enough information for them as an individual:
To a ce 
things But it was ideal and I think we just stuck around about six questions at them
at the most Rod, 68, HGG
In summary, intervention participants felt supported by the Navigator through the
consultation planning process to prepare for their consultation. Reflecting on their situation
with the Navigator enabled participants to focus on and articulate their concerns and
questions. This time for planning appeared to promote clarity of their situation and for HGG
participants it enabled communication between partners. When compared to control
feeling more prepared for a conversation about their situation with their clinician. The next




       
             
            
             
          
             
              
      
        
 
 
          
            
                 
              
            
             
                  
                   
  
         
         
 
8.3.2. Information exchange in the consultation.
Information exchange in this theme, included the ability to ask the clinicians questions,
satisfy information needs and convey information about oneself to the consulting clinician
within the consultation. When prepared for information exchange the quality of two way
communication, between patient and clinician, appeared improved. Within the consultation
asking a question facilitated the exchange of information; the delivery of a question
satisfied by tailored answers from the consulting clinician. To develop this notion further, the
role in information exchange are
discussed from the perception of the participants.
Navigated participants perceived clinicians used their consultation plan to structure
information exchange. Participants reported consultants had copies of the plan in the
consultation and appeared to use the plan as a checklist to ensure all the questions had been
covered. Some clinicians made a point of checking questions off as they were covered.
Participants considered that providing clinicians with a copy of their consultation plan
increased the likelihood that they would receive high quality answers to their questions:
He was very good, I mean he looked at it [Consultation plan] from the start, he had it
before I went into the room and he made a point as it were of ticking, you know, going
59, Navigation.
[Consultation plan] going to clinicians before you get there




           
            
           
               
               
            
 
               
                 
                 
   
                 
       
 
                
     
     
                    
                 
              
    
 
                
       
Participants further felt their clinicians used their consultation plans to prepare for their
unique information needs. Clinicians were able to answer their questions, offering more
individualised information in the consultation. This in turn meant the clinician-patient
dynamic felt like a partnership ( it just brings the sides together easier. Pam, 56, HGG).
Furthermore, the clinicians appeared more able to provide the information at a level that was
appropriate for each participant, as this had been communicated through the consultation
plan:
I have a rare neurological condition which I didn't expect the consultants to have the
great knowledge of but they took a note of it and they tried to tailor the treatment
knowing that there was something else going on and to a greater extent than I expected. 
Phil, 61, Navigation.
They would know, because they had it in advance, at what level to come in on the
discussion. Partner of Donna, 59, HGG.
Writing a list was utilised by some usual care participants to help inform the clinician further
about received would then be
tailored to their specific needs:
I would hand over a list of things; 'this is what's been happening to me'. I think my role is
very much to let them know how I felt and they could then work out, medical experts
could work out whether the treatment was appropriate or had to be monitored or
changed. Mike, 57, Control.
Lists of questions were seen as a way of impacting on the behaviour in clinic and




                
                 
              
        
 
              
          
  
             
     
 
             
          
                 
                  
               
 
           
            
                
      
   
    
When I go in with my list of questions, and I thought about them and researched a
bit, and I think they respond in an appropriate way, if you see what I mean. They
recognise that these are questions that have been thought through and they needed an
answer and I get it. Barry, 59, Control.
However, if clinicians did not have time, nor space within the consultation for shared
decision making, then the answering of questions became problematic:
ng, you
it was like they were telling you before letting you ask them the
Jeff, 65, Control.
This resulted in participants gathering information needed through the internet or the hospital
cancer charity centre to gather the answers to their questions:
And so I went online and three to five months, I thought right well that explains it
then, maybe I'm still getting worse and it wasn't until May that I started to feel a lot
better. I did find I was Googling quite a lot. May, 65, Control.
There was an expectation amongst participants experiencing usual care (CRC control
participants) that clinicians would provide the information they needed without requiring any
input from the patient. This suggested that in usual care, participants trusted clinicians to tell
them what they needed to know:
your reports are




       
        
 
              
                 
              
               
          
            
 
                
              
  
  
   
 
               
              
                
              
          
               
        
                 
Oh not really, no [did not prepare questions]
in the hands of experts. Alex, 70, Control.
Control participants felt their care was impacted when they were seen at later appointments
by a clinician they had not met before. This lack of continuity in care resulted in patients
feeling uneasy and distrusting. Meeting a new clinician each time impacted on how confident
participant s felt during the consultation ( They can read the notes, but you do feel more
confident if it Mike, 57, Control). This posed a barrier to
asking questions for participants who wanted to gather information from their named
clinician:
I got an appointment to say I was seeing Dr [name], came along, and then this




In direct contrast when patients took an active role in the information exchange and were
prepared to ask questions (as in intervention participants), being seen by new clinician was
not a concern. Through the addition of their consultation plan to their medical notes, the
consulting clinician was always aware of the information required by a participant, and this
appeared to result in a sense of participants feeling known:
Whichever consultant you see has that info, you know, as well, so that they are
already preparing a full answer. Jen, 39, HGG




                
              
 
 
     
    
            
             
                   
 
               
    
              
             
             
           
              
    
 
               
             
 
              
              
that they knew me and this... they just had so much information about me that, yeah,
they did understand and they did appreciate what was important to me. Rose, 39,
Navigation.
e in information exchange
Planning for the consultation
during the consultation, and the role occupied by the participant. Ultimately, intervention
participants were more prepared to exchange and gather information ( I felt well prepared
and you know it was good to have a list of questions ready to go. Daniel, 59, Navigation).
In being clear about the questions to ask in the consultation, participants felt confident to
articulate these ( When
Harriet, 57, HGG). Having the Navigator in the consultation room, someone who also knew
of their concerns and situation and understood their unique situation was perceived as
supportive to the patient role in exchanging information through enabling participants to feel
confident to ask questions and engage in the consultation process:
The Navigation thing gave you a little more confidence that you could ask these
Angus, 69, Navigation
She actually made me feel better, her presence being there because I knew she knew
what I was thinking before I went in the room. Rose, 39, Navigation
Participants were aware that in order to gather pertinent information in the consultation and




               
    
                  
 
                
    
 
            
             
   
       
              
                 
              
              
                
                
 
 
           
             
           
important to them. If this was undertaken then participants left the clinic feeling they had
satisfied their information needs:
You go to the clinicians or you go to the dentist and you mention two or three things
I find with this Navigator thing I come out of there and because of the pre-questions,
Ted, 69, HGG
information exchange and gathering skills within the appointment when compared to control
participants. Asking questions within the consultation was significantly less dependent on a
(Brian, 66,
Navigation) to remind participants of their questions:
Going into the clinicians, there's a million other things you think about asking and
you never actually do, so having them down in front of the clinician to start with is,
like, it's just brilliant. It really is, 'cause I'm terrible at remembering, getting
everything out. So, no, it's been really, really useful. Carrie, 29, HGG
I mean you always forget to say something at a meeting anyway and you come out
and you're I should have said that, should have asked that, but I didn't. Brian, 66,
Navigation.
Participants recounted some interesting and unique experiences in which the consultation
plan supported the two way exchange of information in the consultation. One CRC




              
               
       
               
      
                  
                
        
              
                
 
 
           
             
             
             
      
 
           
                  
                  
 
              
              
even when she was unable to physically verbalise her concerns. Two HGG participants found
the consultation plan helped them to remain part of the discussion with their clinician, even
when discussing emotional or distressing issues:
My husband and I had been trying for a baby and I remember that appointment
where I really needed to kno 
as I thought about it I was getting upset and the clinician was able to bring up that
subject, talk about that subject without you having to actually say what it was that in
my head, what needed answering. Rose, 39, Navigation
Donna: the questions form an agenda or a kind of conversation with the clinician.
Partner: to have that agenda allows you to keep a vague grip on reality Donna, 59,
HGG
When patients reflected on the Navigation consultations whilst reading through their
Navigation summaries, it was evident for these participants how much information they had
managed to gather. Often participants could not remember asking the question or receiving
the information. However, the consultation plan was successful in assuring these outcomes
listening and communication skills at that
moment:
[summary] that I needed to know, but at the time,
I think it would have just been a shock. You know, the statement that Dr [name] made
about it not being a curable condition that would have been me. Mick, 47, HGG.
Without any prompt sheets or preparation, participants in the CRC control group, spoke about




        
              
             
           
             
                  
                    
                  
       
 
              
              
         
              
             
         
 
            
            
              
        
                  
questions which they forgot to ask in the consultation little questions Interestingly,
these were the types of questions often captured in the preparation phase with Navigators.
Furthermore, they found questions would arise once they had left the consultation. The
following quote illustrates how control participants recognised the importance of preparing
their questions but found it difficult to allocate time to implement this plan:
I forgot to ask her about hair loss, and they were just little questions that kept sort of
go in, but you always think well it's all over, this is just a follow up and you have at
the back of your mind things that you want to ask and then you forget about it when
you go in May, 65, Control.
For participants who did make a list to inform the information gathering, including three
control participants, it was clear how this facilitated the gathering of information that May 
in the previous quote had found difficult to gather:
The information that was most needed was how to deal with side effects from
chemotherapy. It was just general helpful day to day practical information, which I
think was fairly easy to obtain, when you asked. 
Another challenge within a consultation resulted when no specific information was available
for participants, for example when participants were told how different people react
differently to treatment. This appeared to make control participants feel as though the amount
and relevance of the information gathered was limited:





     
     
 
              
              
           
            
               
            
          
            
           
           
             
 
       
             
              
            
             
          
         
        
Ian, 51, Control.
Jill, 52, CRC Control.
In summary, this theme has explored the key issues to arise from information exchange
within the consultation from the perspective of all participants. Within this theme some key
differences emerged. Control participants experienced challenges in gathering the amount of
information they had wanted. When a control participant prepared their questions, this
overcame some challenges although a lack in the continuity of care when trusting in the
experts to provide information was a barrier to information exchange. In contrast,
intervention participants felt confident and well-supported to ask their questions.
Remembering and asking questions was not impacted by their memory and intervention
participants felt satisfied that all information had been gathered. Furthermore, intervention
participants felt clinicians had prepared for their individualised consultation, tailoring the
information to their needs, with an understanding of the patient s unique situation.
8.3.3. Recall and understanding of the consultation
All participants, regardless of trial arm or cancer site, acknowledged the challenges inherent
with trying to recall accurately all the information provided in the consultation. Factors such
as feeling particularly stressed or shocked during the consultation, the impact of
chemotherapy on memory, and the over-focusing on one piece of information, all negatively
impacted on recall of the information provided in the consultation:
have been as well with the chemotherapy and
[Clinicians name] 
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Recall and understanding of the consultation was important to participants in several ways.
This is now presented through discussion on: Enabled to be present in the consultation,
providing a safety-check, and enabling information for others.
Enabled to be present in the consultation
Participants who had access to an audio and written summary of the consultation
(intervention participants) reported feeling more relaxed and focussed within the consultation
as the pressure of remembering the information and questions to ask was removed:
Well, I think that certainly the consultations through the Navigator have made that
I think if I miss something I'm going to pick it up from the tape, from the CD. Ted, 69,
HGG
It means I can concentrate on other things, rather than... it's like, 'I've got to
remember this, I've got to remember that.' And so, yeah, it does make my life easier. 
Carrie, 29, HGG
When my part in the navigation was over I actually recorded it (the consultation)
myself and I found it useful. Cause I think it made everybody focus on what they were
saying Daniel, 59, CRC Navigation
Providing a safety-check
Accurately recalling the information provided in the consultation was important to all




                
               
             
              
                 
                
         
 
               
             
               
   
             
                    
                
   
 
              
              
         
      
 
                
            
think what was that again? We can always run through it as well David, 56, HGG.). It was
evident from the data that many participants were often troubled with the concern that they
had remembered something incorrectly. In using the information record to check the accuracy
of their memory this removed the need to contact healthcare staff for the information:
'I thought of something, and I just wanted to make sure that I was thinking the right
thing, you know. What I've been told, so go back and find Claudia, 34, HGG
would look it up again, yeah. Angus, 69, CRC Navigation.
Partners of HGG participants were also concerned about any gaps in their memory or their
accuracy of recall, and were able to access the information. This became particularly
important if partners had adopted a caring role and were asked questions by a participant
about their care:
I'm quite good at remembering what people say, but (participant name) would maybe
say 'what have I to do about such, such a thing' and I think 'oh God, is that was she
said?'. So you can listen to the CD and say 'yeah that's what she said'. Partner of
David, 56, HGG
Equally when partners had differing impressions of the information they could use the record
to check and resolve any conflicts in understanding quickly Helps iron things out when two
people have taken away differing impressions of what
(Partner of Donna, 59, HGG).
Specifically, participants used the CD and summary as a memory aid and this helped them to:





               
                   
                
           
 
               
  
 
              
              
            
              
        
              
 
           
 
              
       
 
 
            
             
                 
Ted, 69,
HGG); gather answers and clarification as and when they were needed (When things were
getting a bit stressful I could look at that [summary] and say right I get those, the eight cycles
of that, that means that that means this. Rose, 39, Navigation); and to check the symptoms
they were experiencing were expected side effects I felt really, really
. 
Jen, 39, HGG). Overall the record appeared to be provide a sense of reassurance for
participants.
As mentioned earlier HGG participants only, reported the need to pace their understanding of
their situation. They reported being unable to assimilate all the information provided in the
consultation. The information record subsequently enabled HGG participants to be in control
of their level of understanding. It provided participants with the choice of gathering more
information through reading or accepting their current level:
k to me, I can see back over it and it just helps me
-sized chunks really. It was a bad, bad time, trying
at it in wee bits when you can sort of cope steel
yourself to think about it again
Where intervention participants were enabled to recall and understand their situation through
reading or listening back to information about their consultation, control participants found it




                  
         
               
         
                  
 
 
               
              
       
                  
            
   
 
             
                
                  
               
           
         
time and you hear and understand it but I think you do need the actual words that were
). They engaged in strategies to aid their memory
which included bringing along a partner or family member to listen alongside or take notes,
or ask for a copy of their clinic letter:
brings it back. So we talk about it coming home in the car, which means when I come
When a participant did not engage in any strategies to remember they regretted this later
I should have, because before it was always up here but now I
Alex, 70, Control). However, for one participant
once she had consolidated the information in her mind she did not feel the need to revisit the
content. This was similarly found for some of the intervention participants:
Jill, 52,Control
In contrast to the intervention group data the majority of control participants accounts
suggested they did not fully understand their situation. They appeared to be missing pieces of
information that would help them to understand. It is unclear if this is due to memory, not
asking the questions (as reported in the previous theme) or not being provided with the
information. Not fully understanding their situation meant information was gathered from




                  
              
              
      
                
     
              
                
 
    
                
              
              
              
                
               
              
     
                 
  
          
 
picked up a lot when I was getting the chemotherapy from other people who were getting it as
well Jeff, 65, Control.) Control participants appeared to frequently feel as though they were
confronting the unknown. In addition, there was an acceptance that facing the unknown was
an intrinsic part of having cancer:
I mean the biggest thing I suppose part of this is...is unknown, you know, kind of
Barry, 59, Control.
months than what I have ever used in all my life Jeff, 65, Control.
No-
just got to find these things out as you go along. Edna, partner of Jeff, Control.
Enabling information for others
Having accurate recall, and also a written record was important to share with others as an
update on events. Ensuring those close to the participant were kept informed and up-to-date
was important. Having a record created by an independent body provided those unable to
attend the consultation reassurance about the reliability and validity of the content (If we
come back we're not really, like, saying like how the clinician said it anyway. Carrie, 29,
HGG). An accurate record of the consultation was reassuring for those unable to attend the
appointment and meant participants did not have to explain their situation entirely based on
their ability to recall:
The other benefit I have is my two children can listen to the tape, or read the
- er to




             
     
           
         
        
               
                




            
              
                
                 
                
              
             
                  
           
                  
                   
  
    
For some HGG participants they reported being able to share reliable and accurate
information with loved ones helped
understanding. Ultimately they reported providing their loved ones with the summary
appeared to ease their situation and reassure loved ones
situation, making life more manageable for participants:
I actually feel like it's calmed everyone down slightly. Everyone was, like, on panic
and, like, 'Oh my God,' you know. But, I think that [provision of summary] has
actually calmed the whole family down a bit, because it's in black and white, written
it first-
HGG participants, in contrast to CRC participants, continued to use their summary 
following the end of their treatment. This provided them with some reassurance and hope
they had managed to cope with how their situation had been. CRC participants did not review
the summaries at this time point and preferred not to be reminded of their situation in an
effort to move on. This contrast highlights the differing nature of the disease where a CRC
participant feels able to move on, a HGG participant knows inevitably their disease will
recur. Again this was not present in the palliative CRC participants:
I don't think there would be any benefit in listening to it now. I mean I've moved on.
They were very useful at the time Brian, CRC, Navigation.
n some ways it was quite nice to read it all again and remind myself of, yes, how





          
                
               
             
     
                
             
           
                
 
                
               
           
        
 
             
             
            
              
           





The majority of intervention participants preferred the written summary of the consultation 
and not the CD. Participants felt the written summary was an accurate and reliable record of
the consultation and so the need for the CD in addition was minimal. Many participants
reported feeling uncomfortable hearing their own voice recorded and so preferred not to
listen to the recording. ( 
Angus, 69, Navigation.) Although for some it was important to listen to the CD because it
provided participants with the tone of how information was relayed ( but listening to
somebody speaking is different than the written word Brian, 66, Navigation). Moreover,
locating pieces of information in the summary was much easier and faster than using the CD:
( 
time Jen, 39, HGG). For HGG participants, listening to the CD, especially of their first
consultation was too painful, ( I knew perfectly well we were terribly upset at various points
ite unnerving to hear all that. n to the actual
tape, too raw. Partner of Donna, 59, HGG).
In bringing together this theme, recall of information was important and often participants
found themselves searching to check remembered facts and the accuracy of memories for
reassurance to understand what was happening. For Navigated participants, the CD and
summary was useful for this purpose, specifically the written summary, to ensure they had
accurate recollection of information provided in the consultation. Ensuring loved ones




      
               
             
             
           
              
     
     
              
      
 
               
            
      
             
       
          
              
 
               
              
             
              
              
8.3.4. Decision making in the consultation
It is evident from the data presented so far that all participants utilised various strategies,
where possible, to ensure they gathered the information needed. All participants were asked
about the processes by which their treatment decisions were made. Unanimously it appeared
participants perceived decisions were made by their clinicians. Consequently, findings about
how decisions were made lack a certain depth of account, reflective of how participants
perceived their role and their c 
in the data, this
section will present findings in order to further demonstrate how decisions were made; a
primary aim of this thesis.
Most participants identified that they did not feel as though they had the responsibility for
making decisions about their care. Participants reported that their clinicians, using evidenced
clinical guidance, provided clear treatment recommendations:
Although ultimately they'll [the clinician] say 'you make a final decision', really there
is no choice. Mike, 57, CRC Control.
you hope for the best outcome. Brian, 66, CRC Navigation.
I was told. [Laughter]. 'This is what you're having Carrie, 29, HGG
Perceiving treatment decisions in this way meant the options for a participant were reduced to
a binary decision: to accept the treatment, or not. This process was generally not
distinguished as a decision for participants as they perceived no viable alternatives. This
feeling was particularly evident if the emphasis of the consultation was weighted on the




        
       
                 
                
 
 
             
              
     
    
 
 
            
         
             
               
      
                   
     
             
    
 
participants, regardless of trial arm, perceived their clinician as encouraging She
says in order to reduce recurrence:
You know and they call it belts and braces, that's what they call it, you have the
operation, it took all the cancer away, this is just a wee extra. Jan, 75, CRC
Navigation.
Participants did appreciate that treatment plans were decisions based on best practice clinical
guidance and as such there was little room for negotiation and deliberation, limiting the
potential for shared decision making:
Mick, 47,
HGG
fundamental goal within this medical experience was the eradication of their
cancer, and of survival I just Amy, 52, Navigation).
knowing what was right for them. The interaction between a strong clinical recommendation,
the aim of survival and complete trust in the clinicians expertise, resulted in all participants
accepting recommended treatment decisions with confidence:
I have to trust that they know best what's going to make sure that I'm safe in the long
Mike, 57, Control.





            
             
            
                
   
 
            
              
              
       
                
             
             
      
             
   
                  
      
 
  
However, all participants recognised they were not committed to a treatment path before
having time to discuss this with their clinician, and acknowledged this conversation was
important in enabling them to understand the best options for them:
know 100% committed to it. I want to hear what the arguments for and against are. 
Barry, 59, Control.
Although participants did not feel they had made any ultimate decisions, intervention
participants did report feeling involved in the process, ultimately nothing had or could go
ahead without their consent ( Although you're involved in the decisions you're going to go
Ted, 69, HGG). While the outcome
may have been predetermined by the framing of the decision, slight nuances in the trial arms
experiences were evident in the data. Intervention participants appeared to engage in the
process of deliberation and recognised the importance of understanding why the decision was
being made through asking considered questions ( 
Carrie, 29, HGG). In this way some participants reported working together with clinicians
about decisions:
Well I did expect and got most of the time a sense of being a collaborator rather than






           
    
 
           
               
              
           
             
    
             





             
              
           
            
               
              
           
        
st for you but you are taking the guidance and the
Rose, 39, Navigation
Control participants also recognised the importance of understanding why decisions were
being made and tried to fulfil their information needs to understand the decision but appeared
less active in this process and perceived more barriers to gathering this information than
reported by the intervention participants. Subsequently, it appeared control participants were
left still trying to un Nothing, no, it was never ever spoken, this is
(Jeff, 65, Control).
Furthermore control participants reported a level of anticipated regret in the refusal of




This theme has explored decision making from the perspective of the participants. It
highlighted the experience of decision making was similar for both oncology groups and both
trial arms. Participants perceived their clinicians provided a strong treatment recommendation
and encouraged the uptake of this decision. Participants felt confident that this
recommendation was made in their best interests by an expert. Between the trial arms few
differences in this experience were evident. What does appear apparent is the difference
between how intervention and control participants perceived barriers to gathering information




     
              
              
            
            
             
  
 
              
             
              
             
          
             
            
            
  
 
             
              
      
  
8.4. Summary of Findings
This chapter has presented the interview data gathered from the HGG and CRC participants
and contrasted the experiences within and between the cohorts. Across each of the four
themes, the importance of: preparation for the consultation; information exchange in the
consultation; recall and understanding of the consultation; and decision making in the
consultation has been explored. Within the four themes key differences between groups were
identified.
All participants did not feel treatment decisions were theirs to make, although some wanted
to and utilised strategies to engage with clinicians in reaching the decision. Intervention
participants appeared supported to prepare for their consultation, aided to take part in the
consultation to gather and exchange the required information and enabled to recall and
understand information provided in their consultation. Control participants were: not
supported to prepare for their consultation, although some did engage in strategies to
undertake this; experienced barriers to gathering information within the consultation, such as
time pressures and forgetting questions; and reported gaps of understanding about their
situation.
The next chapter will present the qualitative evaluation of the intervention from the
consulting clinicians. These two sets of findings (patient and clinician) will be integrated in




   
 
  
         
             
              
          
             
              
 
   
           
            
            
             
               
            
             
              
               
            
                 




Chapter 9: Q 
9.1. Introduction
Colorectal Cancer and Neuro-oncolog views about Navigation were explored
through interviews. The aim of these interviews was to ascertain the healthcare perspective
of: the Navigation materials and how Navigation impacted the patient, the consultation and a
he relevance of Navigation within their speciality was also explored.
Interviews were analysed using framework analysis as described in Chapter 7. The findings
across the sample (HGG and CRC) are synthesised and presented in this chapter.
9.2. Sample
Eight consulting clinicians in the colorectal or neuro-oncology clinics were approached
regarding their participation in interview. All clinicians invited had consulted with a
minimum of three Navigated patients over all three appointments: initial treatment decision,
mid-treatment review, and end of treatment review. All four colorectal consultants agreed to
take part in an interview about their experiences with the intervention. Two out of three
neuro-oncologists agreed; one declined due to workload pressures. In addition, one senior
registrar in the neuro-oncology clinic met the eligibility criteria and was also interviewed.
One participant had worked in both the colorectal clinic and the neuro-oncology clinic during
the study period and so was able to provide a perspective across the populations. Four
interviewees were female, three were male. To maintain anonymity of participants, quotes
will be identified by use of the numbers assigned to each clinician. Therefore C1, C2, C3, C4




     
              
               
            
               
       
              
   
         
      
             
              
            
         
              
     
              
    
 
    
      
       
            
 
             
9.3. The Intervention
Much of the clinicians evaluation of Navigation was based on their views regarding the
consultation plan (CP). Conceivably, this is because the CP is the element of the intervention
that most impacted on the content and process of sultation. To put
Navigation into context, the points below are made to identify how Navigation impacted on a
clinician consulting with an intervention patient:
A patient s Consultation Plan was emailed to the consulting clinician in advance of
the clinic appointment.
A hard copy of the Consultation Plan was
clinician to review before their meeting.
Clinicians received no formal instruction about how to integrate the Consultation Plan
into their consultation. Previous studies of the same intervention had occurred at the
study site and so informal conversations with breast and prostate cancer clinicians
may have informed their practice in this study.
The Navigator attended the appointment with the patient to type summary notes and
audio record the consultation.
Clinicians were subsequently sent the written summary for review before it was sent
to the patient.
9.4. Findings
ing the intervention were categorised, utilising
framework analysis, into three main themes:
Usefulness for patients: reports the perceived benefits and potential disadvantages for
xplored




          
            
         
            
              
            
 
     
              
              
  
 
    
            
              
                 
               
       
                   
                
 
           
            
               
      
Acceptability for clinicians: describes benefits and drawbacks of consulting an
intervention patient when compared with usual care patients. The areas explored are:
using the consultation plan and impact on time.
Sustainability: explores the relevance of Navigation to each speciality and the
implication for resources needed to sustain the intervention in its current model and is
detailed as: acceptability within the service and feasibility within the NHS.
9.4.1. Usefulness for Patients
This theme examines clinicians views regarding the impact on patients of preparing for their
consultation, receiving a record of the consultation and the most relevant appointment for the
intervention.
Preparing for the consultation
All participants reported that by engaging in consultation planning and generating the
consultation plan (CP) the patient was more likely to have all their questions answered.
Clinicians all made an effort to use the CP with the patient and cover all the documented
questions. To ensure a patient s prepared questions were covered, clinicians used the CP as a
checklist at the end of the consultation:
Now I tend to read it (CP) in advance to try to remember to cover the topics and
then check with the sheet and the patient at the end that we've covered everything C4
Clinicians recognised that through this preparation stage, patients had certain information
expectations of the consultation that needed to be met. Neuro-oncology clinicians reported
this process of preparation was beneficial to patients as it ensured the consultation met a




               
     
                   
        
 
          
             
             
           
              
  
                
              
                
   
             
 
              
               
              
              
  
I would read through the consultation plan to make sure that we cover everything the
patient expects to cover. C2
they want, out of the journey and this is going to put it into their language and kind of
meeting what they want from their consultation. N6
Neuro-oncology clinicians identified that consultation planning appeared to enable patients
attending the consultation to be more prepared for a discussion about their healthcare
situation They were sort of perhaps just a little bit be N5). Through the
process of formulating their questions and concerns beforehand, clinicians suggested patients
appeared more at ease with letting the consultation flow, knowing their questions would be
answered:
I think where it helped was that it stopped patients from perhaps leaping straight to a
question that was not appropriate because they knew that all the questions had been
given and so they were more prepared to go with the flow with the consultation, um
whereas sometimes people wh 
straight away with questions that are not really relevant at that stage. N5
For two colorectal clinicians however, some patients were perceived as not engaging in the
process. They reported meeting patients who did not want to ask questions but felt, because
of their study participation, that they should. Those not wanting to ask questions were





                
  
               
           
        
 
          
            
     
               
      
    
 
              
 
    
                 
     
             
                
         
 
There are some patients who will sit there with the consultation plan, ticking it off.
C1
There have been a few patients who just haven't particularly wanted to engage with it
, by and large just want to be guided to what
to do and get on with it. C4
One colorectal clinician felt Navigation might be detrimental to a
wellbeing, potentially heightening the anxiety levels through pressurising those who did not
wish to ask questions:
I think it can raise anxiety levels in patients who are already anxious and sometimes
can be a bit artificial for pat 
obliged to ask questions. C1
No other participant interviewed commented on the impact of the intervention on wellbeing.
A Consultation record
All clinicians thought that it was useful for patients to be provided with a record of their
consultation ( C1). The information record
was unanimously perceived as the biggest benefit of the intervention for patients:
I suppose the advantages is that it they get then a record of their consultation. C4




             
               
             
              
                
    
         
      
 
              
    
             
  
 
           
             
           
           
                 
                  
       
 
Most clinicians suggested patients would prefer the summary over the audio recording. The
summary was viewed as a succinct record of the key information points without the small
talk inherent in consultations. It was suggested listening again to potentially distressing news
via the recording may be upsetting for patients. However, one clinician was aware patients
had shared their recording with family members who could not be present at the consultation:
hear that again. C3
, just in terms of trying to relax a
pa with the important stuff. N6
It was also highlighted that recording of the consultation sometimes occurred as part of
routine consulting practices:
Some patients ask to you know record their own consultations anyhow, out with
C3
Additionally, the intervention provoked thoughts about how current practice could be
improved through routine sending of clinic summary letters to patients, although it was
recognised that extra resources would be key to implement this:
I know in some places we copy letters to patients -
about lots and I think you would end up in oncology writing two letters, to, from the
clinic, one for the patient and one for the GP. And again we are just not resourced to




             
            
           
              
                
                
                 
             
          
 
               
               
  
                 
  
      
                 
   
 
             
             
A concern arising from the use of Navigation was regarding risk of litigation. One clinician 
reported that less experienced medical staff were deterred from consulting with Navigated
patients as they would receive a recording of the consultation:
Some of the junior doctors have been put off seeing patients who have been
navigated, because of the anxiety of it will be taken down and used in evidence. We
try to reassure them, but it can be a bit disconcerting, particularly in this day and
age, with patients who are some patients take notes, and it can make you feel quite on
learning you worry about saying something that, you know, is not 100% accurate.
juniors on the team seeing patients who are navigated. C1
However, it was suggested that recording the consultation in this way could help clarify for
patients and clinicians where information gaps were due to memory or lack of provision:
there is
this sort of process, then we know that they have actually been told it and so that
ink the
navigators do find that out. N7
Sometimes none of us know what the patients take on board, but at least if it s written
C3
treatment discussion, mid treatment review and end of treatment. Clinicians all agreed the




             
     
               
       
   
          
             
 
            
               
              
        
       
  
 
             
             
            
 
 
decisions were made. The mid-treatment review appointment was seen as the least useful
When undergoing treatment clinicians reported
patients had many opportunities to ask their questions, this resulted in less perceived need of
the intervention for the mid treatment appointment:
particularly useful. C2
d treatment, because eh, patients are going to be reviewed
during treatment anyway so any questions they have will be picked up. N6
One colorectal clinician proposed the last appointment, after the completion of treatment,
may also be useful for patients to be Navigated. This was an appointment where information
was given about what was next. Most notably there were no informative documents to
support patients through this transition point:
So I think at that point the sum 
Neuro-oncology clinicians also supported the opinion that there was most need for the
intervention at the first consultation, as opposed to follow-up consultations. This was ascribed





    
    
 
    
            
          
              
             
   
 
    
               
               
  
               
  
                
               
  
 
              
           
A lot of our patient 
s been said. N5
9.4.2. Acceptability for Clinicians
This theme explores how acceptable clinicians found the intervention when integrated into
their usual clinic time. It examines how the intervention
impacted the process of the consultation, the patient and their time. All clinicians, when
asked, reported that they were comfortable with the Navigator being present in the
consultation room.
Receiving the consultation plan
Receiving the consultation plan prior to meeting the patient was viewed by all clinicians as
beneficial. This plan gave clinicians an awareness of what the patient knew and wanted to
know:
The pre-consultation plan at least gives you an idea what the patient knows when you
C2
that the patient knows nothing and then ask them a few questions and build on that.
But the navigation does help because it sort of clarifies what patients are aware of
beforehand. N6
There was a difference in how Navigation was used, and therefore accepted, by the neuro-




      
  
      
             
   
             
           
   
   
 
            
              
  
                 
            
   
 
              
               
              
tumour was incurable, due to the overwhelming
-oncology clinicians
ing such distressing news. In this
way, neuro-oncology clinicians were enabled to tailor their delivery of information to ensure
they would
Also helpful from the doctor s point of view because we know the patient s
understanding and what their questions are beforehand and particularly in the neuro-
was told the b 
N6
Comparatively, the colorectal clinicians reported that receiving the consultation plan did not
impact how they delivered information to patients, nor about how they told patients about
treatment decisions:
I suppose it helped me in terms of what the focus of patients concerns are, but in
terms of me giving the information it had no impact whatsoever. C3
treatment decisions. C1
All clinicians spoke about having a pre-existing consultation structure that was used to guide
how they delivered information to patients in their consultation. This structure was to ensure




           
            
        
                 
             
                 
    
             
               
 
               
                
 
                
               
                
      
        
 
                
          
           
             
colorectal clinicians as distracting from their usual structure of delivering information to
patients. While neuro-oncology clinicians felt their usual structure used to deliver information
often covered the majority of patients concerns listed:
If you use that as a way of delivering the information that you have to deliver about
the plan, treatment course, you can become very detracted to things that actually
might not be you know important in terms of the plan, okay they might be important to
the patient. C3
Actually often the questions were about information we were going to give the
patient anyway, so it was part of our, a big part of our consultation. N7
For one clinician, the consultation plan did not affect the order in which information was
delivered, but it did appear to impact the emphasis and focus of information delivery to the
patient:
t does kind of change how you think and how you phrase things and how much
information you give to patients, you know, go through the history and the own format
of what a consultation would be. But maybe focussing more on some of the areas the
patient wants to talk about, and
all then I would do that N6
In contrast, it was suggested by one colorectal clinician that the CP did not provide any
questions or concerns as: We know what patients are
concerned about. C1). The clinicians identified that the consultation plan could become




             
                
              
           
 
    
            
            
               
            
         
                 
               
             
                  
      
 
              
          
                 
      
irrelevant. In this instance, the consultation plan was useful in forewarning the clinician that
the patient had little understanding of the news they were about to be informed of:
Often the questions that were less predictable were from the patients that we realised
become redundant when they did find out what was happening. N5
Impact on time
All clinicians reported that the intervention had impacted on their clinic appointment
schedule, requiring increased time commitment to read the consultation plan, ensure all
questions were covered in the consultation, and later check the summary for accuracy. It was
suggested, especially by the neuro-oncologists that although Navigation took extra time, this
was worthwhile in enhancing the experience for the patient:
It certainly increases the, yeah even if it doesn't take that long to read the plan and
check through the summary, it adds to the medical time, not dramatically but if we
were doing it on large numbers of patients, it would add up. C4
I think everyone will say that it has taken a bit extra time and I think everyone will
say it has been worthwhile. N7
To this end, neuro-oncology clinicians spent extra time searching for the information prior to
the meeting, to ensure questions could be correctly answered:
are any questions that the patient has that are going to be addressed, you may have to




          
    
             
      
                  
                  
                 
    
 
               
              
             
      
                
             
              
               




Furthermore, the neuro-oncology clinicians reported that gathering and answering the
-Navigated appointments. With the
intervention, the patient had already spent time formulating their questions and were ready
and prepared to discuss these:
time. Because if I were to ask them just as they came into clinic do you have any
they have time to think about it or the family have some time to think about it, maybe
get these questions down on the sheet of paper, and then they are more likely to get
these questions answered. N7
An alternative view was held by the colorectal clinicians who viewed some of the questions
on the consultation plan as inappropriate for their consultation. It was perceived that some
questions added to the clinic appointment time and would be more appropriately addressed
by the Clinical Nurse Specialist:
In a busy clinic its difficult, I guess, err, sometimes the plan put forward by the
patient is completely different from what you would suggest are the important issues
from the medical point of view, so it does lengthen the consultation sometimes. C2
There's a tendency sometimes for patients to eh focus on eh maybe topics that aren't




          
  
 
              
             
 
       
 
               
                
             
        
                  








Topics deemed more appropriate for the clinical nurse specialist included the following: 
C1
However, when the clinical nurse specialist could spend time with the patient before their
clinic appointment they used the plan and ensured these questions were addressed where
possible:
can actually focus on core business C1
A specific aspect of Navigation noted to be time-intensive was the checking of the summary
for accuracy before it was sent to patients. This was seen as time consuming by clinicians
who felt some of the content needed correcting thereby distracting from clinical time,
although this was variably reported across the sample:
No I would always have a quick look through them just to make sure that it was an






   
              
              
        
 
    
               
       
               
               
                 
 
 
           
            
              
             
           
             
             
                
   
          
9.4.3. Sustainability
This theme explores how relevant the medical staff perceived the intervention was for their
service, and examines their opinions on whether the intervention in this form could be
sustained in their practice and within the NHS.
Applicability within the service
It was clear that the intervention was seen as successful in helping patients understand what
was important to them for their consultation:
I think the concept of patients having some sort of preparation and thought about the
purpose of the consultation is reasonable. Quite how you put it into place is another
matter. I think the navigation appears to work well as in the process of it works well 
C4
However, concerns were raised regarding engagement of clinicians with the Navigation
process. It was suggested that some colorectal clinicians were unfavourable of seeing
C1). All clinicians were asked if they would prefer their consultation with or
without Navigation; two colorectal clinicians said without, two reported no preference and all
three neuro-oncology clinicians reported they prefer their consultation with Navigation. A
clinician with the experience of working in both specialities suggested reasons for this
difference in acceptability and applicability may be due to a patient s care pathway,
specifically how informed and supported a patient was by the health care team, prior to their
first clinic appointment:




     
  
               
                  
               
      
 
            
               
            
                 
                  
      
 
            
              
              
               
   
              
             
          
been following them through, clarifying
, and
a more hurried path with getting their diagnosis, their surgery, may or may not be
told all of the information they need to know. A lot of surgeons in the hospital are still
worried about saying the word cancer. Like you know, a patient coming to a cancer
ncer is a big problem. N6
This difference was supported by a neuro-oncology clinician who felt following surgery
patients about to be diagnosed with a High Grade Glioma arrived at their appointment with
very little awareness of the news they were about to receive:
I think for a lot of our patients as well, they have come via the neurosurgical route,
so its maybe an opportunity for them to stop and have a think and come along a bit
better prepared to the consultation. N5
Colorectal clinicians reported very few treatment options were provided to their colorectal
patients. As such they suggested clinical situations in which Navigation may be more useful.
These health service areas broadly included; where more than one viable treatment choice is
available, when there is a lot of information to convey and for those with multiple
comorbidities.
With colorectal cancer for any given situation there's a fairly narrow lot of options
and therefore it, I suspect Navigation probably doesn't have a huge impact on




             
               
      
       
 
               
              
            
                   
            
   
 
    
              
               
   
    
                  
   
of two, three, four, five radically different treatments. Most of our Navigation is
usually about a single decision of treat or not treat, which is, arguably a more
adiotherapy, surgery and different forms of
surgery, so a more complex decision C2
It was further suggested by one clinician that the level of patient education and patient
informed-ness may impact on the benefits gained by a patient from the intervention:
Very well educated, well informed patients maybe would benefit less from navigation
because they tend to be the ones that have read up on things and tend to come in with
questions and have very focussed aims from the consultation anyway. You know,
ma 
more f N6
Feasibility within the NHS
All clinicians felt the intervention in its current form was too resource intensive (time
commitment) and therefore expensive, and would not be prioritised nor funded by the NHS:
mitations of the
healthcare system financially C2





               
                
 
              
              
              
            
             
                
   
              
    
               
    
 
      
             
             
              
              
               
 
             
         
              
One solution suggested was charity funding ( I think this is something that charities would be
interested in getting involved in N7). An alternative solution was to integrate the role of the
Navigator
perceived to hold the skills to undertake this i.e. specialist medical knowledge and developed
communication skills, there were concerns that this could also be an expensive solution and
that they may have little time available to integrate this into their role:
The navigators have got to be highly trained, have good medical knowledge,
background. Good communication skills, that they can meet the patients, get on well
with them, and help them understand what the problem is. As well as, help the doctor
understand what the patie 
Quite expensive I would probably say, not just someone off the street. N7
oo resource and time-intensive.
are certain aspects of the approach that could be maybe rolled into the job for
clinical nurse specialists C4
9.5. Summary of Findings
This chapter has presented the views of the intervention from the consulting clinician
perspective. All clinicians reported preparing for the consultation and being provided with a
written summary was useful for patients. Within the intervention, patients were more likely to
have all of their questions covered and were supported to recall the information provided.
Furthermore, it was agreed Navigation was most useful at the initial treatment discussion.
Disparities in the acceptability of the intervention were present between the colorectal and
neuro-oncology clinicians. Neuro-oncology clinicians appeared more favourable of the




                
             
             
            
  
 
           
             
               
               
                
             
  
 
              
           
          
 
                






concerns in order to tailor their consultation to the specific needs of the patient. In contrast,
colorectal clinicians felt the consultation plan negatively distracted from the focus of the
consultation. All clinicians found the intervention added to their, already limited, clinical
time. Neuro-oncology clinicians suggested this added time was added quality to the
consultation.
When compared with colorectal participants, clinicians recognised the High Grade Glioma
participants were less informed and received less health care support before their first
appointment, due to their care pathway. This suggests HGG clinicians may have been more in
need, and so more receptive of, the information and support provided by the intervention for
their patients This difference in care pathway and knowledge may help to explain some of
the differences in clinician perspectives of the applicability of the intervention to their
services.
All clinicians held the opinion the health service would not provide funding for this
intervention. Charity funding was suggested. Clinicians believed Navigators should be
highly trained in order for the role to work effectively.
The next chapter will discuss these findings in the context of the results from the RCT,




     
    
               
              
             
            
 
                 
               
              
              
             
       
 
    
                
              
            
               
          
             
               
             
           
Chapter 10: The Discussion
10.1. Overview
The aim of this study was to determine the effectiveness of Navigation in enhancing the
quality of decision making in oncology consultations over time when compared to usual care.
Furthermore, the study aimed to explore the experiences of the intervention from the
perspective of the participants and their clinicians, when contrasted with usual care.
This chapter will begin with an overview of the study and a summary of the results. These
will then be discussed in the context of current understanding and literature about the specific
populations and the present evidence base of the intervention. This will be followed by
focussed discussion on the applicability of Navigation in the context of oncology care and
health policy. The chapter will conclude with a critical review of the methodological
approach and limitations of this thesis.
10.2. Study overview
To inform this evaluation, three studies were conducted in order to build evidence for use of
the intervention over time and in the wider cancer population. Primarily, a longitudinal RCT
was utilised with people diagnosed with colorectal cancer (CRC) to determine the
effectiveness of the intervention from the point of post bowel surgery to the end of
chemotherapy, compared to usual care patients. Secondly, qualitative evaluation was
undertaken with CRC trial participants to contrast the experiences of the intervention with
usual care. In addition, evaluation of the intervention with a cohort of people diagnosed with
High Grade Glioma (HGG) was utilised to enable comparisons of experiences with the




            
       
 
      
           
             
               
    
 
             
             
             
           
         
          
          
            
             
            
          
             
            
          
           
CRC consulting clinicians to further the understanding of the intervention s relevance and
utility from the service provider perspective.
10.3. Summary of results
Information sharing and decision making during oncology consultations is complex. All
participants acknowledged the need to plan for their involvement in consultations and engage
in decision making about their cancer treatment. In reality, achieving this as part of usual
practice was challenging.
Use of Navigation with CRC participants did not improve decision self-efficacy (p<0.05) nor
reduce decision conflict (p<0.05) throughout the course of treatment for their cancer. All
participants felt participation in decision making was limited to accepting or declining the
treatment recommendation. However, the consultation planning stage of the intervention did
significantly increase intervention participants decision self-efficacy (p=0.04) in preparation
for their initial clinic consultation. Navigation also significantly prepared intervention
participants for decision making (p>0.001) in the consultation. Intervention participants
reported that consultation planning prepared them for their consultation, as the Navigator
enabled them to critically reflect on their information needs and formulate their questions.
Within the consultation, use of the consultation plan ensured participants information needs
understanding. Summaries provided intervention participants with a reassuring safety check
for recall of information throughout their treatment, whereas usual care participants felt they
were missing important and informative pieces of information. At follow-up, once a
participant had experienced the consequences of the treatment decisions, intervention




              
  
 
            
             
           
           
       
 
                  
           
              
               
            
            
              
            
         
 
                 
             
          
            
      
                  
with the intervention did not impact anxiety or depression scores as measured at follow-up
(p>0.05).
Navigation was variably received by clinicians. HGG clinicians were supported to deliver
best practice by the intervention, while in contrast CRC clinicians found the intervention
disruptive and time intensive. Despite the benefits identified by participants receiving
Navigation, concern was expressed by all clinicians regarding the resourcing and
sustainability of Navigation in the NHS.
To give more depth to the summary, the primary focus of this thesis was whether use of the
Navigation intervention improved decision self-efficacy (DSE) in CRC and HRG patients.
This was not demonstrated: Navigation did not impact on DSE, over time (p=0.74, p=0.91,
p=0.96). Overall, DSE scores were high at baseline and during the course of treatment for
control and intervention groups. Similarly, Navigation did not impact on the secondary
measure of decision conflict (DCS), measuring uncertainty in decisions, over time (p=0.08,
p=0.57, p=0.58). All participants reported low DCS, and this was maintained over time from
baseline to follow up. However, at the mid treatment appointment, Navigation participants
did report lower uncertainty than control participants (p=0.001).
The lack of impact of Navigation on decision making may be understood in the context of the
perception of limited CRC and HGG treatment options that participants could influence.
Clinicians, particularly CRC clinicians, reported cancer treatment decisions were limited
given that cancer treatment pathways were well mapped out. Participants perceived decisions
about treatments to be reduced to a 




              
               
               
    
 
           
              
              
          
            
               
             
               
           
              
          
            
          
          
            
          
            
               
             
take responsibility for. Participants accepted clinicians as the experts in their care, best
placed to make the treatment decisions. This could explain the high level of confidence in
decisions, low level of uncertainty in all participants, and lack of impact of Navigation on
primary and secondary outcomes.
All participants recognised the benefits of pre-planning for medical consultation. However,
participants experiencing usual care found it challenging to allocate time to plan and despite
using some resources e.g. the internet to prepare, a significant number of barriers to
information exchange in medical consultation were identified. These included: forgetting
questions; lack of dedicated question time within consultation; difficulty of asking questions
with new clinicians and a tendency to assume a passive patient role with clinicians. In
contrast, Navigation enabled patients to plan, be prepared for their consultation and identify
areas of information need. This is supported by limited RCT data and more extensively by
qualitative findings. CRC intervention participants were more prepared for decision making
when compared to control participants after all three consultations, as evidenced in the four
item Preparation for Decision Making scale (p>0.001). Consultation planning supported
intervention participants to critically reflect on their information needs for the medical
consultation and significantly increased decision self-efficacy within the intervention group.
Specifically, consultation planning enabled participants to articulate and formulate their
questions, prioritise and focus key concerns and consider questions for discussion beyond
medical results and management. For HGG participants, consultation planning facilitated
difficult conversations between partners resulting in a shared agenda for their consultation.
The consultation plan provided a template for use in the consultation to ensure all questions




            
     
 
              
             
               
          
            
         
 
             
                
            
              
               
              
    
 
           
         
             
            
           
              
             
questions, helped them to manage anxieties and provided reassurance that clinicians had
prepared for their discussion.
Provision of the Navigation summary was helpful to participants, with preference given to the
written, as opposed to the audio, summary. Clinicians were supportive of the summary,
although the lack of resources available to produce this were noted as a limitation. The
frequent checking of summaries by participants, thereby providing reassurance and
information when needed, may explain why scores of decision conflict were significantly
lower for intervention participants at their mid-treatment appointment.
The concern from CRC Consultants that Navigation may increase patient anxiety, was not
supported by RCT results where mood, as measured by the HADs, was not impacted by the
intervention (HADS-A p=0.54 & HADS-D p=0.56). Levels of anxiety and depression were
low for all participants and decreased at follow up. However, the percentage of participants
reaching the threshold for anxiety increased at follow up for the control group (12.5% at
baseline, 20.59% at follow up) and decreased for the intervention group (25% at baseline,
20.51% at follow up).
Navigation significantly reduced the regret experienced by participants about their cancer
treatment decisions (p=0.039). CRC intervention participants reported significantly less
regret than their control counterparts at follow up (p=0.039). Participants who received the
intervention (HGG and CRC) appeared more aware and knowledgeable about their treatment,
demonstrating realistic expectations of treatment side effects and symptoms. The
consultation summary was particularly useful in this regard. This was in contrast to control




             
              
      
 
             
            
             
              
                  
        
 
           
               
           
          
               
           
 
              
             
             
      
 
through trial and error. Furthermore, for control participants, the amount of appointments
attended was related to an increased decision regret score (p=0.038). It could be conjectured
situation becomes ever more crucial.
Clinicians held mixed views on Navigation and its use in medical consultation. HGG
consultants perceived Navigation as preparing patients for taking part in the medical
clinicians used the consultation plan to inform content and delivery of information. In
contrast, for CRC clinicians, the consultation plan was a helpful checklist to ensure all
questions were covered at the end of the consultation but it did not impact on the way that
information was delivered or how decisions were framed.
Clinicians were concerned about the applicability and sustainability of Navigation within
health care. CRC clinicians reported Navigation to be time intensive and not relevant to CRC
practice, although possible preference sensitive pathways were suggested. In contrast, HGG
clinicians identified Navigation as supporting cancer consultations, thereby supporting them
in providing a higher quality service for their patients. All clinicians expressed concern as to
whether Navigation would be financially supported by the NHS.
Four areas are now considered for discussion to further understand the effectiveness of the
intervention within the two populations and within this health care setting: Navigation and
the cancer populations CRC and HGG; Navigation for people with cancer; and the




      
                
                 
         
             
 
           
            
              
             
              
  
            
              
              
          
             
    
 
    
              
               
              
                  
             
10.4. Navigation and cancer populations
This section will examine results of this thesis in the context of what is currently known
about Navigation in CRC patients and HGG patients and what this study adds to the body of
knowledge in this area. The section will conclude by
results with the body of evidence already attained about the Navigation intervention.
10.4.1. Navigation in a population of people with colorectal cancer
This study aimed to establish effectiveness of Navigation in enhancing decision quality
within a colorectal population during first line treatment with chemotherapy. There is a body
of evidence, explored earlier in this thesis that outlines the uncertainty and concern
experienced by cancer patients at diagnosis and during cancer treatment (Wilson et al., 1999),
(Shaha, Cox,
Talman & Kelly 2008). With information seeking behaviours proposed as strategies to
minimise distress (Shaha et al., 2008) at critical time points throughout the CRC trajectory
(Knowles et al., 1999), the potential impact for interventions such as Navigation are clear.
However to date, studies exploring information needs and decision-making preferences
within the CRC population have provided a paradoxical description of both patient passivity
and patient engagement.
In this egating treatment
decision making to their clinicians. The rationale provided by CRC participants for this action
are in line with the CRC specific literature and the general cancer population literature. The
nature of decision making and patient choices in colorectal cancer care have been well
explored in a series of studies by Beaver et al. (2005, 2007, 2009) where focus of these UK




              
   
 
            
            
             
              
         
       
              
            
          
              
             
               
             
             
              
              
               
             
              
                 
               
              
clinicians. These studies are useful in providing contrast and comparison to the findings of
this thesis.
CRC participants in the qualitative evaluation of Navigation described a strikingly similar
account of decision making in their healthcare consultation when compared to CRC
participants interviewed by Beaver et al. (2005). CRC participants interviewed by Beaver et
al. (2005) perceived that they were informed and advised about treatment options, rather than
provided with choices. Although such treatment recommendations were provided,
parti they were fearful that they may chose
erroneously (anticipated regret). The fear of making an incorrect choice was based on patients
not having knowledge about the treatment options and having difficulty with fully
understanding the complex medical language (Beaver et al., 2005). Consequently,
participants delegated decision making to doctors who they perceived as the experts in their
care and therefore the professionals who would provide the most beneficial treatment (Beaver
et al., 2005). In a further study where CRC patients (n=375) were surveyed about their
attitudes towards decision making, 95.2% (n= 357) of participants trusted their clinician to
decide and 84.8% (n=318) reported clinicians had the medical knowledge and so should
decide what treatment was best (Beaver et al., 2009). In addition, through administering a
survey that explored decision making with colorectal cancer participants, it was found trust in
the clinician was integral for CRC patients in accepting decisions (Salkeld et al., 2003). In
this thesis, CRC participants were confident that their clinician would make a treatment
recommendation based in their best interests, which for participants was to extend their life
for as long as possible. In conjunction with findings from the Beaver et al. (2005 & 2009)
studies, the findings from this thesis suggests that either how decisions are made during the




              
            
 
            
            
            
             
          
             
              
              
                
               
              
                
             
               
      
 
               
                
             
              
                
         
relatively unaffected by the more recent policy drivers that have strongly steered a course
towards a shared decision-making approach (NICE 2011, DH, 2011a, SIGN 2015).
CRC participants and their clinicians in this Navigation evaluation reported there was
minimal patient involvement in the treatment decisions, with any involvement limited to
accepting or declining treatment. Beaver et al., (2007) similarly found through interviews
with health care professionals that treatment choices were limited for CRC patients as
complex management plans were created during separate multi-disciplinary team meetings
devoid of patient input. Such management plans were then presented as recommendations to
CRC patients during their clinic appointments. Similar findings with regards to lack of CRC
patient involvement in treatment decisions were identified in a study undertaken by Nagler et
al. (2010) who hypothesised that this was due to the lack of treatment options inherent in
following a standard treatment pathway of care. This raises the question whether there is need
for Navigation within clinical situations where a defined pathway of care exsists. As
proposed by CRC clinicians in this thesis, if the aim of Navigation is to encourage shared
decision making, findings from this work question whether certain cancers and even disease
trajectories may be more suitable to Navigation than others. This will be revisited and further
discussed later in this chapter.
Whilst a key finding from this thesis was that neither Navigated nor usual care participants
felt able to impact on the outcome of the treatment decision, it was clear that patient
participants wanted to be involved in the process of decision making, without holding
responsibility for the final outcome. Similarly Beaver et al. (2009) found 94.7% of patients
wanted to know what was happening and be involved in decisions, but only 51.7% wanted to




               
              
             
               
              
      
 
              
                 
            
        
              
             
               
              
               
              
           
              
            
        
 
            
              
              
wanted to be guided in decisions. This position of patient engagement was similarly held by
the CRC participants in the qualitative study. Participants ultimately wanted to be guided to
understand the decision, not challenge it. This distinction between involvement in the
process of decision making and not the outcome of decision making, so clearly articulated in
the qualitative evaluation in this thesis, was key to understanding what was important for
CRC participants in this thesis.
The qualitative findings have clearly defined involvement in the decision making process as a
key aim for participants. What is less clear is why this did not impact on primary and
secondary outcome measures. There is evidence that cancer patients who experience strong
treatment recommendations during consultation, subsequently report significantly less
involvement than those who do not perceive strong recommendations to be made (Frongillo,
Feibelmann Belkora, Lee & Sepucha, 2013). However, what is interesting is the perceived
level of involvement did not impact on the participants rating on the Decision Conflict Scale.
No significant differences were found on the reporting of the DCS between participants who
reported feeling involved compared to those who did not. This finding suggests that the DCS
measure may not be sensitive to the changes affected by the Navigation intervention given
that qualitative patient reports demonstrated improved involvement in the consultation.
However, it also raises whether involvement in the process of decision making constitutes as
shared decision making (SDM) thereby revisiting the question posed earlier: whether SDM
speaks to decision-making processes or decision-making outcomes.
When patients delegate making decisions about clinical treatments to clinicians, patients are
often described as taking a passive role in their care (Tariman, Berry, Cochrane, Doorenbos,




             
             
             
                
              
            
 
                
                
               
               
    
             
                 
               
   
 
            
           
            
              
         
 
clinical situation. All participants in this study actively engaged in behaviours to gain some 
understanding of their situation, but with acceptance that clinicians would make the final
decision. The amount and type of information provided to patients and the environment
created by their clinicians had a direct impact on how involved patients could be in decision
making. However, clearly there was tension for patients about the level of involvement in
decision making and if this would impact on the decision outcome.
When reflecting on the nature of SDM in this thesis, the question posed by Clayman and
Makoul (2009) comes to mind: is SDM engaging in the final decision or is SDM engagement
and sharing of the decision making processes? An early exploration of this area indicated that
a lack of involvement in decision making where the decision outcome cannot be influenced is
). This may be
participants perceive that decisions would only be made with their consent and acknowledged
that they had the option to decline treatment, which some of them did indeed chose. In this
way, it could be seen that participants could indeed influence the outcome, although in a
limited way.
The decision-making behaviours described by CRC participants in this evaluation and Beaver
emands a revisiting of the conceptualisation of SDM to clarify the
definition of patient participation in SDM with regards to decision-making processes and
outcomes. This will help to clarify the relevance of SDM in circumstances where treatment




             
            
              
            
            
            
          
           
             
 
           
          
              
               
         
              
               
              
         
             
              
               
 
               
         
Patient engagement in the decision-making process in this evaluation, was enabled by the
participation in clinic consultations through asking of questions and gaining information.
Whilst traditionally, these are areas of difficulty for patients (Beaver et al., 2005), Navigation
enabled participants to gain information about their disease and its treatment, thereby
building knowledge and aiding understanding, rather than informing decision making; this is
an important and nuanced finding of this work. Consultation planning was especially
important in achieving these outcomes. Within qualitative accounts, intervention participants
expressed confidence in asking their questions whilst control participants reported difficulties
in finding space and time in the consultation to ask their questions.
Consultation planning gave a structure to achieve effective communication within the
consultation appointment, with Navigation summaries used after consultation to ensure
understanding of the information shared during the clinic. Time is well recognised as a
barrier to information sharing in consultations (Frosch, et al., 2012), as is the challenge for
patients when communicating complex information (Joseph-Williams Natalie, Edwards &
Elwyn, 2014). For participants experiencing usual care, and as reported previously by Beaver
et al. (2010), learning was more a process of trial and error in seeking information.
Assimilating information in this way during usual care holds a risk of having misleading
expectations about treatment. Indeed, this may have impacted up 
scores of regret. However, it remains unclear as to why Navigated participants scored
significantly lower regret when, for the majority of participants, regardless of trial arm, the
fear of choosing incorrectly was the driver for delegating the decision to the clinician.
As discussed in Chapter 2, it is well understood that receiving a cancer diagnosis and




          
              
              
              
             
        
               
            
              
             
     
 
       
                
             
               
            
             
                
              
           
           
 
chemotherapy side effects and the possibility of needing to discontinue treatment (Beusterien,
Tsay, Gholizadeh & Su, 2013). However, the prevalence of anxiety and depression in this
evaluation study was not impacted on by the Navigation intervention. There may be some
understanding as to why this may be so. A systematic review determining whether anxiety
was an appropriate measure of decision aid effectiveness concluded against its use (Bekker,
Legare, Stacey, The authors advised that increased anxiety
levels may actually be beneficial to the decision making process resulting in better recall and
systematic evaluation of information. However, this thesis does not support that conclusion:
the mean change in anxiety reduction was more for intervention (-0.95) than control (-0.42)
participants pre-post with whole group mean scores of anxiety and depression declining from
baseline to follow up.
participants were identified as experiencing high
anxiety ( ) at baseline 36.72% and follow up 32.43%, compared with 19% (n=24) of a total
CRC sample (n=128) tested by Simon et al., (2009). However high depression prevalence
( ) appeared relative (20.31% at baseline and 13.51% at follow up) when compared with a
meta-analysis (n=211) of depression prevalence in the general population of cancer patients,
which found 17% (95% CI=16-19%) of participants were highly depressed (Krebber, et al.,
2013). Patel et al., (2011) found 9.64% of CRC participants met the criteria for a depressive
disorder ( ) and 6.14% met the criteria for anxiety ( ), 9 weeks post diagnosis.
were clinically depressed (4.05%). These comparisons could infer the sample studied




              
                
                   
                 
              
            
             
           
            
 
            
            
         
               
        
   
 
                
              
              
                
            
                 
This study has provided further support for the evidence that colorectal cancer patients want
to be involved in the process of decision making to understand their situation and the impact
of treatment, but not the outcome. It is unclear if this is an attitude unique to the experience of
colorectal cancer. It is also unclear if this attitude is an antecedent to or a consequence of
participants overcome the barriers to getting involved in the process of decision making to
support and facilitate the two way communication between the clinician and patient.
Although shared decision making was not achieved, as indicated by the measures, the
qualitative report suggest the intervention did support the attainment of individualised
information to satisfy needs and reassure participants throughout their treatment.
10.4.2. Navigation in a population of people with High Grade Glioma
This thesis has qualitatively evaluated an intervention which aimed to support HGG
care and treatment choices. This has been an area
identified as needing review for some time, as demonstrated in the results of two substantial
needs (Davies & Higginson, 2003: Catt et
al., 2008).
Chapter 2 has already detailed the nature of the HGG disease with more common pathway of
care beginning with rapid initiation of urgent hospital treatment (Guilfoyle et al., 2011). This
results in the person receiving the diagnosis of HGG following surgery, often with little
awareness as to the impact of the information that will be shared with them during the
following medical consultation; indeed this perspective was confirmed by the HGG clinicians




              
            
 
             
                 
                
              
              
            
               
            
 
              
             
              
              
             
              
               
             
               
             
              
               
               
al., 2005), it can be appreciated that the information shared during that initial medical
consultation is literally life changing for patients, and therefore often traumatic.
Navigation participants, similar to the experiences of HGG patients in other studies (Leopola
et al., 2001; Keir et al 2008), experienced profound distress and shock in adjusting to a HGG
diagnosis. The impact of this diagnosis, and of the uncertain future that lay ahead, was also
experienced by their next of kin/carers and their wider social support network as evidenced
by direct report from partners within interviews. This finding on the impact beyond the
patient/carer dyad supports previous findings from Sterckx et al. (2012). In acknowledging
the devastation caused by receiving the diagnosis of HGG, the impact of Navigation on HGG
patient decision making and on the decisions made, is now considered.
HGG participants, all of whom received the Navigation intervention in this thesis, did not
perceive opportunity to take responsibility for decisions made about their treatment. In this
way Navigation did not succeed at involving HGG participants (nor in fact CRC participants)
in the outcome of their treatment decisions. When triangulated with interview data from HGG
clinicians, it appeared this was due to clear clinical guidance and pre-determined treatment
pathways that directed clinical treatments for a high grade glioma. For HGG patients to
accept medical treatments, meant that there was some hope for the future, whereby to refuse
treatment would result in certain and early death for the patient. Participants perceived
clinicians as working to include them in the process of decision making and making decisions
based on their best interests. However, participants also acknowledged that with no viable
alternatives provided, the reality of this meant that their involvement in the decision making
was, in fact, minimal. This corroborates findings by Halkett et al., (2009) who identified that




              
           
             
               
        
 
               
     
            
               
             
           
              
              
            
              
              
      
 
            
           
            
            
               
was effectively reduced to treat or not treat. This situation is particularly pertinent for HGG
patients where no alternative treatment options are realistically available. Although the
literature suggests that with time, patients wish to have greater involvement in treatment
decision making (Shaha et al., 2008), the reality of this is difficult when treatment decisions
are perceived in such a binary way.
There are two important points to come from this finding. Firstly, Navigation did not impact
on the outcome of a
disease with well-established and evidence based treatment pathways. This again raises the
issue of the place of decision support tools, such as Navigation, in clearly defined pathways
of care. Secondly, that the initial consultation, where the diagnosis and treatment decisions
following surgery were initially shared between clinician and patient, was extremely
influential for patients. Although the focus of HGG interviews was to reflect back on
experiences over a minimum of three consultations, as seen in the data excerpts all
participants focused their accounts on experiences of decision making during the initial
medical consultation. Given the significance placed by patients on this time, this indicates the
fundamental importance of this consultation, in how it is conducted, and in the decision
making process used in influencing
Although involvement in the outcome of decisions was not successfully achieved for
making process, including information gathering, sharing and recall, were improved when
compared with other studies. Participants in this Navigation study reported information needs
were satisfied, and recall of information was supported. These experiences contrast with




               
                 
 
             
                
                
               
 
               
              
             
              
             
             
            
             
              
               
            
                
               
               
           
              
usual care experience is often defined by a lack of, and need for, clinical information about
treatment (Strang & Stang, 2001; Janda et al., 2006; Halkett et al., 2009; Cavers et al., 2012),
resulti ,
p.1301). Having appropriate information has been found to reduce anxiety for many people
with HGG (Cavers et al., 2012) and whilst Navigation was not able to take away the
uncertainty inherent in a diagnosis of HGG, it did appear to allow patients to feel reassured
that they understood their situation and were informed about the challenges they were facing.
It is clear that many HGG patients leave medical consultations wishing that they had asked
more questions and wanting more information about their prognosis during the course of the
treatment, and indeed beyond (Diaz et al., 2009). In addressing such concerns, the
opportunity and space to ask questions is known to be a useful strategy in
managing the uncertainty and furthering understanding of a HGG diagnosis and the treatment
decisions (Halkett et al., 2009). Through the consultation planning stage of the intervention,
participants were supported to critically reflect on their situation to generate important
questions and information to share with their clinicians. Participants acknowledged this to be
a beneficial aspect of Navigation enabling them to ensure that the consultation was planned
so that they would receive the clinical information they needed. Through clinician use of the
consultation plan participants perceived the information they received as high quality and
tailored to their specific needs, this left them feeling known and attended to as an individual.
Tailored information is known to be an important aspect of care for HGG patients (Halkett
al., 2009) and is also reported in qualitative data gathered about consultation from a general
cancer population (Thorne et al., 2005). In this study the




              
             
 
             
              
  
              
              
            
                 
               
              
               
               
             
            
            
            
       
 
            
                
              
                 
                  
medical consultation which reports patients have both a cognitive need, the need to know and
understand, and an affective need, the need to feel known and understood.
Whilst the consultation planning stage of Navigation clearly had benefit for the participant,
data from HGG interviews also addresses some of the social awareness concerns to arise
HGG together.
The way in which consultation planning brought patients and their partners together to ensure
a shared agenda of questions before the consultation was another unique finding of this
thesis. Cavers et al., (2012) noted that differences in information preferences between
relatives and patients was often a source of tension and distress. This is reported to be a
complex area with carers noted to have a higher need for information than patients (Salander
& Spetz 2002) and yet also patient satisfaction of information received reported as being
greater than that of their spouse (Catt et al., 2008). Such discrepancies between patient and
partner need were not revealed in this Navigation work with partients and their partners felt
supported to plan for the appointment together and discuss their information needs. Although
coping strategies such as denial and distraction activities are reported during information
seeking and discussion about HGG (Cavers et al., 2012), HGG consultation planning
undertaken by an independent trained Navigator appeared to facilitate, enable and encourage
open and direct discussion between parties.
The consultation planning phase of Navigation involves two components: development of a
prompt list of questions; and coaching from a Navigator. It is clear that HGG participants felt
supported by the presence of their Navigator throughout their clinic appointments. This is not
surprising given that in a review of the literature, Catt et al. (2008) identified HGG patients as




                
              
              
              
             
              
                
              
         
             
   
 
               
           
             
                
             
                 
              
           
                
            
               
              
recent study exploring use of the Patient Concerns Inventory (PCI), a list of prompt items to
discuss within the consultation, found use of the PCI provided focus for consultation and
facilitated the asking of questions, requests for further referrals and support in care (Rooney
et al., 2014). However, when interventions such as question prompt sheets or decision aids
are combined with coaching, as in this Navigation intervention, this can further improve
knowledge and the satisfaction of information needs (Stacey et al., 2012); although review of
the literature offer conflicting results here (Stacey et al., 2013). It is difficult to identify which
component of the Navigation had most impact here (prompt sheet vs. Navigator). What is
finding that the consultation planning assisted them in clarifying
their thoughts and questions prior to consultation. It also encouraged question asking within
the consultation.
HGG participants in this study reported that having a record of the consultation was helpful
in aiding recall of information. Similar to findings in Halkett et al. 
and written information was helpful in remembering what was discussed with them during
initial consultations because at the time they were numb with shock and unable to absorb the
information given (Cavers et al., 2012). A particular finding about the Navigation summary
in HGG patients, was how it was used to pace the uptake of information by the patient
according to their individual adjustment to the diagnosis. This approach of staging uptake of
information through assimilating incremental doses of information has been reported as
preferable for HGG patients as they gradually come to terms with the reality of their disease
and prognosis (Rosenblaum et al., 2009). With the Navigation summary, participants were
provided with a factual account of their situation and, as discussed before, this appeared to




              
             
              
              
              
     
 
             
              
              
              
               
             
              
              
            
              
    
 
       
               
               
             
            
               
detailed and accurate information to loved ones who could not attend the consultation. This
was particularly valued by HGG participants as Navigation summaries were used to support
conversations with others about HGG and reassure loved ones with accurate up to date
information. This is an important finding as often talking about HGG, its treatment and
prognosis is an area that can lead to miscommunication and unrealistic expectations in others
(Moore et al., 2013).
Findings from this study have identified that all components of the Navigation intervention
were important in order for participants and their partners to have their information needs
met. This is important given that when compared to other cancer populations, HGG patients
find clinical information and advice hard to access (Adelbratt & Strang 2000; Davies, 2011).
This study is the first to provide understanding of how the unique combination of elements
within Navigation can enable and support patients and clinicians to share information and
meet patient information needs in a HGG population. Although small scale and qualitative in
nature, this study has provided evidence to indicate further study of Navigation with HGG
participants is required. Furthermore, comparable interventions such as the PCI, which may
be a more cost effective intervention, also require further study to contrast strengths and
weaknesses between the interventions.
10.5. Navigation for people with cancer
This work has extended the body of evidence for Navigation by exploring its effectiveness as
a decision support and communication aid for patients with CRC and HGG. As reported in
Chapter 3, the Navigation intervention was originally designed by Belkora (2005) to support
breast cancer patients in their decisions about medical treatments. This complex intervention,




              
              
                
     
 
               
            
             
             
          
 
               
             
              
 
              
           
               
            
              
            
              
               
 
 
recording, has now been trialled in America with breast cancer patients (Belkora et al. 2008,
2015) and more recently in Scotland with prostate cancer patients (Hacking et al. 2013,
2014). In using Navigation with CRC and HGG patients, this further extends this body of
work into new cancer populations.
In addition, this is the first work to undertake a longitudinal mixed methods exploration of
Navigation, thereby building understanding of how this intervention works across a primary
cancer treatment pathway. This section will now compare and contrast outcomes of the
different Navigation studies to understand what knowledge has been added by this study
about the impact of Navigation across different cancer populations.
To provide structure to this discussion on how this thesis, undertaken with CRC and HGG
cohorts situates, compares and contrasts with other studies in other cancer populations, the
first area to be discussed focuses on the primary and secondary outcome measures.
Within this thesis, no significant difference was found in the primary (DSE) and secondary
outcome (DCS) measures between groups across each consultation. This contrasts with
results obtained by Hacking et al. (2013), in a RCT study that tested the feasibility,
acceptability and effectiveness of Navigation in early state prostate cancer patients (n=50
intervention, 40 control). Hacking et al. (2013) found a significant change in DSE score
between control and intervention groups following the initial consultation (p=0.01) and this
was maintained at six months follow up (p=0.03). This thesis did not measure decision self-




            
          
           
                
              
           
                  
            
               
             
             
         
            
              
              
              
              
                 
             
         
 
              
              
         
               
In the baseline DSE scores reported by Hacking et al. (2013) Intervention DSE baseline
scores (M84.9, SD13.3; Control M81.9, SD17.1)) were comparable to this study 
Intervention DSE baseline scores (M84.24, SD1.86; Control M79.83, SD1.83). Participants in
this thesis and the Hacking et al. (2013) sample had a relatively high baseline level of
decision self-efficacy. These results are also similar to those reported by Belkora et al.
DSE scale was scored using a range of 1-5. The
challenge of such a high baseline score is that it limits the amount of improvement that can be
detected following exposure to an intervention. Although this measure has previously been
shown to have a large effect size (0.85) when evaluating the intervention (Belkora et al.,
2008) it was not impacted by the intervention within this current evaluation population.
Interestingly, in contrast Hacking et al. (2013) found a significant difference between groups
(intervention vs. control) post initial consultation (p=0.011), intervention participants
reported higher decision self-efficacy when compared with usual care with this difference
maintained at six month follow up (p=0.032). This difference in results may highlight the
differences in the patient populations being studied. Within the Hacking et al. study (2013)
the population was patients diagnosed with prostate cancer. This is a disease with preference
sensitive decisions that require the patient to decide their own treatment as clinical evidence
is balanced in favour of more than one alternative (Hacking et al., 2013). In contrast, the CRC
pathway has a clearly defined and evidence-based treatment plan which requires little input
from the patient, or deliberation with the clinician.
However, there were further differences in the outcome measure of DSE from this evaluation
study and with previous work. With regards to patient reports of DSE measured for
intervention patients only from baseline to post-consultation planning (pre-consultation)




             
   
             
             
            
             
           
                 
             
 
             
              
            
               
              
            
             
              
             
 
            
          
               
            
                 
(p=0.053). In contrast the RCT in this thesis identified that consultation planning did
-efficacy (p=0.044). Belkora
work (2008, 2015) also found the DSE scores increased post consultation planning (p<0.001).
This study therefore adds to this body of knowledge by suggesting that Navigation
consultation planning increases decision self-efficacy, although it cannot offer any results to
support that Navigation increases DSE when measured post consultation. As a RCT that
administered serial outcome measures, this study provides new evidence that multiple
exposures to Navigation over time does not appear to impact on scores of DSE in the CRC
population, however it must be acknowledged that this study was underpowered over time.
Within this evaluation study, decision conflict was also not impacted by the Navigation
intervention over time. In contrast, Hacking et al. (2013) found scores of DCS were
significantly different post consultation (p=0.047) although this was not maintained at follow
up (p=0.052). When comparing, in this study, between group scores at each time point (post
consultation mid treatment, end of treatment and follow up) scores were found to be
significantly different at the mid treatment appointment (p=0.007) in favour of the
intervention participants. In this way, this thesis can provide evidence that repeated exposure
to Navigation may impact on DCS, however this was not maintained over time. Furthermore
interaction effects could suggest this may not be due to the intervention.
Whilst such contradictory and conflicting evidence may prove perplexing, there were some
outcome measures that demonstrated similarity with previously published Navigation work.
The HADS was not impacted by the intervention in this study or in Hacking et al. 
(2013). Additionally, scores of decision regret were significantly different between groups at




            
             
            
       
 
             
             
                
               
              
             
            
              
                 
               
                
             
              
          
       
 
               
            
               
               
up (p=0.036). This study therefore provides further evidence to support that Navigation
significantly reduces decision regret when measured six to nine months after the initial
treatment consultation. It further supports that repeated exposure to Navigation does not
impact on this significant finding.
Participants in this thesis were significantly more prepared for decision making then control
participants after each consultation (p>0.001) although due to the framing of the questions,
these may have been biased in favour of the intervention group. Belkora et al. (2015) and
Hacking et al. (2013) both used the same items from the Preparation for Decision Making
scale but only used these with intervention participants, and not the controls. In making
accurate comparisons across the studies there are some further challenges. Hacking et al.
(2013) only provided percentages of responses to the items, thereby limiting comparison.
However, Belkora et al. (2015) used three items from the preparing for decision-making scale
and reported the mean score for each item: think how about involved you want to be in
decisions (M4.17); identify the questions you want to ask your doctor (M4.02); prepare you to
talk to your doctor about what matters most (M4.25). This thesis found very similar results at
post consultation (T3) respectively reported; M4.50, M4.67, M4.69. It can therefore be
concluded that this thesis provides evidence that, due to high mean scores being maintained
after each consultation, Navigation prepares participants for decision making for
consultations throughout the first treatment pathway.
Earlier chapters in this thesis have detailed how cancer care patients find it difficult to
understand and articulate their treatment preferences and to explore concerns about prognosis
and survival in medical consultations where medical staff are often perceived to be too busy,




             
               
              
     
 
          
            
            
            
             
            
             
                
               
                 
            
           
              
               
               
                
          
             
               
2001). With cancer patients clearly recognising that health care professionals need to be
aware of their information needs and to tailor the way information is provided (Halkett 2010),
the thesis adds to understanding of the importance of two-way communication for both CRC
and HGG patients.
Qualitative evaluation in this thesis demonstrated that Navigation improved communication
between clinician and patient from the perspective of the patient. Although patient
participants reported not being involved in the outcome of treatment decisions, intervention
participants strongly reported feeling involved in the decision making process. What was
striking throughout the analysis was the similarity in experiences of Navigation between the
two oncology populations (HGG and CRC). Many studies examine information needs and
patient experiences across oncology populations and it can be difficult to ascertain whether
findings are resultant from the impact that the cancer and the cancer journey has on patient
experiences, or are resultant from other factors e.g. impact of experiences at that cancer clinic
or setting. There is no current consensus on this in empirical work. Beaver et al. (2005) have
drawn comparisons between the experience of breast and colorectal cancer and found
differences in decision making preferences. By comparing the qualitative reporting of
experience of Navigation from the perspective of someone with breast cancer (Belkora et al.
2009) to this study with colorectal cancer it can be argued the reported experiences are
work (2014) are comparable with findings of Navigated CRC and HGG patients in this thesis,
it would appear that the cancer site does not impact on the experience of Navigation when
reported qualitatively; however quantitative differences, as discussed earlier in this
discussion, are present. This raises the question about whether the quantitative measures used




           
          
 
           
          
            
               
               
              
               
             
                 
              
           
            
             
 
             
                
             
                
             
              
              
             
with Navigation. Further work to evaluate Navigation with different measures is
recommended, particularly when there are no preference sensitive decisions.
As a decision and communication support intervention, Navigation offers support through
several mechanisms including: consultation planning, coaching and provision of a
consultation record. All intervention participants in this thesis found the consultation
planning to be most helpful. This supports Belkora et al. (2009) who reported the experience
of Navigation through case study with a breast cancer patient. In this, the participant reported
consultation planning to be beneficial in helping her to clarify and think through questions.
The participant reported finding value in knowing that the clinician could set the delivery of
information to her individual level of understanding. This resulted in a discussion weighted
less on the discovery about what was important to her and more on what she wanted to
discuss. Similar to patient experiences reported in Chapter 8, the participant in Belkora et
al. (2009) reported clear understanding and recall of information shared during
the consultation, noting the difficulty of remembering the small issues discussed whilst
attempting to process the bigger picture of the situation of her diagnosis.
Another significant finding from this evaluation thesis is the importance of each component
of Navigation for patients. A key issue for Navigated patients in this work was how the
consultation planning helped them prepare for the medical consultation. This has also been
identified by Hacking et al. (2014) where such planning also prepared patients to take part in
the consultation by asking questions of their clinician. Following the consultation, across all
Navigation studies, the written summary and CD were used to recall and further understand
decisions made. A key component of this complex intervention evaluation was the




            
               
             
              
               
            
      
 
                
           
            
             
           
            
              
                
              
              
             
              
            
               
              
             
                
Navigator in the consultation planning, throughout the consultation with the clinician and
following the consultation as someone with whom they could reflect on their situation. In
this way, the Navigator was invaluable as an independent and objective facilitator for
patients; literally a mechanism by which the patient could navigate their way through medical
consultations. By acting in a way that enabled use of the evidence based strategies e.g.
prompt list, coaching, use of summaries, Navigated patients were able to proactively
participate in the decision making processes.
A unique feature of this study, and of the evaluation of this complex intervention, were the
interviews undertaken with CRC patients receiving usual care, and therefore non-Navigated
medical consultations. In this study, this provided a control comparison. Control participants,
or usual care participants reported barriers in the consultation which prevented them from
satisfying their information needs. When compared to experiences of Navigated participants,
these barriers appear to have been overcome by the Navigation intervention. The
communication barriers as reported by the CRC controls in this thesis, are largely consistent
with those reported in the literature. For example, in a recent systematic review (n=45) by
Joseph-Williams et al. (2014), patients reported that lack of continuity of care through seeing
different clinicians in clinic and a passive patient role in medical consultation were major
barriers to involvement in their care. The authors report patients perceived asking questions
as unacceptable and undermining of the clinician. This barrier to involvement in care is
further supported when patients undervalue the expertise they bring to the consultation
(Joseph-Williams et al., 2014). Frosch et al. (2012) in a focus group study conducted with
patients (n=38), reported that patients found it difficult to be heard by their clinician,
resulting in them engaging in independent research to fill in information gaps. Furthermore,




             
               
  
 
               
             
             
                
              
             
                 
              
                
             
            
           
                
            
               
           
               
            
 
                
              
consultation appointment to help them recall the information provided. This was integral to
accurate recall and memory, and to ensure that there was someone to debrief following the
consultation.
This account of being unable to have questions answered in the consultation and having poor
recall following the consultation was not present in the CRC and HGG Navigation
participants. Participants exposed to the Navigation intervention in this thesis were able to
make space in the consultation to ask their questions. The possibility of this occurring had
been endorsed in the consultation planning discussion and by organising the content of the
consultation plan. In addition, the consultation summaries were used after the consultation to
help recall of events and as a document to share with family members and friends to keep
them updated. In this way, the Navigation intervention in this study supports previous claims
made in the literature with regards to the positive impact of decision support aids as outlined
earlier in this thesis. The qualitative findings of Navigation support that two-way
communication between patient and clinician was improved. Moreover, use of Navigation in
situations where participants were receiving devastating diagnoses e.g. HGG, only appeared
to assist people in coping with their situation and satisfaction with the care received. The
Navigation consultation planning stage ensured all questions were identified and asked whilst
the consultation summary and recording provided a record of the answers. In being able to
utilise this intervention in consultations where distressing information was being discussed
means that Navigation is well-suited to a situations where emotions are running high and as
such, difficulties are inherent in formulating questions and recalling the answers given.
What is clear from this thesis is that whilst qualitative findings from this study offer positive




               
           
            
          
              
    
 
             
             
              
               
              
              
               
             
               
               
  
              
                
             
                 
    
Such a dichotomy in results is made reference to in a systematic review (n=33) undertaken to
assess the effects of decision making and communication interventions before medical
consultations (Kinnersley et al., 2008). This review concluded that such interventions could
significantly increase question asking and patient satisfaction. However, the authors
concluded that these findings may not be enough to make notable changes to other
quantifiable patient outcomes.
The final aspect of evaluation conducted in this thesis resulted from interviews with
clinicians. This demonstrated a difference of opinion regarding the utility of Navigation
within each cancer specific service. HGG clinicians were more in favour of Navigation when
compared to CRC clinicians. When comparing this to other work in this area, for example,
Belkora (2008) and Hacking et al. (2014), the perspective offered by HGG clinicians was
to care. Belkora et al. (2008) found clinicians (participant number not reported) endorsed the
Navigation consultation plan as a tool to help patients organise and clarify questions prior to
the consultation. Furthermore, the consultation plan gave clinicians a preview of patient need
which could be used to strategise about how to conduct the appointment (Belkora et al.,
2008). Hacking et al. (2014) also found that clinicians (n=4) used the consultation plan to
s to
allow patients to communicate explicit preferences for treatment. This was ultimately seen to
lead to a better quality of decision. Whilst these are positive and consensus findings, there is
their usual order of information provision to ensure that the necessary information required





                 
              
                
                 
             
                
             
 
              
           
          
             
             
             
              
              
            
         
       
 
               
             
               
            
               
Perhaps one of the most notable findings to come from this thesis was the concern about the
sustainability of Navigation within the NHS, particularly with regards to the costs involved in
its delivery. Interestingly this is not raised in any of the original North American studies, but
is raised by clinicians in the other UK studies, for example, Hacking et al. (2014). This may
highlight a difference in decision making culture, or between the legal and financial
frameworks of healthcare systems in the UK and the USA. This in an important area that
requires further exploration and critique and is discussed further in the next section.
10.6. Applicability of Navigation in the context of oncology care and health policy
In this thesis, Navigation improved patient experience and satisfaction of medical
consultation, information sharing and information understanding. Patients were positive in
their evaluation of Navigation and, taken from the patient perspective, Navigation was useful
in providing decision support. However, clinicians were divided in their views on Navigation,
with HGG clinicians more supportive of the intervention than the CRC clinicians. For
clinicians, the key differences lay in whether the Navigation consultation plan was seen as
helpful or distracting in consultations and whether the additional time required to attend to
patient-generated questions was valuable or pointless. This leads to consideration as to
whether differences in cancer treatment pathways and/or distinctive organisational/
professional cultures had bearing on these findings.
The two patient populations used to evaluate Navigation in this study shared the similarity of
having cancer, but were dissimilar with regards to cancer prevalence, prognosis and disease
trajectories. CRC being a common cancer (Ferlay et al., 2015), with a clear evidence-based
treatment pathway (SIGN, 2015) and well identified areas of clinical and emotional




              
              
             
      
 
             
             
              
                
                 
            
              
               
   
 
            
            
           
           
             
            
              
            
(Mirimanoff et al., 2006) with current treatments being more palliative than curative in nature
(Wang & Jiang, 2013). As evidenced in both literature and participant/clinician reports in
this thesis, each pathway holds distinctive and critical junctures for information sharing, and
decision making (or lack of).
Empirical study on decision making assessment and support interventions are often tested in
one cancer patient population with few studies exploring applicability across centres and in
different stages of cancer (Carlson, Waller & Mitchell, 2012). Therefore, the ability to make
across disease trajectories is a strength of this work. This reminds us of the difference in
cancer care pathways, on the types of decisions to be made, and how this can impact on
patient information needs. This must be acknowledged theoretically and empirically. In doing
so, this not only provides understanding of patient information needs but also provides us
with an ability to explain some of the differences in clinician perspectives on the applicability
of Navigation.
HGG and CRC clinicians held different perspectives on Navigation. This requires exploration
as to whether there were distinctive professional and/or organisational cultural factors that
were influencing factors. In highlighting the professional differences between HGG and
and normalisation of SDM into [some] medical consultations remains challenging. However,
many factors may impact on this. One qualitative study that interviewed 22 oncologists,
reported that when treatment decisions were evidenced based with high success rates,
oncologists made the assumption that patients wanted a good outcome and therefore were not




              
              
             
            
            
          
             
                
               
              
               
           
 
                
                
              
               
          
               
             
             
           
             
              
to support patient involvement because their skills lay in manual dexterity (Shepherd et al.,
2011). Perhaps another challenge for medical staff in developing a more positive and flexible
approach to SDM is resultant from medical education in this area. Many patient-doctor
interventions focus on developing the communication skills of doctors through using a
standardised script approach. This is often doctor-led and medically driven (Fallowfield,
Maguire, & Ramirez, 2004). Therefore, communication skills performance remains highly
case specific (Baig, Violata, & Crutcher, 2009) implying that the transfer of communication
skills from one patient encounter to another is neither obvious, nor easy. As identified in this
thesis, attending to the specific needs of the patient in the context of their disease/illness
pathway is important. This required clinicians to recognise the extent to which patients wish
to be involved in their treatment (British Medical Journal, 2011) and have an awareness of,
and confidence in using adaptable approaches and scripts in medical consultation.
A final area for exploration in this section is the sustainability of Navigation in the current
health care system: an area of concern expressed by all clinicians. Even with strong policy
drivers for SDM in health care (NICE, 2011; DH, 2011a; SIGN, 2015; Independent Cancer
Taskforce, 2015), the reality of achieving SDM continues to be problematic. The goal of
embedding shared information, shared evaluation, SDM and shared responsibilities (Coulter
and Collins, 2011) into current health care practice needs much further work. In a paper
outlining the challenges in achieving such a SDM culture change (Elwyn, Laitner, Coulter,
Walker, Watson & Thomson, 2010), three conditions were identified as important: access to
evidence-based information about treatment options; support for patients on balancing risk
versus benefit of treatments; and a supportive culture that enables patient engagement. This




             
   
 
             
              
              
             
             
             
 
            
              
              
               
               
            
              
              
       
                
            
              
              
             
             
and testing of interventions, less work has focussed on the sustainability of these
interventions in practice.
With a clear ethical mandate to support SDM (Health Foundation, 2011) and detailed
exploration of patient barriers (e.g. not knowing what questions to ask) with approaches to
overcome these (Joseph-Williams et al., 2013), there is less exploration with regards to the
organisational-related barriers, for example, lack of time for SDM, lack of medical continuity
within clinics, and on-going funding for delivery of decision support intervention. These are
all serious operational barriers to the on-going use of Navigation in the NHS.
Given the current resource constrained health care environment, these are important concerns
requiring careful review. Future options worthy of consideration are that the same model of
Navigation be delivered, but by trained volunteers or others e.g. medical students, who may
be more affordable. However, it is worth noting that all clinicians involved in the qualitative
evaluation study held the opinion that Navigators should be highly trained in order for the
role to work effectively. Therefore any substitute Navigators would require suitable support
and training. External funding sources were suggested by clinicians in this thesis, for
example charitable funding, and this could be modelled on a similar approach to the
Macmillan volunteers (https://volunteering.macmillan.org.uk/). An alternative option would
be to look at different models of delivery. For example, in this study, the first Navigation
appointment and first medical consultation held greatest impact with regards to decision
making for patients. Even though this was a longitudinal study, patients and clinicians mainly
spoke of the discussions and decisions in the first clinic appointment: all others were
perceived as less significant. Consideration of this, and perhaps targeting the first medical




             
          
              
             
              
             
          
 
           
               
             
                 
             
           
 
               
               
              
              
        
 
             
               
               
            
decision making support required. An alternative approach would be to utilise specific and
selected components of Navigation. Such initiatives could include having disease-specific
pathway information, readable and accessible to all, use of summary clinic letters for patients
following consultation and/or the provision of consultation recordings. A final option would
be to consider utilisation of Navigation in patient pathways where there is greater potential
for variance and increased options in decision making, as opposed to where standardised
evidence-based guidelines exist for the treatment of certain cancers.
Although some junior clinicians reported being inhibited by medical consultations being
recorded as part of the Navigation intervention, use of CD recordings may be an unrealised
and underutilised approach in SDM, especially due to the availability of technology to
undertake this. It is clear that this study has identified a need for summary and recording of
the medical consultation. Although a written record was preferred by patients and clinicians,
an audio-record should not be dismissed as a viable alternative.
With regards to the three conditions required for instituting SDM in healthcare (Elwyn et al.,
2010), this thesis would suggest that attending to the last condition, that of developing a
supportive culture that enables patient engagement will be critical to the on-going use of
interventions, such as Navigation in the NHS. Indeed, future research should focus on the
sustainability of such decision support interventions in practice.
SDM in health care constitutes the active discussion between and sharing of, expert
information by the doctor (for example, risks and side effects of treatments) and the patient
(for example, values and preferences for treatment). What is clear from this thesis is that




              
                 
                   
             
      
 
       
             
               
              
              
            
             
          
 
                 
             
             
            
             
              
             
                
   
engagement of clinical champions, and organisational support at the highest level in order to
be sustainable. However, for SDM to be truly part of the fabric of health care, SDM should
not stop at the clinic door. The principles of SDM need to be built in at every level of
decision making, from cancer treatment options for an individual, through to cancer services
commissioning for many individuals and communities.
10.7. Methodological critique of the study
This thesis reports on evaluation of the effectiveness of Navigation, a complex intervention,
in enhancing decision making quality over time when compared with usual care, in a cohort
of CRC patients. It also explores the experiences of the Navigation intervention from the
perspective of CRC and HGG patients and consulting clinicians. To undertake this, a mixed
methodology using a pragmatic randomised control trial with nested qualitative studies was
undertaken. Critique across this design is now offered through discussion on overall study
design; the RCT; the qualitative studies; and the Navigation intervention.
A strength of this work was the use of quantitative and qualitative paradigms to meet the aims
of the study. By providing methodological triangulation through use of RCT and qualitative
interviews and using multiple perspectives, the results have provided a more expansive and
detailed understanding of SDM in specific cancer contexts than previously known. Findings
from the in-depth qualitative interviews provided explanation and new insights into the RCT
results. This identified that Navigation in CRC and HGG cancer contexts may operate in
ways different to other disease trajectories. It brings new insights to understanding how





               
            
            
             
            
             
                
             
                
             
              
            
 
          
          
             
                
           
             
             
             
    
           
     
 
Whilst use of a pragmatic longitudinal parallel-group RCT was a strength of the study, there
were some identified limitations. The process of randomisation and recruitment were robust,
given the confounding variables and constraints of what the trial population were
experiencing i.e. receiving diagnosis of, and treatment for cancer. Whilst the potential for
different commitment between intervention and control patients in RCT leading to a
differential drop-out rate of patients (Campbell, 2000) is recognised, there may have been
further sample bias in both arms of the RCT given that a high proportion of participants
reached the threshold for borderline anxiety when compared with similar studies. A further
limitation of this study, was that it was underpowered over time due to high attrition rates
reported. Despite use of statistical assumptions and calculations to calculate the initial sample
size, and attempts to increase recruitment through an extension on the time frame for
recruitment, the sample population at the final time point (T3) was small.
Longitudinal measures were undertaken on primary (decision self-efficacy) and secondary
(Decision Conflict, Decision Regret, Preparation for Decision Making, anxiety and
depression) outcomes in order to evaluate the effectiveness of the Navigation intervention on
the quality of decision making. There are limitations within this aspect of the trial design that
merit acknowledgment. A more uniform pre-post design across all measures, including
decision conflict, may have been more sensitive to identifying variations over time and
provided a more rigorous and standardised approach to analysis. Given lack of statistical
significance in the primary and, to an extent, secondary measures, this raises concern
so given that the
interviews described a qualitatively different experience for patients when using Navigation




              
              
              
            
             
               
            
            
             
                
             
               
                 
    
 
               
                 
              
              
             
  
 
            
              
               
Given results from the RCT in this thesis, other theories and variables, apart from decisional
self-efficacy and decision conflict may need to be explored in future research. This may
include utilising the concept of patient activation that explores how the knowledge, skills and
confidence a person has, influences strategies to manage health. Measures have been
developed from this work (Hibbard, Stockard, Mahoney & Tusler, 2004) that have high
reliability in longitudinal study and may be more appropriate to use of Navigation in this
setting. Furthermore, further work is required to determine whether the Preparation for
Decision Making sub-scale used, was valid. Results demonstrated there may have been
question bias towards the intervention arm, with less validity and applicability for control
participants. This needs further work. In addition, the order of items per scale were not
changed throughout the repeated completion of measures over the time points they were
administered. The DSE and DCS in particular were administered four times to both trial arms
over the nine months. This may have biased responses that are based in favour of recall rather
than actual events.
A final concern in this longitudinal trial was contamination. It was noted by the Clinical
Nurse Specialists that towards the end of the study, there was a perception amongst staff of a
practice change in the CRC clinic. More patients were using self-made questions lists for
appointments. It can only be inferred that staff were influenced by the study, integrating
advice to patients about preparing for consultation, and this may have influenced study
results.
With regards to the qualitative component of this evaluation study, prospective qualitative
interviews were conducted with the CRC cohort of patients, patients with HGG, and their




                
              
                
          
 
                
           
                 
         
              
              
 
            
              
            
              
             
          
 
            
            
           
              
           
sample size. Whilst this is in keeping with qualitative work, this may not have been adequate
to capture the full range of experiences. However, data saturation was evident in analysis.
With data collection limited to two clinics in one tertiary site, findings are specific to these
populations and transferability of findings limited to this context.
Both a strength and a limitation of this study was the longitudinal nature of the evaluation
undertaken. As the concern regarding contamination was highlighted earlier, such culture
making and consultation. A further limitation to be noted is that as a longitudinal study, it is
acknowledged that the researcher-participant relationship changed over time. With
recognised potential to impact on rigorous data collection, details have been given in earlier
methods chapters as to how the researcher adopted a reflexive position within this study.
Collecting data through interview provided one perspective of social interaction in the
consultation. It may not have provided an accurate representation of all aspects of decision
making in medical consultation. Further research may consider interview with other data
sources e.g. nurses and carers, and using other data collection methods, e.g. field observation
in ethnography, to provide a more comprehensive description of the social phenomena of
decision making with CRC and HGG patients and clinicians.
Finally, limitations with the intervention tool itself merit brief discussion. As stated
previously, Navigation is a complex intervention that consists of the three evidence-based
practices of question listing, audio recording and summarising, combined into one patient-
centred intervention. A key strength of the Navigation intervention therefore is that it has




              
                
           
               
            
           
             
              
             
             
              
        
 
     
              
                 
            
            
             
              
              
            
               
           
             
used in this evaluation work were detailed and robust. Using and complying with these
procedures in the conduct of the study ensured that the integrity of the study design was
maintained. However, it must be acknowledged that the Navigation intervention was
delivered by two Navigators. In this study these were individuals who were given training in
Navigation and supported throughout by clinical supervision. Navigators in this study were
educated and had professional backgrounds in psychology (one at doctoral level).
Furthermore, it could be suggested that through on-going supervision, not only were the
Navigators skilled and educated individuals, but that they had insight and compassion into the
experience of study participants. Whilst this had potential to contribute to the complex
relationships known to exist between an intervention and the implementation fidelity, it must
be noted that even in such a supportive implementation environment, no significant impact on
the primary and secondary outcome measures were found.
10.8. Summary of Results
Drawing on the literature, this chapter has discussed key results from the evaluation of
Navigation in the CRC and HGG patients. In this, the importance of this work with regards to
contributing to knowledge about the two cancer populations and their respective disease
trajectories has been explored. This mixed methodology study has highlighted the challenges
of shared decision making and identified how information barriers in the medical consultation
can be addressed through use of Navigation. This chapter has identified the contribution that
the Navigation intervention has made to improve the experience of decision making from the
perspective of patients, but also the significant challenges to sustaining and embedding
decision support aids in practice. In the next and final chapter, the contributions that this
work makes to theoretical knowledge and methodological understanding will be presented




    
   
            
              
              
              
               
            
            
          
 
              
          
            
             
            
            
 
            
              






This primary research into the effectiveness of the Navigation intervention in enhancing
decision making quality and the experience of patients and clinicians in its use, has
demonstrated that Navigation has more impact on the process of decision making, rather than
the outcome of decision making per se. Contextual factors that challenge the use of
Navigation in health care consultations include: the nature of decisions to be made in CRC
and HGG treatment pathways; on-going cultural perceptions about patient passivity and a
dominant medical role within consultation; and resource constraints that may hinder the
sustained use of Navigation in the current health service.
In drawing attention to these complex inter-relating factors, this research has brought to the
fore unrecognised assumptions made about decision making processes in medical
consultations and patient goals when meeting with medical staff about treatment options.
This evaluation has raised questions about the portability of interventions developed in one
international clinical setting to another and the generalisability of outcome measures to
determine the impact of decision support interventions in new research settings.
This study has therefore demonstrated important new ways of understanding and made
contribution to knowledge, methodology and method as well as to health policy and practice




     
             
             
              
              
            
          
            
         
 
             
              
            
           
            
    
 
               
             
              
              
                
            
 
11.2. Contribution to knowledge
Results of this evaluation make an important contribution to knowledge by providing new
perspectives in understanding the specific challenges and needs of cancer populations that, to
date, have received little previous empirical review. In exploring the use of Navigation in
CRC and HGG populations, a more in-depth knowledge of the discrete disease and treatment
pathways and the associated decision-making processes has been raised. This study advances
important theoretical knowledge of the complex interaction between medical treatment
pathway, patient choice and shared decision making, thereby identifying what decisions can
and need to be made and by whom.
Further to this, the evaluation distinguishes a shared decision making model focussing on
patient contribution to the decision making processes, from one with a focus on decisional
outcome. In making clear how Navigation enables greater patient engagement in decision
making processes through the asking of questions, facilitating information recall and
understanding of consultation, traditional models that focus on outcomes of shared decision
making are contested.
In challenging how shared decision making has been described in the literature to date, this
research makes an original contribution to the future development of theoretical models and
concepts of shared decision making in health care, and for the theoretical frameworks and
underpinning of similar decision support aids, such as Navigation. It also raises questions as
to whether shared decision making is the a priori concept for consideration in this area, or




       
             
            
            
               
            
            
                 
            
    
 
              
              
           
          
             
          
 
               
              
             
            
              
             
      
11.3. Contribution to methodology and method
This study contributes to understanding the effectiveness of Navigation by using a more
complex study design and more detailed measures than previously described in stand-alone
quantitative or qualitative evaluation of the intervention. In offering an intricate mixed
methods study, this empirical piece is: the first to undertake a longitudinal approach to the
evaluation; unique in undertaking a RCT approach to Navigation evaluation; pioneering in
including a bespoke qualitative evaluation of Navigation from the perspective of clinicians
and a usual care cohort; and the only study to use and test new measures, for example
Preparation For Decision Making, and in previously unexplored samples, for example CRC
and HGG populations.
In undertaking mixed methods research, this study has drawn attention to the benefits and
explanatory power that qualitative study can bring to quantitative work. In this work, whilst
null hypotheses regarding the effectiveness of Navigation on primary and secondary
outcomes were confirmed, findings from the qualitative evaluation studies gave
understanding to the underlying decision making processes in medical consultation and of the
impact of Navigation on the experiences of patients and clinicians.
Given the results of the RCT, this evaluation has also challenged previous assumptions in the
literature about measures perceived as important to assess decision making efficacy in use of
decision aids in this context. With previous research describing use of outcomes focussed
measures, this study suggests that different conceptualisations of shared decision making and
therefore different process oriented measures and scale are required. This is an important new
and original finding that has implications for understanding the evaluation of Navigation in




            
           
         
 
         
                
             
             
             
              
             
              
          
             
             
           
           
               
 
               
              
             
              
         
 
Through the above areas, this research makes a substantial contribution to current
understanding on the Navigation intervention, and on the methodological and methods
challenges in evaluating complex interventions in this area.
11.4. Implications for health care practice and policy
Implications for health care practice arising from this study identify that there is a need for
critical review of the clinician patient relationship with regards to shared decision making
models. More flexible frameworks need to be developed and acknowledged than meet the
needs of patients in given health care circumstances. Results from this evaluation suggest
development of health care practice and policy that supports the needs of individual patients
to engage in decision making processes, rather than engage in ultimate treatment decision
making outcomes, as highlighted in this study, is called for. Interventions that work towards
meeting patient needs for information gathering and improved information management,
essential aspects of Navigation, including improved recall to support their own needs and
those of others, should be recognised as important. Therefore, strategies that promote process
quality areas including; preparation for consultation, raising questions in consultation and
having accurate recall of information, should be profiled alongside making treatment
decisions in local clinical practice initiatives, as well as in national health care policy.
In order to promote information sharing and information exchange at all levels of health care
delivery, a needs assessment is required to determine the area of information that patients
require and integrate these with the medical agenda for consultation. The importance of
written records, an implicit component of Navigation profiled in the findings of this study,




        
               
              
              
              
              
             
            
               
 
            
            
              
              
            
                 
             








Decision making in cancer settings requires re-conceptualisation to ensure significant
commitment is made to the principles of shared decision making that engage patient and carer
in the process and outcome of decision making with clinicians. This would require an
improved recognition of the cancer trajectories and the associated decisions to be made. It
would also require a realistic distinction of treatment decisions made by clinicians and those
available to be made by patients. The principles that underpin such an understanding must
then be consistently integrated across local and government policy. New health policy and
clinical guidelines should specifically address how information needs are met and incorporate
the principles of shared decision making that embrace both clinician and patient perspectives.
Finally, use of decision support interventions, such as Navigation will only become
embedded in healthcare if resource is identified to support implementation and sustainability
of these currently resource-intensive tools. As clearly identified in this study, there is concern
with regards to the adoption of Navigation in current care delivery. Whilst undoubtedly an
expanding body of empirical work demonstrating impact and efficacy of such interventions
will add support to this. Further work is required to determine case of need, cost benefit and
risk assessment in use of Navigation and exploration of alternative models of implementation




   
           
            
             
              
     
 
              
                
              
              
               
             
       
 
              
           
             








Cancer consultations between patients and cancer clinicians and decisions that inform
treatment decision making are processes with associated human experiences. These cannot be
conceptualised as events. Whilst models of shared decision making continue to be highly
profiled in cancer health policy strategies, information exchange and use of decision aids in
medical practice, remains problematic.
This evaluation study has demonstrated that Navigation has more impact on the process of
decision making, rather than outcome of decisions per se. Patients in this study did not want
autonomy for the treatment decision but preferred the experts in their cancer care to
undertake this responsibility. However, participants still needed to be able to feel involved in
the process, to understand their situation and what the decisions meant to them and their
individual circumstances. In this study, Navigation is a tool that enables patient engagement
at the level of information exchange.
A more nuanced understanding of different cancer pathways and the specific decisions to be
made, together with greater consideration of patient priorities for information and
engagement, may inform a more targeted and sustained use of decision support interventions,
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Appendix 3: SCOPED framework
Patient Information Navigation Study
Here are some questions which you might want to ask your doctor during your upcoming
appointment. If you are uncomfortable with any of the questions below please let us know and
we will not address them.
Situation: Key facts about my condition: Do I have any questions surrounding:
- My diagnosis or my condition?
- My test results?
- Do I have any concerns about how treatment might affect other medications, or
medical conditions that I have?
- Is there anything significant or important about my situation which I would like
my doctor to know?
Choices: What are my choices?
- What treatment is available to me?
- Are there any medical/drug trials available to me?
- How will my lifestyle be affected by my choices?
Objectives: Goals, Preference and Priorities
- What are my goals for my appointment with my doctor?
- What are my goals for treatment?
- Regarding my quality of life; what do I want to continue as normal? For example
my work, my hobbies, my daily activities e.g. driving, body image, sexuality,
child-rearing?
- Have I any preferences about, e.g. Appointment times?
- Would I like survival/complications to be explained to me? And how?
People: Roles and Responsibilities in Decision Making
- Who do I want to have a voice in influencing my decisions?
- What kind of information do I want my doctor to give me (i.e. make a
recommendation, and/or make a decision for me?)
-
(understandable) terms or in medical language?
Evaluation (Main Questions):
Do I have any questions surrounding:
- My prognosis with/without any further treatment?




o How my treatment choices will affect my quality of life in the long-term?
Decisions: Which choice is best and what are the next steps.
- Who needs to do what, when, where, how and why?













             
  
                  
                   
   
     
            
              
                
      
           
     
 
    
      
 
    
     
 
 
   
       
 
          
    
           
                 
  
               
 
          
            
Appendix 4: An example of a consultation plan, for a person with HGG. 
Situation
what happened. Can you tell me what happened to me, and what happened
during surgery?
I have lumps on my head, swelling at the back of my head, stiffness and pain in
my neck, and a rash from the base of my neck to the front. My eyes also go a
Are these all
caused by the surgery?
How long will it be until my head stops feeling numb?
Will I be ok to lie on the side where my scar is?
Choices If the tumour is cancerous, I think I might have to have chemotherapy or
radiotherapy - is this correct?
Are there any other treatments available rather than chemotherapy or
radiotherapy? E.g. a drug trial?
Objectives I would
so that I can understand them.
the problem coming back.
ther than chemotherapy if
possible.
People
Consultant to explain things to me.
Evaluation What are the results from surgery?
What happens next?
What can I do to make myself feel better now?
If I have to have treatment what can I do to stop myself feeling ill during
treatment?
Would it be ok to go out and walk about (get back to normal)?
Decisions I am happy to take the recommended treatment.




            
                
                   
               
               
            
          
                  
    
                   
                  
               
 
                  
  
             
         
 
        
      
                
       
                
        
 
           
                
          
              
         
         
                
              
                
 
   
  
  
                  
   
                    
     
                  
 
                  
              
                 
         
               
Appendix 5: An example of a consultation summary from an initial consultation
Situation You had a generalised seizure on the night that you came into hospital.
The mass in your head was putting a lot of pressure on your brain, causing a lot of
swelling, so your surgery had to be done in a hurry to relieve the pressure.
took away as much of the tumour as he could during surgery, so
that your brain is in a better position . We cannot take the
rest of the tumour out as it may paralyse you.
The swelling is due to a little bit of fluid which has collected around the brain, this
will go in time.
You will be ok to lie on the side where your scar is as it looks nicely healed.
The numbness in your head takes a long time to heal as the nerves have been cut
during surgery. The nerves now need to join up again. They can several months to
heal.
Your results tell us that you have a brain tumour. It is malignant which means it is
fast growing.
The treatment will not get rid of this tumour. It is terminal.
Choices The treatments that are recommended to you are:
Radiotherapy
Radiotherapy treatment is strongly advised to you.
This is x-ray treatment.
We use 3-4 x-ray beams to concentrate the x ray beams onto the affected tissue.
You will not feel anything during treatment.
You will have radiotherapy treatment once a day for 6 weeks at the hospital. Each
treatment lasts for 15 minutes every day.
Chemotherapy
We can also give chemotherapy treatment, in tablet form.
You need to take the chemotherapy tablets at the same time as the radiotherapy.
You will take the tablets everyday in the morning.
For someone of your age, it is recommended that you have both chemotherapy and
radiotherapy treatment, as this is the most effective combination.
Objectives To give you the best treatment available.
Treatment can make you live longer and give you good quality time to do things
that you want to do with your friends and family. Without treatment, your survival
could be really quite short (a few months, compared to a few years if you have
treatment).
People
Your GP is a good source of support try and keep in touch with them regularly.
Evaluation Radiotherapy
We will need to make a mask for you. It is made of plastic, which we warm up and
it then goes floppy.
For treatment, you lie on a couch and you are then clipped down using the mask. It
We will do a CT scan and MRI scan. These will be put together (overlapped) onto a
computer. They will then draw around the hole left behind after surgery and any
bits that are lighting up and a rim of about 2 cm around where the tumour was
taken out, as there could be cells left behind.














    
               
 
         
                
                  
     
 
                
       
            
                   
 
      
            
             
        
  
                 
      
Decisions
from the operation.
Radiotherapy has to be planned really carefully which is why it takes some time,
.
Most people cope with radiotherapy really well.
However, it will cause tiredness, and it can make people quite headachy and sicky
You will lose some of your hair, mainly towards the front of the head. It might not
grow back quite as thickly.
Chemotherapy
Chemotherapy can make you have sickness, but we will give you anti sickness pills.
It can affect your immunity, so
can get de have a source of infection during the treatment.
You can go out and walk around as long as you take someone the first time you go
out.
Decisions Made During the Consultation:
for you to have radiotherapy. You will be asked to sign
a consent form for radiotherapy when you come up to have your scans
You have decided to have chemotherapy too.
Next Steps
Planning for radiotherapy treatment CT scan and MRI scan. You will be sent a letter in






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































       
   
    
   
   




                                            
                  
           
         
                   
                   
                     
                   
                  
       
              














Tel: 0131 537 1247
Dear ,
We are currently running a study at the (name of centre) in the Colorectal Clinic. You are receiving
this information because you have an upcoming appointment for Thursday.
The study is called the Patient Information Navigation study.
Included in this envelope is an information sheet, take some time to read over this and decide if the
study is something that you think would like to take part in. Also enclosed is a consent form and
questionnaire, you do not need to fill these in at the moment but if you think you would like to take
part in the study please look over them. A researcher will call you to answer any of your questions
and guide you through the process. Taking part is voluntary and it will not affect your healthcare if
you do not wish to participate.
Please feel free to get in touch sooner if you have any questions.










































       
 




     
 
 
































        
Appendix 13: Decision Regret Scale






       
               
  
 
           
           
           
 
             
 
 













       
        
       
          
       
            
        
          
 
 




Navigation service evaluation (not on control questionnaire)
Please indicate how satisfied you are with the question-listing support you received (check one box
only please).
0 1 2 3 4 5 6 7 8 9 10
Lowest Highest



























1. Help you identify the questions you
want to ask?
2. Help you organise your own thoughts
about your cancer health care?
3. Help you think about how involved
you want to be in treatment choices?
4. Prepare you to talk to your doctor
about what matters to you?



























           
 
          
               
             
             
            
     
 
              
              
              
                
                   
               
     
 
           
               







Appendix 16: Intention To Treat analysis of primary outcome measure
Primary Outcome Measure: Decision Self Efficacy (DSE) Intention to Treat
There was a non-significant main effect of the trial arm F(1,132)=2.46, p=0.119; the rating of
DSE did not differ significantly between groups. Bonferroni corrected post hoc test showed
that the intervention group (M87.49, C195% 84.62-90.36) overall scored higher on the DSE
(Mdiff =3.20, C195% -0.83-7.23) when compared to the control group (M84.29, C195%
81.46-87.12), although not significantly.
A significant main effect of time was found on the rating of DSE, F(1.99,369)=9.43,
p=<0.001. Without acknowledging the trial arm participants were part of, the DSE was rated
different according to the time it was completed. The Bonferroni corrected post hoc test
showed that rating of DSE at baseline (T1) was significantly lower than the time points T3
(Mdiff =-4.86, C195% -8.24 - -1.48, p=0.001), T4 (Mdiff =-4.97, C195% -8.52- -1.42,
p=0.002), T5 (Mdiff =-4.40, C195% -8.19 - -0.60, p=0.014). All other changes in DSE score
across time were non-significant (p>0.05).
However, a non-significant Time x Trial arm interaction was found F(1.99,369)=0.89,
p=0.914, the rating of DSE over time did not differ between intervention and control groups,




             
      
        
      
    
    
     
    
    
     
    
    
     
    




          
 
 
Table 1. Mean scores of the Decision Self-Efficacy scale for all responders over time
T1-T5, per trial arm.
Time Trial Arm n Mean Std. Deviation
Baseline T1 Intervention 66 84.02 13.08
Control 68 80.65 19.81
Total 132
T3 Intervention 66 88.46 11.32
Control 68 85.92 12.71
Total 132
T4 Intervention 66 88.94 12.02
Control 68 85.66 14.91
Total 132
T5 Intervention 66 88.53 11.42
Control 68 84.93 15.51
Total 132




      
        
 
      




            
         
 
           
             
              
     
  
          
 
                
                
   
 














Appendix 17 HGG invitation sheet
Title of project: Patient Information Navigation Study
Dear [ 
Office address and telephone number
Date
]
Thank you for your interest in the Patient Information Navigation Study which
is currently being trialled at the [Name of centre].
The study is evaluating a new service called Patient Information Navigation
which is designed to help you prepare for your consultation and provide you
with personalised information about your health care, in the form of a CD and
written summary of consultations.
I have enclosed an information sheet about the study.
A member of the study team will be contacting you in the near future to answer
any questions you may have, and if you are happy to take part, take you through
the consent process.







     
 
        
 
   
      
     
             
             
 
              
           
      
 
               
            
         
 
               
     
 
               
           
              
    
 
          
               
               
               
  
 
           
 
     
                              
 
     
        
           
Appendix 18 HGG Consent form
Title of project: Patient Information Navigation Study
Participant CONSENT FORM
Principal Investigator: Dr. Belinda Hacking
Please initial boxes
1. I confirm that I have read and understand the information sheet (Version
3) for the above study and have had the opportunity to ask questions.
2. I understand that my participation is voluntary and that I am free to
withdraw at any time, without giving any reason, without my medical
care or legal rights being affected.
3. I agree that the written information I provide can be stored with my name
removed from all records and used in the presentation of the research.
My data will not be used to identify me
4. I agree to take part in three interviews throughout the study to talk about
my experience of navigation.
5. I agree that the audio information I provide in the interview can be audio
taped, transcribed, stored with my name removed from all records and
my words used in the presentation of the research. My words will not be
used to identify me.
6. I agree to take part in the study
7. I agree for my GP to be informed about my participation in this study
AND for a consultation summary to be sent to my GP (you do not have
to initial this box, if you would prefer NOT to have your GP informed of
your participation).
8. I would like to be informed of the results
________________ _________ __________________
Name of Patient Date Signature
________________ _________ __________________
Principal Investigator Date Signature




      
       
  
   
             





                   
           
       
 
              
              
        
 
           
 
                
                      
                  
                
      
 
       
 
                  
              
              
               
              
                 
    
 
                  
                
        
 
Appendix 19 HGG Information Sheet
An Evaluation of a Patient Information Navigation
Service (neuro)
Patient Information Sheet
If you would like further information about this study, or would like to




We are inviting you to take part in a research study. We are studying whether a new approach to
helping patients discuss their concerns with their doctor is helpful.
What is the Purpose of this Study?
This study is trailing Navigation, a way of supporting patients to gather and remembering
information about their health care. Navigation has been successful in the USA. Results of
the trial will help to inform practice.
Why have I been asked to take part in this study?
You have been asked to participate in this study because you are attending an appointment to
discuss your surgery. It is up to you whether you take part or not. If you decide to take part,
you will be asked to sign a consent form. If you decide to participate now but change your
mind later, you can withdraw without giving a reason. Your decision to take part does not
affect your treatment in any way.
What will happen if I take part?
If you decide to take part and agree to the statements on the consent form you will be
will help you think about your questions for your upcoming appointment. This can happen
for up to 4 different appointments where relevant to your healthcare. With your permission,
the navigator will accompany you to your consultation and will note the answers to your
questions, as well as other important information. You will be provided with this summary
and a digital audio recording of the consultation (CD). The summary will also be sent to your
GP, with your consent.
Throughout the study you will also be asked to take part in 3 interviews to talk about your
experiences in consultations. This will be at 3 different time points over the next 6 months.




                   
           
 
      
 
                  
               
        
 
          
 
                 
                   
         
 
                
                
 
             
 
                   
               
                     
                   
    
 
         
 
                  
           
              
  
 
       
 
                
                 
             
   
 
             
    
 




It is your choice if you would like a relative or someone who is involved in your care outside
of the health profession to be involved in this process.
What do I have to do?
The meeting with the navigator will take 30 minutes; this can be done by phone or at the
hospital. The interviews can also be done over the phone and approximately 45 minutes, or
however long you want to talk for.
What are the potential benefits and disadvantages of taking part?
This study could help us to improve the quality of our services for future patients. By taking
part, you will also be able to have a summary of your own meeting with your doctor as well
as a digital audio recording of the meeting.
If any part of the Navigation or interviews make you feel uncomfortable or upset, you are
free to decline to answer any questions, or to discontinue your participation at any time.
What will happen if I don't want to carry on with the evaluation?
If you do not want to continue with the evaluation part way through, we may still use the data
that you have given. However, you are free to withdraw from the evaluation altogether and
we can remove all your data from the evaluation if you ask. If you choose to do this you do
not have to give a reason for your choice. Your treatment will not be affected in any way by
withdrawing from the study.
What will happen to the results of the evaluation?
All participants will be offered a short newsletter at the end of the study. The results of the
study will be disseminated in peer reviewed journals, professional publications and
presentations made at relevant conferences. Results will be reported in such a way that
preserves anonymity.
Who is organising and funding the evaluation?
The evaluation of this study is being conducted by a team based at Coventry University. If
you have any concerns or questions about this evaluation or the way it has been carried out,
you should contact the principal researchers (Sarah Shepherd (tel number) or Dr. Belinda
Hacking (tel number).
For further information about the study or if would like to volunteer to
take part, please contact:




        
 
 
        
 




      
 
    
 
             
       
 
            
         
          
           
  
 
            




       





Appendix 20 The clinician consent form
Title of project: Patient Information Navigation Study
Clinicians CONSENT FORM
Principal Investigator: Dr. Belinda Hacking
Consenting statements Please tick
boxes
1. I agree to take part in an interview to talk about my
experiences of the Navigation intervention.
2. I agree that the audio information I provide in the interview
can be audio taped, transcribed, stored with my name
removed from all records and my words used in the
presentation of the research. My words will not be used to
identify me.
3. I understand my participation is voluntary and I am free to
withdraw at any time.




       
    
          
                  
               
              
               
         
          
 
          
   
            
             
      
            
        
                   
        
               
                  
           
                   
           
  
         
             
               
               
Appendix 21 The interview schedules
Interview schedule with patients
Researcher introduces self and aims of the interview:
· To ascertain in-depth understanding of patient perspective of consultation
· To ascertain patient satisfaction with consultation
Informs the patient the interview will take approximately 30 minutes, or however long they
have something to talk about. The questions below are not intended to be spoken verbatim
but provide examples of questions and topics to cover.
Ask the patients for permission to audio-record the interview. Begins;
your surgery was complete? ecent and work back, or whichever
way you prefer 
1. Did you prepare for your consultations?
1. In what way? Did you receive any help?
2.
3. If you prepared, did this help/how there
would have been any benefit to preparing?
4. What did you expect your role to be as a patient in consultations?
2. With regards
1. Where would you say your main source of information was?
2. How did you find this source of information for telling you everything you
needed/wanted to know? Did you feel like everything was covered?
3. What kind of information did you feel was important? How easy was it to
gather this information? Was there any information you would have liked
more of?
3. Thinking about your consultations
1. How satisfied where you with your consultations? Why?
2. How did you find gathering information in these consultations? Why?




            
  
                  
                  
       
                       
 
                    
            
       
       
        
                                                      
          
         
        
  
          
              
       
        
                
           
        
             
              
          
                
             
 
              
 
 
4. Did you feel the consultant understood you and your situation as an
individual? Why?
5. Do you feel the consultant engaged with you and asked you questions?
6. What do you feel the role is for a patient within their consultations?
4. Decision Making
1. Do you prefer to make the choices, the dr. to make the choices or for it to be
shared?
2. Did you feel you had a choice with regards to treatment when you were in
your consultations? Please explain this. Did you want this choice? Did you
feel informed enough to make this choice?
5. Your journey
1. Looking back
i. Treatment how informed have you felt?
ii. were you happy with the treatment choices you made?
iii. Have you felt well enough informed about self-management
issues such as diet, exercise, stress, alternative and
complementary therapies?
How has this impacted the way you have coped?
6. Is there anything else you would like to add to the interview?
Navigation Materials intervention patients only
a. How did you find Navigation?
b. How was having the CD? Summary? did you use them? when / why / how
1. Did you ever share this CD / summary with anyone?
2. Have you used them with your GP?
c. Are there aspects of Navigation that have been more helpful than others?
d. How did you find having another person in the consultation with you?
e. Would you change the service in any way? How?
f. How did you feel about speaking with a Navigator to create your list of questions
g. Did you feel the consultant you had used your question list appropriately?





   
   
      
            
            
           
          
                   
            
              
 
             
               
   
          
              
    
             
          
    
 
  
           
       
             
           
           
          
             
            
           
               
      
                 
 
           




1. Clinicians understanding of the intervention
- What do you understand to be the aim of the intervention?
- What do you understand to be the role of the navigator?
- Do you think the intervention met these aims? How why
2. Clinicians use of the intervention materials explain materials CP/CS/CR
- How useful did you find the consultation plan? Did you read it? If yes, when? If no,
why? Did you implement the plan during the consultation? Why/why not? How?
- Do you see a benefit for recording consultations? For patients? For clinicians? Yes?
Why/how
- Did you have an opportunity to read the consultation summary after the
meeting? Were you satisfied that it was an accurate reflection of what was said
during the consultation?
3. The impact of the intervention on the consultation PATIENT
- Looking back how do you think the consultations with patients who were receiving
the intervention went?
- How do consultations with patients who have not received this intervention compare




b. Was there a difference in how intervention patients engaged your
consultations compared to usual care consultations?
c. Was there a difference in understanding the information which you felt was
important for them to remember compared to usual care consultations?
d. Did you the intervention impacted on treatment decision making?
4. The impact of the intervention on the consultation PRACTICAL
- In general, were you happy with the way intervention consultations went? Why/why
not? What do you think the benefits of this intervention are?
- Did the presence of the navigator affect the consultation?
- How did you feel about the consultation being recorded? Have you requested a copy
of the recordings at any point?
- Do you think the intervention could have been improved in any way? If yes, how?
Why?
- Do you feel the time taken for consultation was affected?




             
  
            
 
    
                
  
              
       
 





















- Has the intervention impacted upon how you conduct your consultations outside of
the study?
- Has the study highlighted anything for you in terms of practice?
6. Relevance within practice
- Do you feel the intervention has a place in the normal care pathway for cancer
patients?
- Do you feel that there are barriers to supporting patients in making treatment
decisions? How might these be overcome?
Thank for participation and time in interview and intervention.
336
Appendix 23 An example from one N 
indexing stage of framework analysis.  
Colour key: Green =preparation for consultation, Blue= Recall and understanding, Yellow= 
Information exchange, Purple = decision making 
P: Yes, I had been, Mrs X, she was a navigator, she came to the consultant with me and she was good 
, so you know when things like that 
DVDs and everything for me, so yes that did help, prepared before I went in any questions I wanted to 
ask him, if I forgot she was reminding me, sort of thing, so yeh, it was really useful to have a 
navigator I must admit.  
I: So, do you feel...how do you feel that helped you that...creating the questions yourself? 
P: It did help and also she could prompt me as well cause she was thinking about saying the things 
 you know, so yes it was helpful all round. 
 
 
I: And, so during the consultation, you used the question list? 
P: Yes, I did, I have yeh. 
I: So, was that just to refer back to? 
P: It was, yeh,  and I think in the consultancy also got a copy beforehand. They all requested 
 
I: So he made use of it as well? 
P: Yes, he did. It worked all round for everybody.  
I: So, did you feel you got more out of it by the two of you having the same information in front 
of you? 
P: I think so, yes I think you get more out of it cause I see 
 
 
P: That was fine, no problem at all. She was very discreet an
 
I: How did you feel about having it recorded as well, when you were at the consultation? 
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